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!Zusammenfassung 
Im Laufe der letzten zehn Jahre hat sich DNA durch die Selbstorganisation komplementärer 
Sequenz als sehr vielseitiges Baumaterial auf der Nanometer Skala bewährt. Die Struktur der 
DNA erlaubt die Konstruktion von beliebig geformten, nanometergroßen Objekten und die 
Modifizierung mit einer Vielzahl an (Bio-)Molekülen mit Nanometer Genauigkeit, definierter 
Orientierung und kontrollierbarer Stöchiometrie. In dieser Dissertation wurden DNA-basierte 
Nanostrukturen für die Nachahmung membranbedingter biologischer Ereignisse und 
zielgerichteter Transportapplikationen vorgestellt. 
Im ersten Teil der Arbeit wurden das Potenzial zur gezielten Verabreichung und die Stabilität 
der entworfenen DNA-Nanostrukturen in zellulärer Umgebung untersucht. Zu diesem Zweck 
wurden DNA-Nanoröhren durch ein einzelsträngiges DNA-Kachel-Anordnungs hergestellt 
und mit Folat-Molekülen und siRNA funktionalisiert um spezifisch Gene in Krebszellen, die 
den Folatrezeptor überexprimieren abzuschalten. In dieser Studie beobachteten wir, dass 
DNA-Nanoröhrchen zum Endosom geleitet wurden, aber nicht zum Cytosol der Krebszellen. 
Übereinstimmend mit dieser Beobachtung, konnte kein Abschalten der Zielgene detektiert 
werden. Darüber hinaus stießen wir auf einige Herausforderungen hinsichtlich der Stabilität 
der Strukturen, die bei der Anwendung in vivo berücksichtigt werden müssen.  
Im zweiten Teil wurde die hierarchische Anordnung von membrangebundenen DNA-
Origami-Strukturen untersucht. Dazu wurden dreischichtige DNA-Origami-Blockstrukturen 
über Cholesterin-Moleküle an die Lipiddoppelschichten gebunden, die frei auf den 
Membranen diffundierten. Eindimensionale Polymere und zweidimensionale Gitter wurden 
durch programmierten Selbstorganisation der Strukturen auf den Membranen unter 
Verwendung verschiedener Sätze von Verbindungsoligonukleotiden gebildet. Weiterhin 
wurden DNA-Origami-Triskelione zu sechseckigen Gittern zusammengebaut, die der Bildung 
von Clathrin- Vesikeln während der Endozytose glichen. Darüber hinaus führt die 
Gitterbildung zu einer Verformung der Lipidmembranen, die auf das Potential des Systems 
für eine kontrollierbare Formgebung der Membranen aufzeigt. Die Studie zeigte, dass  
selbstorganisierte DNA-Origami-Strukturen die hierarchische Assemblierung von 
Multiproteinkomplexen auf zytoplasmatischen Membranen nachahmen könnte.  
Im letzten Teil wurde die Verwendung von DNA-Nanoröhrchen untersucht, eine 
Immunreaktion in vivo zu induzieren oder zu unterdrücken. In der ersten Studie wurden 
DNA-Nanoröhren mit unmethylierten Cytosin-Phosphat-Guanin-Oligodesoxynukleotiden 
(CpG-ODNs) funktionalisiert und in den Skelettmuskel anästhesierter Mäuse injiziert, um 
eine Immunstimulation gezielt herbeizuführen. Wir beobachteten, dass DNA-Nanoröhren 
durch gewebsständige Makrophagen internalisiert wurden und in den Endosomen 
akkumulierten. Nur Mikroinjektion von CpG-funktionalisierten DNA-Nanoröhren, aber nicht 
undekorierte Nanoröhren oder CpG-ODNs induzierte eine signifikante Rekrutierung von 
Leukozyten zur Injektionsstelle sowie eine Aktivierung des NF-κB-Signalweges. In der 
zweiten Studie wurden DNA-Nanoröhren mit dem anti-inflammatorischem Wirkstoff 
Dexamethason über i-Motivsequenz funktionalisiert. Wir haben gezeigt, dass die Strukturen 
die Leukozyten-Rekrutierung  in das entzündete Gewebe aufgrund der i-Motiv-abhängigen 
Freisetzung von Dexamethason hemmen.!
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Abstract 
Over the last decade, DNA has proven to be an extremely versatile building material through 
the self-assembly of complementary oligonucleotides. The structure of DNA allows the 
construction of arbitrarily shaped objects in nanoscale which can be modified with a variety 
of (bio)molecules with nanometer precision, defined orientation and fully controlled 
stoichiometry. In this dissertation, DNA-based nanostructures were demonstrated for 
mimicking membrane-related biological events and targeted delivery applications.     
In the first part of the thesis, targeted delivery and the stability of the designed DNA 
nanostructures in the cellular environment were investigated. For this purpose, DNA 
nanotubes were produced via the single-stranded tile assembly method and functionalized 
with folate molecules and siRNA to specifically silence genes in folate receptor over-
expressing cancer cells. In this study, we observed that DNA nanotubes reached to the 
endosome but not to the cytosol of the cancer cells.! Consistent with this observation, no 
silencing of the targeted gene could be detected. Furthermore, we encountered several 
challenges concerning the stability of the structures that have to be taken into account during 
in vivo delivery applications. 
In the second part, the hierarchical assembly of membrane-bound DNA origami structures 
was investigated. For this, three-layer DNA origami block structures were attached to the lipid 
bilayers via cholesterol molecules and diffused freely on the membranes. One-dimensional 
polymers and two-dimensional lattices were formed upon the programmed self-assembly of 
the structures on the membranes using different sets of connector oligonucleotides. DNA 
origami triskelions further assembled into hexagonal lattices that resembled the formation of 
clathrin-coated pits during endocytosis. Moreover, the lattice formation leads to deformation 
of the lipid membranes that indicates the potential of the system towards controllable 
sculpting of the membranes. The study demonstrated that self-assembled DNA origami 
structures could mimic the hierarchical assembly of multi-protein complexes on cytoplasmic 
membranes. 
In the last part, we investigated the use of DNA nanotubes to induce or suppress the immune 
reactions in vivo. In the first study, DNA nanotubes were functionalized with unmethylated 
cytosine-phsophate-guanine oligodeoxynucleotides (CpG ODNs) and microinjected into the 
skeletal muscle of anesthetized mice to induce immune stimulation. We observed that DNA 
nanotubes were internalized by tissue-resident macrophages and accumulated in their 
endosomes. Only microinjection of CpG functionalized DNA nanotubes but not of plain 
nanotubes or unfolded CpG ODNs induced the significant recruitment of leukocytes to the 
injection site as well as the activation of the NF-κB pathway. In the second study, DNA 
nanotubes were functionalized with the anti-inflammatory drug dexamethasone via an i-motif 
sequence. We demonstrated that these structures inhibited the leukocyte recruitment into the 
inflammed tissue due to the i-motif dependent release of dexamethasone.!
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1. Introduction to DNA Nanotechnology 
1.1 DNA Structure and Properties 
! Deoxyribonucleic acid (DNA) is the molecule that carries the genetic information of 
all living organisms and many viruses. DNA was first isolated by Friedrich Miescher in 1869 
and its molecular structure was discovered by James Watson and Francis Crick in 1953 where 
the model building is based on the X-ray data acquired by Rosalind Franklin and Maurice 
Wilkins [1-4]. The discovery is awarded with the Nobel Prize in Physiology or Medicine in 
1962. DNA structure is a long polymer made from repeating units of nucleotides. Two 
complementary chains hybridize to form right-handed DNA double helical structure where 
the distance between following nucleotides is 0.34 nm and a helical pitch of 10.5 nucleotides 
[5]. (Figure 1.1A) The diameter of a double helix is 2 nm. DNA exists in several 
conformations including right-handed B-DNA, A-DNA and left-handed Z-DNA depend on 
the conditions such as base sequence, type and concentration of metal ions and direction of 
supercoiling [6]. B-DNA is the most common one found under cell conditions.  A DNA 
nucleotide is composed of one of four bases including Adenine (A), Thymine (T), Guanine 
(G) and Cytosine (C) which are connected to a sugar group, 2-deoxyribose, and a phosphate 
group. The sugars are joined together by phosphate groups that form phosphodiester bonds 
between the third and fifth carbon atoms of adjacent sugar rings. These asymmetric bonds 
lead to a chemical polarity and give a direction to each polynucleotide strand with a terminal 
phosphate group at the 5' end and a terminal hydroxyl group at the 3' end of the DNA strand. 
DNA strands form the double helix structure through the hydrogen bonds between nucleotide 
pairs known as Watson-Crick base pair which are adenine-thymine and guanine-cytosine [7-
9]. (Figure 1.1B) Hydrogen bonds between base pairs and stacking interaction between 
aromatic nucleobases drive the formation of double helix structure. The asymmetric 
arrangement of DNA strands leads the formation of two grooves with different sizes as a 
result of the non-diametrical glycosilic bonds of the base pairs: a major groove with a width 
of 2.2 nm and a minor groove with a width of 1.2 nm. 
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Figure 1.1: DNA double helix structure. A) Schematic illustration of DNA double helix. 
Reprinted with permission from [7, 9]. Copyright 2004 Elsevier. B) Watson-Crick base pairs 
showing the two hydrogen bonds between Adenine and Thymine, and three hydrogen bonds 
between Guanine and Cytosine. Reprinted with the permission from ref. [8, 9]. Copyright 
2004 Elsevier. 
The four nucleobases are classified into two types according to the number of aromatic 
rings: purines are A and G, which are formed by the fusion of five- and six-membered 
heterocyclic rings and pyrimidines are, C and T, which only have six-membered rings. The 
Watson-Crick base pairs have different number of hydrogen bonds between purines and 
pyrimidines, in which adenine binds to thymine with two hydrogen bonds, and cytosine binds 
to guanine with three hydrogen bonds. This makes a DNA with high GC content more stable 
than a DNA with low GC content [10]. Since the base pairing is based on hydrogen bonding 
(5-30 kJ/mole binding energy) that is relatively weak compared to covalent bonding (100 
kJ/mole binding energy), the strands could be separated and rejoined by high temperature and 
mechanical forces.  The stability of DNA is depend on the GC content, sequence (base 
stacking) and length which is measured by the melting temperature; the temperature at which 
50% of the double stranded DNA molecules are converted to single stranded DNA molecules 
[11]. The melting temperature is dependent on ionic strength and the concentration of DNA. 
In addition to Watson-Crick base pairs, DNA sequences that are rich in guanine or cytosine 
also form alternative tertiary structures such as G-quadruplex or i-motif via different 
hydrogen bonding mechanisms where the tertiary structures are stabilized by the presence of 
cations.                
1.2 DNA Nanotechnology 
DNA Nanotechnology was first introduced by Ned Seeman´s groundbreaking vision 
of self-assembled six-arm branched junctions into a three dimensional lattices with the 
purpose of accurately positioning proteins for crystallography studies during early eighties 
[12, 13]. (Figure 1.2A) The field is based on using nucleic acids as non-biological engineering 
materials rather than as genetic information carriers. In 1991, Seeman experimentally 
constructed the first DNA object which is topologically equivalent to a cube [13, 14]. (Figure 
1.2B) Since then the field rapidly evolved into an interdisciplinary field crossing with physics, 
chemistry, biology, materials science and computer science. Starting with the Seeman´s cube 
distinct DNA nanostructures have been developed such as polyhedra, nanotubes, 1D and 2D 
periodic lattices and 3D complex arbitrary shapes as well as molecular machines and DNA 
computers.  
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Figure 1.2: Origin of DNA nanotechnology. A) Scaffolding biological macromolecules using 
DNA crystals. Macromolecules are oriented parallel to each other for the structure 
determination by X-ray crystallography. B) Self-assembled DNA cube using six single 
stranded DNA strands first introduced by Seeman in 1991. Reprinted by permission from 
Macmillan Publishers Ltd: Nature ref. [13], copyright 2003.    
1.2.1 DNA as Building Material 
DNA is a unique building block for nanotechnology applications for many reasons. 
First of all, DNA has a nanometer scale structural geometry, a 2 nm diameter and 3.4 nm of 
helical pitch as previously mentioned. Second, DNA has programmable and predictable intra- 
and intermolecular interactions, adenine and thymine (A-T) and guanine and cytosine (G-C) 
base pairs which hybridization energies could be estimated. Single stranded overhangs and 
sticky ends are programmable to connect double helical domains. Third, DNA has combined 
stiffness and flexibility. The persistence length of a double-stranded DNA is 53 nm which is 
stiff enough to build constructs in the nanometer range [15]. Moreover, the flexible angles at a 
bend in any branched structure tolerate the small strains and allow folding of arbitrary 
designs. Lastly, DNA can be synthesized using phosphoramidite chemistry and modified by 
enzymes that allow labeling, ligation or cleavage.  
In order to create stable DNA constructs in multiple dimensions, programmed 
branched DNA molecules must self-assemble into lattices and compact structures. The 
Holliday junction allows the formation of such lattices and structures via hybridization. 
Named after the molecular biologist Robin Holliday, in 1964, the Holliday junction is a 
branched DNA molecule contains four double-stranded arms joined together [16].  The 
Holliday Junction occurs in the process of genetic recombination as well as double-strand 
break repair mechanisms. During this process, since the junctions have homologous 
sequences the branch point slides over the branched DNA molecule in which the process 
called as “branch migration” [17]. Synthetic DNA nanotechnology takes the advantage of 
using asymmetric sequences to avoid branch migration and immobile Holliday junctions 
allow the formation of specific designed geometries with high degree of structural rigidity. 
Moreover, the oligonucleotide synthesis allows the formation of multi-armed junctions such 
as three, five or six armed junctions [18, 19].   
1.2.2 DNA Tile-Based Assembly 
DNA tile assembly is based on the idea of combining sticky-end cohesion and 
branched DNA junctions to build geometric objects and periodic 2D or 3D lattices which 
could be seen for the first time in Seeman´s cube design. The same group later developed 
double crossover (DX) molecule by joining two double helices through strand exchange 
which is two times stiffer than linear double stranded DNA [20-22]. Then, triple crossover 
(TX) molecules were developed where single DNA strand connects three parallel helices in 
one plane [23]. These molecules self-assembled into periodic 2D lattices using proper sticky 
ends [24-26]. Like these molecules, four-helix, eight-helix and twelve-helix tiles were later 
shown that can self-assemble into 2D arrays and nanotubes [27, 28]. Moreover, Mao group 
developed the concept of sequence symmetry by utilizing several tile designs such as cross-
!
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shape, triangular or three-point star motifs which were shown to self-assemble into large 2D 
assemblies with hexagonal or triangular cavities [29]. The sequence symmetry minimized the 
number of unique single DNA strands and avoids any unpredictable distortion which allows 
the formation of larger periodic 2D arrays up to millimeter range. Apart from the periodic 
lattices, aperiodic lattices were also developed via the directed nucleation DNA DX tiles 
along around a long scaffold [30]. A modification of DX tile, DX-J tile motif, which carries 
an extra domain perpendicular to the plane, was used together with DX tile to visualize the 
formation of barcoded tiles into 2D arrays by atomic force microscopy. 
  In the following years, tiles with different sequences of sticky ends were used in 
order to create different geometric shapes such as octahedron, tetrahedron, polyhedra, 
icosahedron and addressable finite-sized arrays [31-35]. In 2008, DNA nanotubes and ribbons 
with programmable circumferences were developed via single stranded tile (SST)-based 
assembly [36]. Monodisperse DNA nanotubes with various circumferences (4,5,6,7,8,10 and 
20 helices) were self-assembled using this technique. The design is based on 42-base long 
single stranded DNA motif which has 10 and 11 base domains complementary to neighboring 
tiles. (Figure 1.3A and Figure 1.4A) This technique was used in associated publications P1 
and P3. In order to form more complex structures the SST approach was extended by using 
362 distinct tiles [37]. Complex 2D shapes and tubes were assembled from a self-assembled 
rectangle that serves as a molecular canvas in which the exclusion of corresponding tiles from 
the canvas allows the formation any desired shape. (Figure 1.3B) Using the similar SST 
approach, based on 32-base long single stranded DNA motifs with 8 base-long domains, 
complex three-dimensional shapes were self-assembled from hundreds of distinctive DNA 
sequences [38]. Moreover, by introducing uniform curvature into the repeating units of single 
stranded tiles DNA nanorings were self-assembled from 4 and 6 helix DNA bundle units [39]. 
 
Figure 1.3: Self-assembly of molecular shapes using single-stranded tiles. A) Single-stranded 
tile motif and design of an SST structure using 42-base long standard tiles (labelled U) and 
21-base long half tiles (labelled L). B) Design of arbitrary two-dimensional shapes from 
molecular canvas. Reprinted by permission from Macmillan Publishers Ltd: Nature ref. [37], 
copyright 2012. 
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1.2.3 DNA Origami 
In 2006, Paul Rothemund revolutionized the field of DNA Nanotechnology with the 
breakthrough technique called DNA origami [40]. Named after Japanese art of paper folding, 
the technique is based on the folding of the long single stranded DNA (derived from the 
genomic DNA of M13mp18) using over 200 complementary short oligonucleotide staple 
strands. (Figure 1.4B) Using this technique, Rothemund showed that self assembly of single 
stranded DNA with short single stranded oligonucleotides in a single pot thermal annealing 
reaction resulted in arbitrary shaped 2D DNA origami structures with 100 nm diameter and 6 
nm spatial resolution such as squares, stars, triangles and smiley faces. (Figure 1.5A) He also 
further showed the structures can be programmed to form complex images and words on the 
structures using hairpins at determined positions and form larger assemblies like periodic 
lattices or a hexamer of triangles using connector sticky ends. The advantage of this technique 
in compare to previously shown DNA tile based assembly technique is avoiding the 
stoichiometry and purification related problems that commonly occurred in the methods 
required many short DNA strands. 
               
Figure 1.4: DNA self-assembly techniques. A) Programmed single-stranded tiles self-
assemble into 6-helix DNA nanotubes during thermal annealing in the presence of Mg2+. B) 
In DNA origami method, staple strands fold the single-stranded scaffold DNA into a 
predesigned shape.  
3 years after the successful demonstration of two dimensional DNA origami 
assemblies, Shih group developed three-dimensional DNA origami objects using honeycomb 
lattice arrangement of DNA double helices [41]. (Figure 1.5B) In this technique each inner 
!
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helix are connected to three neighbor helices by the staple cross-overs at distances of 
multiples of every 7 base pairs which leads to angles 0°, 120° and 240° between the 
crossovers when assuming one full turn (360°) of B-form DNA consists of 10.5 bases. To 
enable more close-packed and flat edge structures, same group developed another way of 
folding of DNA origami structures based on a square lattice arrangement of DNA double 
helices [42]. In compare to honeycomb lattice where 1 full turn of DNA consists of 10.5 bp, 
the square lattice forces 1 full turn at every 10.67 bp (or 3 turns at 32 bp) which leads to 
angles 0°, 90°, 180° and 270° (or staple cross-over at every 8 bp) between the cross-overs of 
adjacent DNA double helices. Both honeycomb and square lattice folding techniques can be 
used and desired DNA origami designs can be produced using caDNAno [43], a graphical-
interface based computer-aided design program developed by Shawn Douglas. DNA origami 
structures can also be intentionally curved or twisted by forcing cross-overs into the structure 
at non-natural intervals via targeted insertions and deletions. Dietz et al. showed that the 
degree of curvature could be controlled with a minimal radius of curvature of 6 nm using this 
technique [44]. In this technique which DNA double helices arranged into honeycomb lattice, 
the deletion of a base pair (cross-overs forced to be < 7 bp) results local stretching and 
overwinding which leads the shortening and a left-handed torque. Conversely, the insertion of 
a base pair (when the full turn is forced to be > 7 bp) results under-winding and compressive 
strain which leads the lengthening and a right-handed torque. Intricate DNA origami 
structures were developed such as wireframe beach balls, gears and spirals with this approach. 
(Figure 1.5C) In addition to these approaches, different design tools were also developed by 
researchers to form distinct DNA origami structures such as DNA boxes, DNA tensegrity and 
DNA gridiron structures [45-47]. (Figure 1.5D-F) Most recently, with the help of computer 
design software DNA scaffold can be routed from the arbitrary polygonal meshes to form any 
kind of DNA origami structures[48]. (Figure 1.5G) 
Figure 1.5: DNA origami structures. Top: Schemes of structures. Bottom: Designed 
structures imaged by AFM (A) and TEM (B-G). The size of the structures: 30-100 nm. A) 
One of the first DNA origami structures developed by Rothemund: a disk with three holes 
which resembles a smiley face. Reprinted by permission from Macmillan Publishers Ltd: 
Nature [40] Copyright 2006. B) 3D DNA origami structure by Shih and co-workers. 
Reprinted by permission from Macmillan Publishers Ltd: Nature [41] Copyright 2009. C) 
Curved structure by Dietz et al. From [44]. Reprinted with permission from AAAS. D) DNA 
origami box with a controllable lid by Andersen et al. Reprinted by permission from 
Macmillan Publishers Ltd: Nature [46] Copyright 2009. E) DNA tensegrity structure by Liedl 
7!
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et al. Reprinted by permission from Macmillan Publishers Ltd: Nature [47] Copyright 2010. 
F) DNA origami sphere by Yan and co-workers. From [45]. Reprinted with permission from 
AAAS. G) 3D mesh of a Stanford bunny rendered in DNA by Högberg and co-workers. 
Reprinted by permission from Macmillan Publishers Ltd: Nature [48] Copyright 2015. 
Today, the realization of the power of programmable DNA self-assembly and the 
ability of DNA functionalization with nanometer precision with a wide range of molecules 
allow the use of DNA nanotechnology by researchers in many diverse research areas 
including plasmonics, nanoelectronics, biophysics and biomedicine. DNA structures often 
function as template to position flurophores [49], gold nanoparticles [50], quantum dots [51], 
polymers [52], proteins and other biomolecules [53]. During the course of my work, I focused 
on using DNA nanostructures which are functionalized with a variety of biomolecules for 
mimicking membrane related biological events and cellular delivery applications.  
The successful delivery of DNA based nanostructures is composed of three main steps 
that have to be completed. First, the designed structures should maintain the structural and 
functional integrity in the biological fluid. Second, the functionalized structures should 
specifically target and interact with the cellular membrane which is a selective barrier that 
separates cell from the outer environment. Third, the structures should reach the cytoplasm to 
perform the desired action such as delivery of the payload. In the light of this sequence of 
events, three different projects were presented in this dissertation as three parts. In the first 
part, we demonstrated the importance of structural integrity of the designed structures for the 
functionality and targeted delivery. In the second part of the thesis, we successfully 
demonstrated how the interaction of DNA nanostructures with lipid membranes could be 
achieved to form hierarchical structures resembling the formation of clathrin coated pits 
during endocytosis. The technique showed here could be further implemented on the 
biological membranes. In the last part, we successfully demonstrated the delivery of CpG 
oligonucleotides and drug molecules in vivo using DNA nanostructures.   
 
Figure 1.6: Towards the delivery of DNA-based nanostructures. 1) The stability of DNA 
nanostructures in the biological fluid. 2) Membrane-assisted polymerization of DNA origami 
structures after cholesterol-mediated binding and lateral diffusion. 3) Cellular uptake of CpG 
decorated DNA nanotubes and subsequent expression of pro-inflammatory genes. 
!
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2 DNA-based Nanostructures for Cellular Delivery 
2.1 DNA Carrier Systems for Cellular Delivery 
! DNA structure allows the precise control of the shape of the building material upon 
self-assembly and spatial arrangement of any kind of molecule (e.g. drugs, small molecules, 
antibodies, proteins) on the material which is not possible for other common delivery systems 
such as liposomes, polymers and inorganic materials. It has also potential for drug loading in 
high density and tunable release properties with environmental changes (e.g. pH) based on the 
sequence programmability. Since DNA is constitutively found inside the cells it is also 
inherently biocompatible material. Therefore, DNA-based nanostructures offer a great 
potential as delivery agents.!! 
 Up to now, DNA nanostructures have been functionalized with wide range of 
bioactive molecules such as proteins, antibodies, anticancer drugs, synthetic oligonucleotides 
or small-interfering RNAs to elicit different therapeutic effects in vivo. To enable the desired 
therapeutic effects of DNA nanostructures, most of the time, they need to overcome the first 
biological barrier which is lipophilic membrane to gain access to cytosol and then reach the 
targeted cellular compartments including nucleus and mitochondria. Due to the anionic nature 
nucleic acid molecules are often impermeable to cellular membranes. Several studies reported 
that gene delivery vectors such as plasmids or antisense oligonucleotides are considered as 
using different cell entry mechanisms including receptor mediated endocytosis, pinocytosis or 
through interaction of cell membrane nucleic acid channels [54, 55]. One common approach 
used for the uptake of DNA nanostructures is specifically targeting cell surface receptors 
which lead the receptor mediated endocytosis of the DNA nanostructures that are 
functionalized with proteins, antibodies or small molecules. Mao et al. showed that folate 
conjugated DNA nanotubes are designed to target folate receptors that are overexpressed on 
many cancer cell types can enter ovarian cancer cells [56]. The modification of nanotubes 
with fluorescent dyes showed that the structures or their fragments are internalized upon 
receptor binding. Modi et al. designed two different DNA nanodevices which are respectively 
targeting furin and transferrin receptors on the cell membrane to investigate the pH change of 
the furine retrogate endocytic pathway and the transferring endocytic/recycling pathway 
simultaneously on the same cancer cell line [57]. Most recently, transferrin receptors were 
also targeted using 2D DNA origami nanostructures. The study presented by Okholm et al. 
showed that increasing the number of transferring molecules on the nanostructure correlates 
with the cellular uptake of the structures [58]. DNA nanodevices were also used to target 
specific tissues in vivo. For this reason, the Krishnan group designed pH sensitive DNA 
nanodevice called I-switch which was microinjected to multicellular organism, 
Caenorhabtidis elegans [59]. Upon injection, the nanodevice was targeted to specific 
scavenger cells that present cell-surface anionic ligand-binding receptors and upon 
internalization they showed that the device could map the endosomal maturation.   
DNA based nanostructures were also used to modulate cellular activities externally by 
targeting cell surface receptors, eg. membrane proteins. The interaction between cellular 
membrane receptors and DNA nanostructures could be established via functionalizing DNA 
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structures with aptamers, antibodies, proteins or carbohydrates.  One striking example of such 
an approach is a logic-gated DNA origami nanorobot developed by Douglas et. al. [60]. 
(Figure 2.1A) The barrel-like nanorobots were loaded with fluorescently labeled antibody 
fragments against human leukocyte antigen (HLA-A/B/C) which are controlled by the 
aptamer encoded logic gates. The structures are only opened if the cell surface markers 
expressed on the cells that are recognized by the aptamers and then presented antibodies are 
available to bind to antigens. Using different aptamer combinations they tested the structures 
on 6 different cell lines which express different profiles of antigens. Furthermore, they 
showed that it is also possible to use nanorobots to selectively bind to a single cell type in a 
mixed cell population.   DNA nanostructures are also capable of spatial orientation of ligands 
to investigate certain cellular pathways. Nanocalipers developed by Shaw et. al. demonstrated 
the well-positioned Ephrin ligands on the structure directed the levels of EphA2 receptor 
activation in human breast cancer cell lines [61]. (Figure 2.1B) Recently, the study presented 
by Sut et al. showed that DNA tile structures can be functionalized with lactose molecules to 
target lectin receptors, which are carbohydrate binding receptors and highly expressed in 
many cancer cell types [62]. They found that the functionalization of DNA structures with 
lactose increased the intracellular uptake efficiency of the structures in compare to 
unmodified tiles and release of doxorubicin, anti-cancer drug, to the cancer cells. 
 
Figure 2.1: DNA-based structures for cellular targeting and delivery. A) A logic-gated DNA 
origami nanorobot to target cells and subsequently displyay molecular payload. From [60]. 
Reprinted with permission from AAAS. B) DNA origami nanocaliper to position two Ephrin 
ligands either 40 nm or 100 nm apart from each other. Reprinted by permission from 
Macmillan Publishers Ltd: Nature Methods [61] Copyright 2014. C) Twisted rod-like DNA 
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origami nanostructure for doxorubicin delivery. Reprinted with permission from [63]. 
Copyright 2012 American Chemical Society.  
DNA nanostructures have been also used as drug delivery vehicles to deliver 
anticancer drugs such as doxorubicin. Doxorubicin is a cytotoxic drug commonly used in 
cancer therapeutics and since doxorubicin intercalates in the major groove of DNA it is an 
optimum delivery agent for DNA based vehicles. Moreover, doxorubicin can able to cross the 
lipid bilayer membranes. Even though DNA nanostructures more likely trapped in the 
endosome, they can release the doxorubicin to cytosol which can then go to nucleus 
eventually. Chang et al. showed for the first time that DNA icosahedra modified with an 
aptamer that recognizing MUC1 receptors were internalized by human breast cancer cells and 
released doxorubicin upon internalization [64]. Using 2D origami triangle and 3D origami 
tubes, Jiang et. al. observed enhanced drug loading and delivery in compare to unfolded 
structures. Drug loaded structures had more cytotoxic effect on drug-resistant cancer cells 
compare to the unloaded structures or free drug controls due to the uptake and slow release in 
lysosome. [65]. Shortly after, the Högberg group developed a twisted DNA origami which 
enables tunable release of doxorubicin. [63]. (Figure 2.1C) Another drug delivery study using 
Daunoribicin also showed efficient uptake and drug release to the drug resistant acute 
promyelocytic leukemica cells [66]. Finally, Zhang et al. studied anti-tumor effect of 
doxorubicin intercalated DNA origami triangles by injecting the structure into the teil vein of 
tumor-bearing mice [67]. They found that doxorubicin loaded DNA origami structures 
possessed enhanced tumor passive targeting and long-lasting accumulation properties at 
tumor region. 
In the following study where the results are presented in associated publication P1, we 
investigated the targeted delivery of DNA nanotubes in several cancer cell lines which over 
express folate receptors. DNA nanotube structures were folded using single-stranded tile 
assembly method which was mentioned in detail in section 1. To target folate receptors, the 
structures were conjugated with folate molecule by using click chemistry. Moreover, DNA 
nanotubes were hybridized with siRNA molecules that are against GFP, a model gene, that 
are stably expressed in the targeted cells.  
2.2 Folate Receptor-Mediated Delivery of siRNA conjugated DNA Nanotubes 
 Folate (folic acid) is a vitamin which has high affinity to folate receptor proteins that 
are highly expressed on the many cancer cell types [68, 69]. Since the folate molecule is 
involved in several metabolic pathways and required for biosynthesis of nucleotides it is 
highly consumed by proliferating cells. The accessibility of the folate receptors is also limited 
on the regular cells due to its location on the apical membrane. Due to its high binding 
affinity, ease of modification, small size and low immunogenicity it becomes a promising 
targeting agent in cancer therapies in recent years [70]. Folate receptors are membrane 
associated proteins attached to the glycosylphosphatidylinositol (GPI) anchor. Folate binding 
to its receptor initiates cellular uptake via receptor-mediated endocytosis upon formation of 
sub-micron size lipid rafts/receptor rich domains which are devoid of caveolae but rich in 
sphingolipid and cholesterol [71].  
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 Small interfering RNA (siRNA) has become one of the most common drug targets in 
cancer therapy since its nobel prize-winning discovery in 2006 by Fire and Mello [72]. This 
20-25 bp RNA duplex is first recognized and cleaved by the enzyme Dicer and then each 
double stranded RNA are spliced into guided and passenger strand. The guided strand is 
incorporated into the RNA-induced silencing complex (RISC) while the passenger strand is 
degraded. Then, RISC complex hybridize the guided strand to the complementary sequence in 
the target messenger RNA (mRNA) which triggers the cleavage and post transcriptional 
silencing of the gene. Using siRNA is highly advantageous in cancer therapies since multiple 
gene targeting is possible simultaneously.  
In this project, we developed 6-helix tile tubes carrying folate molecules for cancer 
cell targeting, siRNA for gene silencing and flourescence molecules for visualization. DNA 
tube assembly, folate conjugation, siRNA duplex formation, and characterization of the 
folded structures are depicted in the Figure 2.2. 
 
Figure 2.2: Design and characterization of 6-helix nanotubes for folate targeted delivery. A) 
6-helix DNA nanotube design carrying folate molecules, Atto488 fluorophores and DNA 
anchors for siRNA conjugation. B) TEM image of DNA nanotubes. (scale bar: 20 nm) C) 
20% native PAGE gel analysis of folate and siRNA conjugation. 
In our experiments, the confocal microscopy results showed that nanotubes are 
delivered to the endosome but not reached to the cytosol to induce gene silencing and the 
uptake of the structures were not elevated by the presence of folate molecule. From these 
experiments, we realized several challenges that need to be considered and improved during 
in vitro and in vivo experiments. 
First of all, DNA nanostructures have tendency to disintegrate in cell culture 
conditions (DMEM medium with ~1 mM Mg2+, 135 mM Na+) since the folding of the DNA 
nanostructures require high salt concentration (~ 20 mM Mg2+). DNA nanotubes used in these 
experiments were stable up to 8 hr in the medium when there is no siRNA on the structure, 
however they degraded in 1 hr when they have siRNA extension. This is mainly because of 
the distorted stacking of the last base before extension and electrostatic repulsion between the 
extended sequence and the structure. Mg2+ depletion-dependent disintegration of several DNA 
origami structures was also observed in similar works [73, 74]. (Figure 2.3A) However, 
13!
!
employing 84-nt long tiles instead of 42-nt long ones enhanced the life-time in the cell 
medium drastically. In addition to using longer DNA strands, Benson et al. showed with their 
DNA polyhedral meshes that designing structures which consist of loosely packed single 
helices, enhances the stability of the structures in biologically relevant buffers such as PBS or 
DMEM at low salt concentrations and elevated temperatures [48]. 
DNAse activity is the other most important drawback for the stability of DNA 
nanostructures in biological applications. Since DNA nanostructures are tightly packed with 
Mg2+ the stability against DNAse are higher in compare to double stranded DNA. Castro et al. 
showed that enzymatic degradation of DNA origami bundles was significantly slower than the 
bare double stranded DNA by incubating structures with T7 endonuclease 1 or DNAse 1 [75]. 
In our work, we have also observed the cleavage of fluorescent dye molecules from the 
structure when the dye modified oligonucleotides were hybridized to the extended handles 
from the structure. The cleaved dyes were located in the cytoplasm near the mitochondria 
when the structures were incubated in the serum (e.g. FCS) containing media. However, we 
observed the endosomal colocalization of the fluorophores instead of mitochondria when they 
enzymatically labeled to the 3´ end of the single tiles.          
Although we observed the uptake and colocalization of DNA nanotubes in endosome, 
similar uptake levels of single stranded DNA tiles carrying fluorophores were also detected 
after 8 hrs of incubation. Since the structures showed the stability in the serum containing 
media up to 8 hrs we assume that they are uptaken during this time. However, similar uptake 
levels of single stranded tiles measured by fluorescence data could be related with the 
degradation of tiles during this time and accumulation of dyes in the endosome.  
In this study and other cellular delivery studies of DNA nanostructures it is shown that 
DNA structures are uptaken by cells up to some extent however the transfection efficiency is 
still low. By quantifying the DNA scaffold using quantitative polymerase chain reaction 
(qPCR) method, Okholm et al. recently showed that planar DNA origami structures were 
uptaken by cells however the amount of uptake was an order of magnitude lower than the 
structures incubated with lipofectamine [76]. This could be explained with the high negative 
charge density on the DNA nanostructures. Therefore the transfection efficiency of DNA 
structures could be improved using modifications such as cationic peptides, polymers or 
lipids. Recently developed virus mimicking particles covering DNA structures showed 
enhanced stability and uptake of the structures. Perrault et al. encapsulated DNA origami 
octahedrons in the PEGylated (polyethylene glycol conjugated) lipid membranes [77]. (Figure 
2.3B) They showed that increasing the number of outer handles for the lipid envelope 
formation protected the structures against nuclease attack for 24 hrs. Almost 85 % of the 
structures, which are formed using 48 outer handles for lipid conjugation, remained stable 
after incubation with 20 units of DNAse I enzyme. Moreover, the encapsulated DNA 
octahedrons showed 17 times greater half-life in compare to DNA oligonucleotides and bare 
octahedrons. Encapsulated DNA octahedrons were fluorescently visible for 2 hrs all over the 
mice body whereas the control samples were accumulated in the bladder. In an alternative 
work, Mikkilä et al. combined virus capsid proteins with DNA origami structures [78]. All 
these works showed enhanced uptake and stability against DNAses. Alternatively, the 
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stability of the DNA nanostructures could be improved by chemical modifications of DNA 
nucleobases using click chemistry. Cassinelli et al. showed that single stranded tiles in the 6-
helix nanotubes could be interlocked by applying click reaction between 3´ and 5´ ends of the 
same tile [79]. (Figure 2.3C) Strikingly, the 6-helix tube structures, which consist of 24 
oligonucleotides, are stable against high temperature (95 °C), exonuclease I, and low salt 
concentrated mediums like DMEM when all strands were interlocked by click reaction. 
Another strategy to increase the stability of DNA structures is the formation of disulfide 
bonds between adjacent DNA strands. The Gothelf group showed that DAE tiles are stable 
under heating conditions (65 °C) and in the presence of denaturing agents [80]. The strategy 
used here is also reversible under reducing environments like cytoplasm of the cells which 
could be exploited for the cellular application such as cargo delivery of the DNA 
nanostructures. 
 
Figure 2.3: Increasing the stability of DNA nanostructures. A) A virus-inspired membrane-
encapsulated spherical DNA origami structure enhancing the stability and pharmacokinetic 
bioavailability. Reprinted with permission from [77]. Copyright 2014 American Chemical 
Society. B) Increasing the stability of tile-assembled DNA nanotubes by click reaction. 
Reprinted with permission from [79]. Copyright 2015 John Wiley and Sons.  
The surface properties of the DNA nanostructures could be altered using specific DNA 
intercalators to enhance the transfection efficiency of DNA nanostructures. The enhanced 
uptake of aforementioned DNA-based drug delivery systems including Doxorubicin and 
Daunorubicin could be related with the altered surface properties of DNA structures. To 
change the surface property of the DNA origami structures several groups also used cationic 
polymers to coat the structures [81]. Most recently, Chopra et al. demonstrated that DNA 
origami structures can be folded in Mg free buffer solutions containing low (< 1mM) 
concentrations of a condensing agent spermidine [82]. These structures are stable in cell 
lysate and in the presence of high electric field pulse which allows the transfection with 
electroporation.  
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!!To summarize, we found out in this study that for the efficient delivery of the DNA 
based nanostructures, the structures assembled in specific folding solution should maintain 
structural and functional integrity inside the biological fluid. One possible direction could be 
using condensation agents such as polyamines which can fold the structures with a salt 
independent manner while at the same time allow the accessibility and functionalization of 
DNA molecules. After surviving the biological fluid then the structures could reach their 
targets on the cellular membranes. 
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Abstract: DNA-based nanostructures have received great attention as molecular vehicles 
for cellular delivery of biomolecules and cancer drugs. Here, we report on the cellular 
uptake of tubule-like DNA tile-assembled nanostructures 27 nm in length and 8 nm in 
diameter that carry siRNA molecules, folic acid and fluorescent dyes. In our observations, 
the DNA structures are delivered to the endosome and do not reach the cytosol of  
the GFP-expressing HeLa cells that were used in the experiments. Consistent with this 
observation, no elevated silencing of the GFP gene could be detected. Furthermore, the 
presence of up to six molecules of folic acid on the carrier surface did not alter the uptake 
behavior and gene silencing. We further observed several challenges that have to be 
considered when performing in vitro and in vivo experiments with DNA structures:  
(i) DNA tile tubes consisting of 42 nt-long oligonucleotides and carrying single- or  
double-stranded extensions degrade within one hour in cell medium at 37 °C, while the 
same tubes without extensions are stable for up to eight hours. The degradation is caused 
mainly by the low concentration of divalent ions in the media. The lifetime in cell medium 
can be increased drastically by employing DNA tiles that are 84 nt long. (ii) Dyes may get 
cleaved from the oligonucleotides and then accumulate inside the cell close to the 
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mitochondria, which can lead to misinterpretation of data generated by flow cytometry and 
fluorescence microscopy. (iii) Single-stranded DNA carrying fluorescent dyes are 
internalized at similar levels as the DNA tile-assembled tubes used here. 
Keywords: DNA nanotechnology; DNA tile; siRNA delivery; stability; folate; cation 
 
1. Introduction 
Therapeutic agents must overcome multiple barriers to reach their target [1,2]. For example, 
siRNAs have to reach the target tissue, enter the cells, be released from the endosomal compartment 
and, finally, silence the target gene via the RISC complex [3]. Up to now, researchers have developed 
a variety of nanoparticle carrier systems to overcome these barriers, such as polymers [4],  
liposomes [5] or conjugates [6], with various levels of efficiency and toxicity. Most recently, with 
improvements in the DNA nanotechnology field, DNA-based nanostructures were developed as carrier 
systems for a variety of active components, including siRNAs [7], antibodies [8], immunostimulants [9,10] 
and cancer drugs [11,12]. DNA nanostructures are promising for delivery applications because they 
can be easily modified with a variety of (bio)chemical moieties for targeting purposes at nanoscale 
precision; they are monodisperse with well-defined sizes and are non-cytotoxic [10,13–18]. To date, 
several groups have investigated the targeted delivery of DNA-based nanostructures using different 
targeting agents, such as cell penetrating peptides or small molecules. Among them, folate is a 
commonly-used molecule, due to the high expression of its receptors on certain cancer cells. Efficient 
folate-mediated uptake has been demonstrated using various DNA-based structures, such as DNA 
nanotubes built from a single palindromic DNA strand [19] or Y-shaped DNA nanostructures prepared 
by rolling circle amplification [20]. Although the DNA-based nanostructures are promising for 
targeted delivery applications, as exemplified above, the stability of these structures at 37 °C in blood 
or tissue is one of the main issues to be considered. In a recent study, the stability of a variety of DNA 
origami structures with different designs, such as octahedron, six-helix bundle tubes or 24-helix bundle 
rods, were investigated using in vitro conditions, and time-and shape-dependent denaturation and 
digestion were observed due to the Mg2+ depletion in the media and the DNase activity of the  
serum [21]. As an alternative to the DNA origami method [14,15] and shape-specific designs, such as 
DNA cubes [22], tetrahedrons [23] or octahedrons [24], single-stranded tile assembly has recently 
proven to be a versatile and modular design strategy to build a wide variety of two- and  
three-dimensional shapes [25,26]. In this study, we intended to show efficient folate-mediated uptake 
and subsequent gene silencing by tile-assembled DNA nanotubes carrying GFP siRNAs in vitro. 
However, we were not able to demonstrate the sought-after effects, but instead observed untimely 
disassembly of our constructs under certain in vitro conditions and, therefore, investigated strategies to 
maintain the structural integrity in relevant environments. We examined the stability of tile-assembled 
structures under limited divalent cations and in the presence of nucleases in buffer and in cell media. 
We then describe a number of artifacts that should be taken into consideration during experiments with 
DNA-based nanostructures in vitro. 
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2. Results and Discussion 
2.1. Design and Self-Assembly of Six-Helix DNA Nanotubes 
We designed tubule-like DNA nanostructures consisting of 24 oligonucleotides that self-assemble 
into six parallel helices using the single-stranded DNA tile assembly method introduced by Yin et al. 
(Scheme 1 and Table S1) [25,27]. Six of the oligonucleotides were alkyne-modified during synthesis 
and conjugated in-house with PEG-folate-azide (Baseclick GmbH, Tutzing, Germany) by a click 
reaction. Reversed phase high performance chromatography (RP-HPLC) analysis and matrix-assisted 
laser desorption/ionization (MALDI) mass spectrometry revealed the almost quantitatively conjugation 
of folate molecules to the alkyne-oligonucleotides. (Figures S1 and S2, Table S2). Another set of six 
oligonucleotides was extended by an 18 nt-long sequence at the 3' end to allow the attachment via 
hybridization of six siRNA molecules that potentially silence the expression of GFP upon delivery. To 
visualize the DNA nanotubes in vitro, two different labeling strategies were employed. In the first 
approach, Atto488-dUTP was enzymatically labeled to the 3' end of a set of 12 tile oligonucleotides 
using terminal transferase. In the second approach, the same set of oligonucleotides was extended with 
another 18 nt-long sequence allowing attachment via hybridization of 12 Atto647-modified (via NHS 
chemistry) oligonucleotides. The nanotubes have a designed length of ~27 nm and an expected 
diameter of ~6 nm for the dried sample. Note that the tube diameter of a six-helix bundle increases in 
buffer to 8 nm and that tubes decorated with additional molecules will have a larger effective  
diameter [28]. 
 
Scheme 1. DNA nanotube assembly. (Left) Click reaction of alkyne-modified 
oligonucleotides with azide-modified PEGylated folate. (Right) Self-assembly of 24 
oligonucleotides into a six-helix tube after a 17-h annealing process. 
Nanomaterials 2015, 5 50 
 
 
The nanotube structures containing the desired subsets of oligonucleotides and modifications were 
folded in TE-buffer containing 20 mM Mg2+ during a thermal annealing process starting at 80 °C and 
cooling down to room temperature over the course of 17 h. Analysis by gel electrophoresis analysis 
showed for all designs prominent bands representing the folded structures (Lanes 2 + 3 + 4 in  
Figure 1). Conjugation of folate and folate + siRNA (Lanes 3 and 4, respectively) to the DNA 
nanotubes leads to a decrease of their mobility in comparison to nanotubes without folate and siRNA 
(Lane 2). Transmission electron microscopy (TEM) demonstrates the correct assembly of the 
nanotubes and the monodispersity of the samples. The measured length of 27 ± 1 nm and the measured 
diameter of 6 ± 1 nm perfectly match the expected dimensions (Figure 1B–D). 
 
Figure 1. Characterization of nanotubes. (a) Gel electrophoresis analysis of assembled 
nanotubes: (1) 1-kb ladder, (2) nanotube, (3) nanotube + folate, (4) nanotube + folate + 
siRNA, and (5) individual oligonucleotide. Electron micrographs of (b) Nanotubes;  
(c) Nanotubes with folate; and (d) Nanotubes with folate and siRNA (scale bars: 50 nm; 
insets: 20 nm). 
2.2. Tubule-Like Tile-Assembled DNA Nanostructures Are Delivered to the Endosome of HeLa Cells 
Independently of Folic Acid and Are Not Capable of Releasing siRNA into the Cytosol 
DNA nanotubes labeled with Atto488 via enzymatic labeling were added to HeLa cell cultures at  
10 nM, together with dextran-AF647 as a marker for endosomal uptake. At various time points 
thereafter, confocal microscopy was performed to evaluate the localization of the construct. After 24 h, 
we found clear co-localization of the nanotubes with dextran (Figure 2A–C). Observations for up to  
72 h did not show any change in localization (Figure S3C,D). 
To determine a potential effect of uptake via the folate receptor, which is highly expressed on the 
surface of HeLa cells, nanotubes with and without folic acid were compared side by side. No influence 
on the endosomal staining pattern was noticed in the fluorescence microscopy images, neither after  
24 h nor after 72 h (Figure S3). For a quantitative analysis of the uptake, we conducted flow 
cytometry-based measurements of the HeLa cells at different time points after the addition of 
fluorophore-labeled nanotubes (Figure 2D). A minor signal was already detected after 4 h, which 
further increased in the course of 24 h. No significant difference was found between the uptake of 
nanotubes with or without folate. 
On a functional level, we tested if the nanostructures released their siRNA cargo successfully to the 
cytoplasm by analyzing the knockdown capacity of siRNA molecules bound to the DNA nanotube. 
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Stably GFP-transfected HeLa cell lines were used together with siRNA directed against GFP (siGFP). 
The siGFP was either bound to the nanostructure via hybridization or transfected into the cytoplasm by 
lipofection as a positive control. The GFP signal of the cells was measured by flow cytometry after  
96 h (Figure 2E). In the condition with lipofection of GFP-targeting siRNAs, the fluorochrome signal 
was markedly decreased compared to lipofection of a control siRNA (siCTRL). However, the addition 
of siGFP to the nanotubes did not result in GFP-knockdown, independent of folate labeling, consistent 
with endosomal trapping of the whole structure, including their siRNA cargo. 
 
Figure 2. Endosomal uptake of nanotubes in HeLa cells. Endosomal staining of nanotubes 
with dextran. (a) Nanotubes; (b) Dextran; (c) Merged image from (a), (b) and a third 
channel (DAPI, blue). (d) Flow cytometry analysis of folate-dependent uptake of  
Atto488-labeled nanotubes over 24 h. Untreated cells act as the control, and the specific 
fluorescence intensity (SFI) of the dye is depicted. (e) Fluorescence intensity of stably 
GFP-expressing Hela cells upon the addition of nanotubes carrying GFP-targeting siRNAs 
or upon transfection of a GFP-targeting siRNA and a non-targeting siRNA, respectively, as 
controls using lipofection (LF). The median fluorescence intensity (MFI) of GFP is depicted. 
2.3. Stability of DNA Nanotubes Differs in Various Conditions In Vitro 
To address the stability of tile-assembled DNA nanostructures in vitro, we incubated them in 
different buffers and cell media. First, we incubated the nanotubes in PBS with different Mg2+ 
concentrations at 37 °C for 2 h. We used PBS as a buffer to simulate the cell media conditions, as both 
cell media and PBS possess several monovalent and divalent cations at isotonic concentrations. 
Importantly, for the assembly and stabilization of the DNA nanostructures, usually Mg2+ concentrations 
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much higher than those found in PBS and cell media are used. While folding of DNA nanostructures 
can also be achieved at high Na+ concentrations [29], the 135 mM NaCl present in PBS are not 
sufficient to stabilize DNA nanotubes at 37 °C, if the individual DNA tiles are 42 nt long. Gel analysis 
revealed that the nanotubes without extensions were stable down to 1 mM Mg2+, whereas the 
nanotubes carrying siRNA started to degrade already below 4 mM Mg2+ (Figure 3A,B). This indicates 
that the addition of extension sequences protruding from the DNA nanotubes destabilizes the structure, 
which may be explained by distorted stacking of the last base before the extension and with an increase 
of electrostatic repulsion between the elongated tail and the DNA duplexes in the nanotube [30]. Next, 
we compared the stability of nanotubes against DNases and incubated the structures in cell medium 
containing 10% FCS. Gel analysis showed that under these conditions, the plain nanotubes are stable 
up to 8 h (Figure 3C). However, nanotubes carrying siRNA were degraded in 1 h when the structures 
were incubated in media containing 10% FCS. These nanotubes were also degraded slightly during 8 h 
in DMEM medium without FCS, likely due to Mg2+ depletion (in all cell media experiments, the 
concentration of Mg2+ was 1.8 mM). 
 
Figure 3. Stability of nanotubes. (a) Stability of nanotubes in PBS with different Mg2+ 
concentrations; (b) Stability of nanotubes carrying siRNA in PBS with different Mg2+ 
concentrations; (c) Stability of nanotubes in DMEM medium in the absence or presence of 
FCS; (d) Stability of nanotubes carrying siRNA in DMEM medium in the absence or 
presence of FCS (L: 1 kb ladder; C: control. All samples were incubated at 37 °C). 
To overcome the problem of premature degradation, DNA tile tubes were assembled from  
84 nt-long oligonucleotides. This design allows longer complementary regions (21 bp for the 84mers 
instead of 10 bp and 11 bp for the 42mers) within the tile assembly, which, in turn, yields much higher 
thermal stability, but also higher resistance to Mg2+ depletion (Figure 4). Our results show that the 
stability of tile-assembled nanotubes is dependent on sequence design, temperature, salt concentration 
and structural modifications, such as the addition of single- or double-stranded extensions to the  
DNA tiles. 
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Figure 4. Stability of nanotubes assembled from 84 nt-long oligonucleotides.  
(a) Schematic depiction of a section of the 6HT demonstrating the hybridization of 84mers; 
(b) Schematic depiction of a section of the 6HT demonstrating the hybridization of 42mers; 
(c) Stability of nanotubes (84mers) in PBS with different Mg2+ concentrations; (d) Stability 
of nanotubes (84mers and 42mers) in DMEM + 10% FCS, DMEM and PBS. Nanotubes 
were incubated at 45 °C for 2 h (L: 1 kb ladder; C: control). 
2.4. Strong Extra-Endosomal Uptake Can Be Feigned by Dye Cleavage 
When nanostructures labeled with Atto647 via hybridization were incubated with HeLa cells, we 
repeatedly observed a very high fluorescence level in the cells during microscopy- or flow  
cytometry-based analysis. Furthermore, the fluorochrome did not co-localize with dextran as an 
endosomal marker (Figure 5A), but instead, mitochondrial localization was detected (Figure 5B). The 
level of uptake and the mitochondrial staining pattern were associated with the addition of serum to the 
culture medium (Figure S4). Similarly, when only the oligonucleotide labeled with Atto647 (via NHS 
chemistry) was added to the HeLa cells, we observed a rapid and strong staining of the cells only in the 
case when serum was added (Figure 5C). This effect was not observed when the fluorophores were 
attached via enzymatic binding. We therefore conclude that Atto647 is cleaved off the DNA by some 
component in the serum and is taken up independently of the nanostructure. 
2.5. Single-Stranded DNA Molecules, But Not Deoxynucleotide Triphosphates, Are Internalized at 
Similar Levels as the Tile-Assembled Nanotube Structures 
Specific uptake of the tubule-like tile-assembled DNA nanostructures was analyzed by direct 
comparison with oligonucleotides and deoxynucleotide triphosphates. All three molecules were labeled 
with Atto488 and incubated at identical molar concentrations with HeLa cells. Fluorochrome uptake 
was measured by flow cytometry at various time points (Figure 5D). No intracellular staining was 
found in the deoxynucleotide triphosphate condition. However, we observed similar uptake of the 
fluorochrome with the oligonucleotide as with the nanostructure. 
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Figure 5. Effect of dye cleavage on cellular uptake. (a) Endosomal staining using Alexa 
Fluor 488-coupled dextran (shown in green) of HeLa cells treated with 
oligodeoxynucleotide (ODN)-Atto647 (shown in red); (b) Mitochondrial colocalization of 
Atto647 (shown in red) in HeLa cells stained with the mitochondrial dye MitoTracker 
Green (shown in green). Nuclei are stained with Hoechst 33342; (c) Flow cytometry 
analysis of fluorescence intensity of cells treated with ODN-Atto647 in the absence or 
presence of FCS; (d) Flow cytometry analysis of fluorescence intensity of cells treated 
with Atto488-dUTP, ODN-Atto488 and nanotube labeled with Atto488. Untreated cells act 
as the control, and the specific fluorescence intensity (SFI) of the dye is depicted. 
3. Experimental Section 
3.1. DNA Nanotube Design 
DNA nanotubes were designed using Yin’s single-strand tile (SST) method [27]. Each tile 
oligonucleotide is 42 bases long and consists of four domains with ten or eleven bases. Twenty four 
individual oligonucleotides were used to form 6 helix nanotube. The domains at the ends of the 
nanotube contain non-pairing poly-A sequences to prevent polymerization. siRNA hybridization to the 
nanotubes was done by extending 3' ends of six tiles with an 18-nt long overhang sequence  
(5'-AGGATGTAGGTGGTAGAG-3'). The used siRNA sequences for GFP silencing were sense:  
5'-GCCACAACGUCUAUAUCAU-3', and antisense: 5'-AUGAUAUAGACGUUGUGGC 
CTCTACCACCTACATCCT-3'. Six oligonucleotides were modified with PEG-folate azide (Baseclick 
GmbH, Tutzing, Germany) using click reactions. The underlined sequence shows the complementary 
overhang. All oligonucleotides were purchased from Eurofins (Ebersberg, Germany) with HPSF or 
HPLC purification. 
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3.2. Folate Conjugation and Characterization of Oligonucleotides 
Each of the six alkyne-modified oligonucleotides (Baseclick GmbH) were submitted to click 
reaction, using CuBr as the Cu(I) source. Ten microliters of a freshly prepared CuBr (0.1 M)/THPTA 
(0.1 M) solution in a 1:2 v/v ratio were added to a 50-µL (0.1 mM, 5 nmol) solution of each  
alkyne-oligonucleotide. The addition of folate-PEG3-azide (2.5 µL, 10 mM in DMSO) completed the 
click reaction cocktail. The mixture was mixed for 1.5 h at 45 °C. Finally, the solution was purified via 
ethanol precipitation. Folate-conjugated oligonucleotides were analyzed by analytical RP-HPLC 
(e2695 system, Waters, Milford, MA, USA) coupled with a photodiode array detector (PDA 2998, 
Waters) using a reversed phase XBridge OST C18 column (4.6 mm × 50 mm, Waters). Before 
injection in RP-HPLC, samples were diluted to 10 µM concentration in HPLC-grade H2O. Samples  
(2 µL) were desalted against ddH2O using a nitrocellulose membrane (MerckMillipore, Frankfurt, 
Germany), and 0.4 µL were spotted onto a MALDI plate (Bruker Corporation, Millerica, MA, USA) 
along with 0.4 µL of 3-hydroxypicolinic acid (HPA, Sigma Aldrich, St. Luis, MO, USA). Measurements 
were carried out with the Autoflex MALDI-TOF (Bruker Corporation). 
3.3. Dye Labeling of DNA Nanotubes 
Fluorescent dyes were conjugated to the 12 oligonucleotides with two different approaches before 
the nanotube assembly. In the first approach, 3' ends of twelve tiles were extended by 18 nt-long 
overhang sequences to hybridize the dye-modified sequence: (Atto647 TTCATTCTCCTATTACTACC). 
In the second approach, the 3' ends of the same tiles were enzymatically labeled with Atto488-dUTP 
(Jena Bioscience, Jena, Germany). For this, Atto488-dUTP (80 µM), CoCl2 (5 mM), terminal 
transferase enzyme (16 U/µL, Roche, Penzberg, Germany) and all DNA tiles (400 pmol) were mixed 
in a 20 µL, 1× TdT reaction buffer and then incubated at 37 °C for 30 min. Then, 2.5 µL of NaOAc  
(3 M) were added, and the solution was filled up to 80 µL with ice-cooled ethanol (99%). After 1 h of 
incubation at −20 °C, samples were centrifuged at 13,000× g for 30 min. Then, samples were washed 
with 70% ethanol for 10 min again, and the supernatant was discarded. The remaining pellet was 
dissolved in distilled water. 
3.4. DNA Nanotube Assembly and Purification 
For DNA nanotube assembly, 400 nM of dye and folate modified tiles, 800 nM of antisense-ODN 
and 1.6 µM of sense-ODN were mixed in a folding buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0,  
20 mM MgCl2). For the plain nanotube assembly, 1 µM of unmodified tiles was used. The DNA 
nanotubes were folded over the course of 16 h (5 min at 80 °C, cooling down to 65 °C at 1 °C/min, 
cooling down to 25 °C at 2.5 °C/h). Purification of the assembled DNA nanotubes was done using 30K 
Amicon Ultra 0.5-mL centrifuge filters (30000 MWCO, Millipore, Schwalbach, Germany) to remove 
excess strands that were not folded into the structures. One hundred microliters of assembled DNA 
nanotube solution were mixed with 400 µL of folding buffer, filled into the centrifuge filter, and 
centrifuged 3 times at 13,000× g for 6 min. After every centrifuge step, the flow-through was removed 
and the filter was refilled up to 500 µL with buffer. After final centrifugation, the remaining solution at 
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the bottom of the filter (~50 µL) was pipetted out, and the concentration of nanotubes was determined 
by measuring the optical density at 260 nm. 
3.5. Gel Electrophoresis and Transmission Electron Microscopy 
DNA nanotubes were analyzed by running samples in an agarose gel. For this, 2% agarose was 
dissolved in 0.5× TAE buffer by heating to boiling. MgCl2 (11 mM) and ethidium bromide  
(0.5 µg/mL) were added after the cooling, and the solution was poured into a gel cask for solidification. 
Twenty microliters of each filter-purified DNA nanotube sample were mixed with 4 µL of 6× loading 
dye before loading into the gel pockets. Six microliters of 1 kb ladder were also loaded adjacent to the 
samples. The gel was run for 2 h at 70 V in an ice-cold water bath to prevent heat-induced denaturation 
of DNA nanotubes. To visualize DNA nanotubes, a JEM-1011 transmission electron microscope 
(JEOL GmbH, Eching, Germany) was used. DNA nanotubes were incubated on plasma-exposed  
(240 kV for 1 min) carbon-coated grids and then negatively stained with 2% uranyl formate for 10 s. 
3.6. Stability of DNA Nanotubes 
The stability of DNA nanotubes was tested in PBS buffer, DMEM and DMEM containing 10% 
FCS, separately. One microliter of DNA nanotubes (50 ng/µL) in 20 µL of buffer/medium was 
incubated at 37 °C for different time points. Two percent agarose gel with 11 mM MgCl2 was prepared 
to analyze the samples, as mentioned in Experimental Section 3.5. 
3.7. Cell Culture Experiments 
HeLa cells were cultured at 37 °C, 5% CO2 and 95% humidity in Dulbecco’s modified Eagle’s 
medium (Life Technologies Thermo Fischer, Waltham, MA, USA) supplemented with 10%  
heat-inactivated fetal calf serum (FCS, Invitrogen Thermo Fischer, Waltham, MA, USA), 2 mM  
L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin. Stably GFP-transfected HeLa cell 
lines were generated by retroviral transduction using an eGFP containing pMP71 vector, as described 
previously [31,32]. To analyze uptake, DNA nanotubes, oligonucleotides and deoxynucleotide 
triphosphates were added to HeLa cells at a concentration between 10 and 40 nM for the indicated 
period of time in DMEM with L-glutamine, penicillin, streptomycin and either supplemented or not 
with 10% FCS. For siRNA-mediated knockdown experiments, GFP-expressing HeLa cells were 
seeded in 24-well plates and allowed to adhere overnight. On the next day, cells were either incubated 
with the indicated nanotubes coupled to GFP-targeting siRNAs or were transfected as a control with 
siRNA oligonucleotides (75 nM) using Lipofectamine RNAiMAX (Invitrogen). After 48 h,  
GFP-knockdown was measured by flow cytometry. The siRNA sequence used to target GFP (siGFP) 
was 5' GCCACAACGUCUAUAUCAU 3'. As a control (siCTRL), we used the non-targeting RNA 
sequence 5' GCGCUAUCCAGCUUACGUA 3' described previously [33]. SiRNAs were purchased 
from Eurofins and contained dTdT overhangs. 
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3.8. Flow Cytometry and Confocal Fluorescence Microscopy 
Flow cytometry was used to determine the uptake of DNA nanotubes, oligonucleotides and 
deoxynucleotide triphosphates labeled with the fluorescent dyes, Atto488 or Atto647, into HeLa cells 
and to assess the knockdown efficiency of GFP-targeting siRNAs in stably GFP-expressing HeLa cells. 
For that, after the indicated time points, single-cell suspensions were prepared and washed several 
times before analyzing the cells on a FACS Calibur (Becton Dickinson, Franklin Lakes, NJ, USA). 
FlowJo software was used to analyze the data. GFP expression was depicted by median fluorescence 
intensity (MFI). For all experiments with fluorescent dye labeling, the data are represented as specific 
fluorescence intensity (SFI), which was calculated by dividing the MFI of the sample by the MFI of 
the control. Confocal fluorescence microscopy was used to determine the subcellular localization of 
nanotubes and RNAs taken up by HeLa cells. For that, HeLa cells were cultured in CELLview cell 
culture dishes with a glass bottom (Greiner Bio One). After incubation with Atto488- or  
Atto647-labeled nanotubes for the indicated time points, cells were washed three times with PBS and 
used for live-imaging on a Leica TCS SP5 confocal microscope (Leica Microsystems GmbH, Wetzlar, 
Germany). Zero-point-two micrograms per milliliter of Hoechst 33342 and MitoTracker Green (both 
from Life Technologies) were used according to the manufacturer’s protocol to stain nuclei and 
mitochondria, respectively. In order to visualize endosomes, 20 µg/mL dextran labeled with Alexa 
Fluor 647 or Alexa Fluor 488 (Life Technologies Thermo Fischer) were added simultaneously with the 
DNA nanotubes. 
4. Conclusions 
In this study, we investigated the cellular delivery of tile-assembled DNA nanotubes carrying 
siRNAs using GFP-expressing HeLa cells via folate targeting. We observed that the nanostructures 
enter the cells via an endosomal pathway, but the nanostructures and their siRNA cargo are not capable 
of reaching the cytoplasm for knockdown and gene silencing. Contingently, no significant decrease in 
GFP expression levels was detectable, and folate modification did not change the uptake kinetics. The 
stability experiments revealed that unmodified DNA nanotubes are stable at 37 °C up to 8 h in the cell 
media and that they stay intact in PBS buffer containing 2 mM Mg2+ or more. However, the extension 
of the DNA tile strands with sequences that allow the hybridization of siRNA or dye-modified strands 
drastically decreases the construct’s stability, a fact that may have contributed to the unsuccessful 
folate targeting experiments. Using DNA tiles that were 84-nt long drastically increased the stability in 
all cell media and buffers with low Mg2+ concentrations. Importantly, we observed that DNA strands 
alone and cleaved dyes are also uptaken by the cells, which can lead to the misinterpretation of 
recorded data. Overall, the results presented in this study demonstrate the importance of rigorously 
testing the stability of DNA nanostructures before applications in vitro and in vivo. 
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3 Hierarchical Assembly of DNA Nanostructures on 
Lipid Bilayer Membranes 
3.1 Interaction of DNA Nanostructures with Lipid Membranes 
Lipid membranes are functional interfacial barriers that allow the structural 
organization and compartmentalization of the cells. Many of the cellular processes such as 
signal transduction, energy conversion, intracellular and extracellular transportation are 
mediated by membrane-associated protein clusters [84-86]. Proteins that are involved in 
endocytosis such as clathrin and caveolin form self-assembled complexes upon receptor 
activation [87, 88]. As another example, FAS receptor, which is a transmembrane protein, can 
trigger apoptosis upon ligand activated multimerization [89]. All these processes require the 
interaction between protein components which is facilitated through their two-dimensional 
lateral diffusion within the lipid membranes of the cells. In order to mimic and potentially 
utilize similar membrane-based self-assembly mechanisms for nanotechnology applications 
such as targeted delivery or protein crystallization, we studied the self-assembly of 
membrane-bound DNA nanostructures which are inspired by and modeled after membrane-
associated protein clusters.  
Lipid membranes consist of different types of amphiphilic molecules such as 
glycerophospholipids, sphingophospholipids and cholesterol. (Figure 3.1A) Phospholipids are 
composed of hydrophobic alkyl tail, a linker molecule and a hydrophilic head group. The 
length of the alkyl tail and the charge of the hydrophilic head group, which could be neutral or 
charged, affect the structural organization and diffusion of the lipid bilayer [90]. The relative 
mobility of the individual lipid molecules in the lipid bilayer can be changed with the 
temperature. This response is known as the phase behavior of the lipid bilayer. At low 
temperatures, membranes are in a solid ordered gel (Lβ) phase whereas at high temperatures 
liquid disordered phase (Lα) is adopted. The adopted phase also depends on lipid structure: 
long, saturated hydrocarbon chains are found in sphingomyelin (SM), so SM-rich mixtures 
tend to adopt solid-like phases; unsaturated hydrocarbon chains are found in most 
biomembrane glycerophospholipids, so these tend to be enriched in liquid phases [91]. Sterols 
by themselves do not form bilayer phases, but together with a bilayer-forming lipid, the 
liquid-ordered phase (Lo) can form. The liquid ordered phase has the high order of a solid but 
the high translational mobility of a liquid. Moreover, several phases could be exist 
simultaneously in mixture of lipids as depicted in the Figure 3.1B, two-phase or three-phase 
regions could be formed in the mixture of DOPC/SM/chol with different concentrations. 
!
!
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Figure 3.1: Lipids. A) Structures of lipid types. B) Phase diagram of a mixture of DOPC, 
sphingomyelin, and cholesterol. (Lα: Liquid crystalline, Lo: Liquid ordered, Lβ: Solid 
ordered). Reprinted with permission from [90]. Copyright 2014 American Chemical Society. 
Phospholipids self-assemble into lipid bilayers as in the form of a two-layered sheet 
with the hydrophobic tails pointing toward the center and hydrophilic head groups pointing 
towards the outside. The size of a typical lipid bilayer is around 5-6 nm. In order to form 
supported lipid bilayer a common technique was used which is based on the fusion of lipid 
molecules on the solid support such as glass or mica [92]. For this, lipids are first solubilized 
in organic solvent. After solvent evaporation under nitrogen and subsequent desiccation under 
vacuum, the dried lipid film is resuspended in aqueous buffer solution which yields a 
multilamellar vesicle (MLV) suspension. From this suspension, small unilamellar vesicles 
(SUVs) with the typical sizes of 25-100 nm can be obtained by sonication.  The further 
addition of water to the SUV suspension induces the lipid bilayer formation.   
There are several ways to enable the interaction of DNA nanostuctures with lipid 
membranes. One common way is the functionalization of DNA with hydrophobic molecules 
such as cholesterol, porhyrin, α-tocopherol or poly(propylene) oxide (PPO) [93-96]. 
Cholesterol-TEG (triethylene glycol) conjugation is mainly used for DNA lipid membrane 
interaction since it is commercially available and does not easily dissociate from the lipid 
membrane unless the hydrophobic interaction is weakened by the detergent molecules [93]. In 
addition to using hydrophobic molecules, charge interaction can also mediate the binding 
between DNA nanostructures and lipid membrane. Since DNA is highly negatively charged, 
it has high affinity to positively charged lipids such as DOTAP or DOTMA [97]. The 
interaction could be also established using divalent cations, Mg2+ or Ca2+, together with 
zwitterionic lipids such as DOPC or POPC with zero net charge [98]. The mechanism for this 
interaction is divalent ion bridging the negative charge of DNA and lipid head group leading 
to the re-orientation of lipid molecules [99]. This divalent ion mediated interaction can be 
switched reversibly by changing divalent ion concentration [100]. 
!!!!!It has been recently shown that DNA-based nanostructures conjugated with 
hydrophobic anchors can be used to mimic membrane-protein functions as occurred in the 
membrane ion channels [101].  Like natural pores, DNA based nanopores can control the 
transportation of waters soluble molecules. In 2012, the group of F. Simmel developed an 
artificial membrane channel with the scaffolded DNA origami method [102]. (Figure 3.2A) 
The structure is made of 54 parallel helices of which 6 inner helices were designed longer to 
penetrate the lipid membrane. The bottom of the cap structure was functionalized with 
cholesterol molecules in order to insert the structure inside the membrane. TEM images 
confirmed the insertion of DNA channels to the SUVs and the electrical measurements further 
proved the channel formation inside the membrane. The conductance of the DNA nanopore 
was around 1 nS, similar to the protein ion channels. In addition to ion transportation, DNA-
based channels were also used for the selective transportation of other molecules such as 
fluorophores across lipid membranes [103]. (Figure 3.2B) For this, the group of S. Howorka 
was designed a 9 nm long 6-helix DNA bundle where the entrance of the pore is controlled by 
the molecular logic gate mechanism. The nanodevice is in closed state when the ´lock´ strand 
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is active which is a duplex formed by the hybridization of two docking sites at the entrance of 
the pore. Upon addition of the ´key´ strand the ´lock´ strand is preferentially hybridized with 
the ´key´ strand and removed from the entrance. The conductivity of the pore is shown in the 
presence and absence of the PEG molecules with different sizes to show that the 
transportation occurs only trough the pores. More strikingly, the selective and gate-depended!
transportation of charged molecules from lipid vesicles was indicated using flourophores as 
cargo molecules. 
 
Figure 3.2: Synthetic DNA membrane channels. A) Left: Schematic illustration of DNA 
origami channel formed by 54 double helical domains packed on a honeycomb lattice. Red 
domains indicate transmembrane stem and orange ellipsoids indicate cholesterol molecules. 
Right: TEM image of DNA membrane channels adhered to a small unilamellar vesicle. From 
[102]. Reprinted with permission from AAAS. B) DNA nanopore features the selective 
transportation of molecules using logic-gate mechanism. Reprinted by permission from 
Macmillan Publishers Ltd: Nature Nanotechnology [103] Copyright 2016.  
As an alternative to DNA origami nanopores, more cost-effective and simple designs 
with smaller pore size were also developed for the ion transportation across membranes using 
tile-based assembly. For this, we designed 4-helix tile DNA nanotubes with a length of 11 nm 
and a central channel with a nominal diameter of 0.8 nm assuming an anhydrated helix 
diameter of 2 nm [104]. Two of the tiles carry terminal cholesterol modifications for 
membrane insertion and two of the additional tiles carry Cy3 dyes for visualization by 
fluorescence microscopy. (Figure 3.3A) After only 60s, a bright ring around a GUV was 
appeared which indicates that tile based structures were incorporated on the membrane of the 
vesicle. (Figure 3.3B) These structures also showed the increased ionic conductivity on the 
GUVs. In order to check ion conductivity, the vesicles were suctioned onto the tip of a 200 
nm diameter glass capillary where they burst and form lipid bilayer. (Figure 3.3C) This 
bilayer is then subjected to current-voltage (IV) recording protocol. Figure 3.3D shows the 
conductance of 170 independent IV recordings of plain GUVs (top) and GUVs incubated with 
DNA nanotubes (bottom). None of the plain GUVs showed a conductance above 0.3 nS. In 
contrast, 12 % of the GUVs incubated with DNA nanotubes showed elevated conductance. 
!
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Figure 3.3: DNA tile-based membrane channels for ion conductivity. A) 4-helix DNA 
nanotubes carrying cholesterol molecules and Cy3 dyes. B) Giant unilamellar vesicle imaged 
in fluorescence mode (ex: 514 nm). C) Illustration of the ionic current measurement protocol 
on lipid bilayer setup. D) Conductances obtained for 170 independent IV recordings of plain 
GUVs (top) and GUVs with DNA nanotubes (bottom). Reprinted with permission from ref. 
[104] Copyright 2015 American Chemical Society.  
DNA-based nanostructures have been also used to interact with cellular membranes.  
Burns and co-workers showed that 6-helix DNA nanopores which are modified with ethyl 
phosphorothioate (EP) groups can be used to target cancer cells [105]. (Figure 3.4A) They 
showed that these structures interacted with cancer cell membranes and cause cell death by 
possibly changing the influx/efflux of the critical ions or disrupting the membrane integrity by 
insertion. In another study, Li and co-workers developed DNA-conjugated gold nanoparticle 
networks (DNA-AuNP) on the cell membrane as a protective barrier against viral infection 
[106]. (Figure 3.4B) DNA-based networks inhibited the viral attachment, entry and budding 
up to 90% efficiency. 
3.2 DNA Origami Growth and Clathrin Mimicking on Lipid Membranes 
In the following study which the results were published in Associated Publication P3, 
we studied the hierarchical assembly of DNA origami nanostructure by mimicking the 
membrane-sculpting protein, clathrin [107]. Clathrin is a protein which forms coated vesicle 
complexes during endocytosis [87]. In order to mimic the function of clathrin we designed a 
truncated-Y shaped DNA origami. Upon addition of specific connector staples three of these 
structures form a trimer as in the formation of clathrin triskelion.  
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Figure 3.4: DNA nanostructures interact with cellular membranes. A) DNA nanopores 
interact with the membrane of cancer cells and cause cell death. Reprinted with permission 
from [105]. Copyright 2014 John Wiley and Sons. B) DNA-AuNP networks on the cellular 
membrane for the protection against viral infection. Reprinted with permission from [106]. 
Copyright 2016 Elsevier. 
In order to understand the dynamics of DNA origami diffusion on the lipid 
membranes, first we designed a three-layer block origami structure to use as a model 
structure. Block origami structures were designed in a way that bottom layer was 
functionalized with 4 cholesterol molecules (Figure 3.5A) while the top layer was 
functionalized with the flourophore molecules to track the nanostructures using fluorescence 
microscopy. We realized that the diffusion coefficient of the DNA origami structures is 
depend on the number of cholesterol anchors and size of the structures. Upon addition of 
various sets of connector oligonucleotides we could able to grow either one-dimensional or 
two-dimensional hierarchical structures (Figure 3.5B and C) Here, lipid bilayers provide a 
two-dimensional confined space that increased the!possibility of interaction of single DNA 
origami structures to form superlattices. We realized that it is not possible to form larger 
lattices in solution using the same conditions. One of the advantages of these lattices formed 
on the membranes is that they provide a two-dimensional platform where the proteins could 
be attached with nanometer spatial resolution for crystallization studies. For that, our lab is 
currently focusing on the positioning of gold nanoparticles on these DNA origami lattices 
which will be investigated using small angle x-ray scattering (SAXS).!!!!!!!!!!
!
!
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Figure 3.5: DNA origami polymerization on lipid membranes. A) Immobilization of DNA 
origami nanostructure onto lipid bilayer using 4 cholesterol molecules. B) Two-dimensional 
polymerization of diffusing DNA origami structures upon addition of connector DNA staples. 
C) AFM image of DNA origami lattices. Reprinted with permission from [107] Copyright 
2015 American Chemical Society. 
As mentioned earlier, another objective of the project was to mimic the clathrin using 
the DNA origami trimers. Upon hybridization on the membrane, the structures freely diffused 
and formed hexagonal lattices as in the formation of clathrin-coated pits. We also showed that 
2D lattices formed by DNA origami structures could bend the membrane of SUVs. (see 
Associated Publication P2) The bending of the membrane using flat origami structures was 
also shown by the group of P.Schwille. In this work, they designed a DNA origami brick to 
investigate the membrane curvature and bending inspired by BAR proteins [108]. They 
showed that brick-like DNA origami structures can diffuse on freestanding GUV membranes 
and form 2D scaffolds which can promote deformation of membranes at high surface 
densities. (Figure 3.6A) DNA nanostructures have also been used recently to study the 
membrane fusion process of SNARE proteins [109]. (Figure 3.6B) In this study, DNA 
origami nanorings were designed to use as a template for v-SNARE-tethered SUV formation 
inside the ring. Formed SUVs then applied to lipid bilayers to study fusion process. With this 
platform they confirmed at the single molecule level that one to two SNARE pairs are 
sufficient to enable tethering and subsequent membrane fusion.  
 
Figure 3.6: DNA nanostructures drive membrane bending and fusion. A) Amphiphatic DNA 
origami bricks labeled with Alexa-488 or Alexa-647 dyes form regular arrays as seen in the 
TEM image (scale bar: 100 nm) which at high surface densities deform a GUV. Reprinted 
with permission from [108] Copyright 2015 John Wiley and Sons. B) Templated SUVs fused 
with SLBs after capture mediated by tethered pairings. Reprinted with permission from [110] 
Copyright 2016 American Chemical Society.   
To summarize, we showed that DNA origami structures can form 2D lattices on the 
membranes and these lattices can bend the membrane as in the formation of clathrin coated 
pits. The next step would be the design of curved DNA origami structures in order to shape 
the lipid membranes more precisely as observed in the membrane fusion processes by clathrin 
or BAR proteins. Moreover, inspired by these structures more sophisticated designs such as 
membrane-coated DNA origami vesicles in specific sizes and shapes or mechanical devices 
that can insert into membranes could be developed to use in drug delivery applications. !
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M
any of the cellular functions and
processes such as traﬃcking of
nutrients, compartmentalization,
control ofmetabolic pathways, immune res-
ponses, cell adhesion, and transmembrane
charge separation are mediated by the
dynamic assembly ofmembrane-associated
protein clusters.1!3 The proteins clathrin
and caveolin, for example, facilitate the
formation of intracellular transport vesicles
by forming self-assembled complexes upon
receptor activation during endocytosis.4,5
Other transmembrane proteins such as the
FAS receptor, which can assemble into the
death inducing signal complex, can trigger
intracellular signalingpathways upon ligand-
activated multimerization.6,7 All these pro-
cesses require the orchestrated interaction
between various components, which is
greatly facilitated through their lateral diﬀu-
sion and two-dimensional conﬁnement
within the lipid membranes of the cells. In
a diﬀerent context, light-induced catalysis
of water splitting in plants and bacteria
relies on the concerted assembly of many
active components into light-harvesting
complexes within lipid bilayer membranes.8,9
In chloroplasts, the membrane between the
lumen and stroma fulﬁlls several crucial
roles to support eﬃcient photosynthetic
charge separation. In addition to the reduc-
tion of space and dimensions available to
the reactants involved in photosynthesis, it
acts as an eﬃcient barrier for charges after
they have been pumped across the mem-
brane. Furthermore, it helps to organize the
components of the photosynthetic complex
with the correct orientation with respect to
each other and the surrounding compart-
ments in the ﬁrst place.
In order to mimic and potentially utilize
similar membrane-localized self-assembly
mechanisms for nanotechnology appli-
cations, we here study the assembly of
membrane-bound DNA nanostructures that
are inspired by and modeled after mem-
brane-associated protein complexes. DNA
nanotechnology allows the construction of
arbitrarily shaped objects at the same length
scale as protein complexes, which can be
* Address correspondence to
tim.liedl@physik.lmu.de.
Received for review January 9, 2015
and accepted March 3, 2015.
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ABSTRACT Biological membranes fulﬁll many important tasks within living
organisms. In addition to separating cellular volumes, membranes conﬁne the
space available to membrane-associated proteins to two dimensions (2D), which
greatly increases their probability to interact with each other and assemble into
multiprotein complexes. We here employed two DNA origami structures functio-
nalized with cholesterol moieties as membrane anchors;a three-layered
rectangular block and a Y-shaped DNA structure;to mimic membrane-assisted assembly into hierarchical superstructures on supported lipid bilayers
and small unilamellar vesicles. As designed, the DNA constructs adhered to the lipid bilayers mediated by the cholesterol anchors and diﬀused freely in 2D
with diﬀusion coeﬃcients depending on their size and number of cholesterol modiﬁcations. Diﬀerent sets of multimerization oligonucleotides added to
bilayer-bound origami block structures induced the growth of either linear polymers or two-dimensional lattices on the membrane. Y-shaped DNA origami
structures associated into triskelion homotrimers and further assembled into weakly ordered arrays of hexagons and pentagons, which resembled the
geometry of clathrin-coated pits. Our results demonstrate the potential to realize artiﬁcial self-assembling systems that mimic the hierarchical formation of
polyhedral lattices on cytoplasmic membranes.
KEYWORDS: DNA origami . DNA nanotechnology . lipid membrane . diﬀusion . arrays . cholesterol . clathrin
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easily modiﬁed with organic molecules with nano-
meter precision, deﬁned orientation, and fully con-
trolled stoichiometry. Membrane-encapsulated DNA
nanostructures and membrane-spanning DNA nano-
pores have already been constructed and have been
introduced into artiﬁcial bilayers by functionaliz-
ing these DNA structures with hydrophobic moieties
such as cholesterol, ethyl phosphorothioate, or por-
phyrin.10!13
Several characteristics of lipid bilayer membranes
are particularly attractive for nanoscale assembly:
membranes are extended, quasi two-dimensional
structures, which naturally divide space into “cis” and
“trans” membrane regions. This confers the possibility
to create asymmetric assemblies with diﬀerent com-
ponents bound to only one side of a membrane or to
embed transmembrane structures in distinct orienta-
tions. In addition, the ﬂexibility and ﬂuidity of lipid
membranes facilitate the creation of potential nonpla-
nar assemblies, which can change shape or dynami-
cally assemble and disassemble. We here utilize these
features to achieve hierarchical organization of DNA
nanoobjects into extended superstructures on sup-
ported lipid bilayers (SLBs) and on small unilamellar
vesicles (SUVs). We characterize the resulting dynamic
assemblies by video ﬂuorescence microscopy and
high-speed atomic force microscopy (AFM) imaging.
In fact, until now only a few examples of DNA self-
assembly across scales have been presented14!17 even
though many ﬁelds of research could beneﬁt from
large, self-assembled superstructures of molecules or-
dered in a deﬁned orientation. For example, arrays of
optically active subwavelength metamolecules could
exhibit novel optical properties,18 and molecular cata-
lysts inserted into ion-impermeable membranes and
assembled with light-funneling nanostructures could
be used to create novel photocatalytic systems. Also
structural biology could beneﬁt from the arrangement of
transmembrane proteins into two-dimensional lattices,
which could ultimately be investigated in grazing
incident X-ray experiments. Two important steps
toward the realization of such applications are the
orientation-controlled grafting of molecularly pro-
grammable building blocks in and on ﬂuid mem-
branes19!22 and their subsequent assembly into super-
structures of deﬁned geometry.
RESULTS AND DISCUSSION
We built and studied two DNA origami structures: a
rectangular, three-layered DNA origami block with
dimensions of 60 nm " 35 nm " 8 nm (Figure 1)
and a bent DNA origami structure with dimensions
of 70 nm " 20 nm " 15 nm that mimics the triskel-
ion assembly of clathrin. Both designs (details can
be found in the Supporting Information, Figure S1)
allow modiﬁcation with up to 16 ﬂuorescent dyes
and four cholesterol moieties. To this end, we ex-
tended staple oligonucleotides with two 18-nt long
sequences (anchor sequences), which are comple-
mentary to those of a cholesterol-TEG-labeled oligo-
nucleotide and an Alexa488-labeled oligonucleotide
(Figure 1A).
We ﬁrst focus on the block structure in order to
illustrate the basic principles of our approach. The
three-layered DNA origami block was created as a
suﬃciently rigid structure that provided multiple posi-
tions for functionalization on its top and bottom layer.
Structurally rigid building blocks are a necessary pre-
requisite for the assembly of extended lattices. This
was particularly important in the initial phase of the
project, when diﬀerent lattice geometries were ex-
plored also in the absence of a supporting substrate.
The positions of the cholesterol anchor extensions
were chosen such that they were located close to the
four edges of the bottom layer of the DNA origami
block while the handle sites for the ﬂuorophores were
Figure 1. DNA origami block on lipid membrane. (A) DNA origami block structure consisting of three layers of 14 double
helices each. The indicated dimensions assume a distance between the base pairs of 0.34 nm and an average distance
between the centers of the helices of 2.5 nm. (B) Cholesterol-mediated binding of origami blocks to a lipid bilayer membrane
(ODN: oligodeoxynucleotide; DOPC: 1,2-dioleoyl-sn-glycero-3-phosphocholine). (C) Programmed polymerization of DNA
origami blocks into diﬀerent superstructures following the addition of connector staples to structures diﬀusing on the
membrane.
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evenly distributed over the top layer. First, we tested
the assembly of DNA origami blocks in the presence of
cholesterol-TEG-modiﬁed oligonucleotides. Choles-
terol-modiﬁed structures have a strong tendency to
form aggregates in aqueous solutions due to their
hydrophobic interactions; in fact, the critical micelle
concentration of cholesterol in solution is 25 to
40nM,23which is below the concentration of cholesterol-
modiﬁed DNA (>100 nM) in our assembly. Agarose gel
analysis shows that the origami blocks that were
modiﬁed with only two cholesterol moieties formed
dimers and higher order aggregates (Supporting In-
formation, Figure S2). For this reason, we folded the
structures without cholesterol-modiﬁed strands and
instead incorporated the cholesterol-bearing oligo-
nucleotides into the lipid membrane during forma-
tion of the SLB as described below and in Figure 1B.
For the sequence-controlled multimerization of the
DNA structures we made use of a speciﬁc feature of
DNA origami designs: single-stranded scaﬀold loops
at the edges of origami structures can be cross-linked
by appropriately chosen “multimerization staples”,
which results in the formation of long chains or
structures extended in two dimensions.14,24!28 In
our origami block design we introduced sticky ends
to induce end-to-end polymerization in one dimen-
sion and a corner-to-corner connection for the for-
mation of a two-dimensional lattice where the nine
helices of the front right corner of one block connect
to the distant left corner of the next block and vice
versa, as depicted in Figure 1A and C. DNA origami
block dimers were fabricated by fusing two single
DNA origami blocks using 12 staple strands as ex-
plained in the Supporting Information Figures S3
and S4. Agarose gel analysis and transmission elec-
tron microscopy (TEM) revealed the assembly of DNA
Figure 2. Lateral diﬀusion of origami block monomers and dimers on supported lipid bilayers. TEM images of DNA origami
blockmonomers (A) and dimers (B) (scale bars: 50 nm). Fluorescence images of DNA origami blockmonomers (C) and dimers
(D) on a DOPC lipid bilayer (scale bars: 5 μm). Example diﬀusion trajectories for ﬁve block monomers (E) and ﬁve dimers (F)
(scale bars: 5 μm). (G) Time-dependent mean-square displacement (MSD) plot of monomers and dimers. (H) Distribution of
diﬀusion coeﬃcients obtained from single-particle tracking of origami block monomers and dimers. The black lines are
Gaussian ﬁts to the distributions.
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origami blocks (Figure 2A and Figure S5) and origami
block dimers (Figure 2B and Figure S5) at high yields
(93% and 94%, respectively).
To observe grafting of the DNA origami blocks and
their subsequent lateral diﬀusion on artiﬁcial lipidmem-
branes by ﬂuorescence microscopy, we prepared lipid
bilayers from a 99:1 mixture of 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC) and 1,10-dioctadecyl-3,3,30,30-
tetramethylindodicarbocyanine perchlorate (DiD) in-
side a microscopy slide ﬂow chamber (Sticky-
Slide VI0.4, Ibidi; cf. Materials and Methods). We then
ﬂushed a solution containing the cholesterol-
modiﬁed oligonucleotides through the channel and
incubated it for 1 h. The ﬂow chamber was mounted
on an inverted ﬂuorescence microscope to image the
membrane and the ﬂuorescently labeled DNA struc-
tures that speciﬁcally hybridized to the cholesterol-
anchored DNA handles. The ﬂuidity of the bilayer
was assessed in ﬂuorescence recovery after photo-
bleaching (FRAP) experiments with Texas Red-labeled
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine
(DHPE) that was introduced at 1% into the membrane
(Figure S6). Observation of diﬀusing DNA origami struc-
tures that were speciﬁcally attached to the cholesterol
handles was crucially dependent on buﬀer composition.
Divalent ions had to be omitted entirely, as the DNA
structures stopped diﬀusing already at low Mg2þ con-
centrations, which we assume is a result of the DNA
structures sticking to the glass substrate underneath the
bilayer. We thus applied the DNA origami structures
(10 pM) to the microscopic chamber in a HEPES
buﬀer (10 mM, pH 7.6) containing only monovalent
cations (150 mM NaCl). After 1 h of incubation and
several washing steps, we observed adherence and
two-dimensional diﬀusion of DNA origami structures in
membranes that were prepared with the cholesterol
handles (Figure 2C and D, Supplementary Movies S1
and S2). In control experiments with lipid membranes
that lacked such cholesterol handles, in contrast, DNA
structures did not adhere and the ﬂuorescent objects
moved in and out of the focal plane instead. Membrane-
adherent particles were tracked with image analysis
software, and 2D diﬀusion maps were generated as
shown in Figure 2E and F. Analysis of single-particle
tracks revealed that ∼80% of the monomers (n = 748)
and dimers (n = 762) were diﬀusing on the membrane,
while the other particles remained stationary. Subdiﬀrac-
tion-sized holes in the membrane may account for the
immobile objects, as DNA structures that encounter such
a hole will permanently stick to the subjacent substrate.
In order to quantify the diﬀusive motion of DNA
origami block monomers (Figure 2C and E) and
dimers (Figure 2D and F);each modiﬁed with either
four or eight cholesterol handles;in DOPC lipid
membranes, we tracked 84 single particles and
50 dimer particles over time. Examples of particle
trajectories obtained from the sequential analysis of
200 frames are presented in Figure 2E and F. From
these tracks we extracted the mean square displace-
ment (MSD) of the particles over time using the two-
dimensional diﬀusion equation ÆΔx2æ = 4DτR. Localiza-
tion errors were accounted for by applying a conﬁne-
ment oﬀset.29 The resulting MSD plots displayed in
Figure 2G reveal an almost linear increase over time
for all tracked particles with a slight tendency for
subdiﬀusional behavior, which may be attributed to
occasional defects in the lipid bilayer. We then calcu-
lated the diﬀusion constant of single particles and
plotted their relative frequency over D (Figure 2H).
The average diﬀusion coeﬃcients of the DNA origami
block monomers were found to be DM,4Chl = 0.4 (
0.1 μm2/s (RM, 4Chl = 0.9 ( 0.1, n = 84) and DM,8Chl =
0.26( 0.1 μm2/s (RM,8Chl = 1( 0.1, n = 49) for four and
eight cholesterol anchors, respectively, while the dimer
assemblies yielded DD,4Chl = 0.3 ( 0.1 μm2/s (RD,4Chl =
0.9( 0.1, n = 48) and DD,8Chl = 0.2( 0.1 μm2/s (RD,8Chl =
1 ( 0.1, n = 50). These values are in reasonable
agreement with previous experiments, which were
performed using other origami shapes and diﬀerent
experimental conditions. Single-particle tracking of
single-layered rectangular DNA origami sheets on
SLBs previously resulted in a diﬀusion coeﬃcient of
D = 0.7 μm2/s.18 In ﬂuorescence correlation spec-
troscopy experiments, DNA origami six-helix bun-
dles were found to diﬀuse on lipid bilayer vesicles
with a larger D = 1.39 μm2/s,19 which may be
expected for a membrane in which both lipid layers
are ﬂuid.
The standard theoretical model describing the diﬀu-
sion of objects inside a lipid membrane originally
developed by Saﬀman and Delbrück30 cannot be
directly applied to our experiments, as the DNA struc-
tures ﬂoat on top of the membrane and only a ﬁnite
number of anchoring cholesterols actually reside with-
in the membrane. On the other hand, the Stokes"
Einstein model for objects ﬂoating freely in solution
predicts diﬀusion coeﬃcients more than an order of
magnitude larger than the observed values. This dis-
crepancy indicates that the drag of the surrounding
ﬂuid is negligible and it is indeed the membrane that
governs the behavior. Previous studies found that the
frictional contributions of few lipid anchors that are
coupled but well separated act additively. This is in
good agreement with our observation that the mea-
sured diﬀusion constants of DNA structures that carry
four cholesterol anchors are almost twice as large as
those of the same structures with eight cholesterol
anchors.31,32
Next, we tested the polymerization of DNA origami
blocks on supported lipid bilayers. We used diﬀerent
sets of staples to polymerize DNA origami blocks either
into 1D or 2D arrays (cf. Figure 1 and Figure S7).
Multimerization staples were added to the ﬂuid cham-
ber 1 h after adsorption of the DNA origami blocks on
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the DOPC lipid bilayer and after rigorous washing
to ﬂush out monomers that were not yet anchored to
the membrane. In ﬂuorescence images taken after
24 and 72 h of incubation time polymers of DNA
origami blocks of submicrometer up to 1.5 μm (24 h)
and 2.8 μm (72 h) length became visible (Figure 3A).
The length distribution would be expected to follow a
single exponential for 1D polymerization processes
with ﬁxed kon and koﬀ rates if a constant supply
of monomers were present in the chambers. Indeed,
for the initial phase of the experiment (up to 24 h) we
observe an approximately exponential length dis-
tribution (Figure 3A). Due to monomer depletion,
however, the growth processes stalled and the ﬁnal
length histogram at 72 h deviates from an exponen-
tial. Note that we subsumed all particle sizes below
the diﬀraction limit of the ﬂuorescence microscope
(∼300 nm) into a single histogram bin. It is also
noteworthy that we still observed rotational and
lateral diﬀusion of the polymerized DNA origami
blocks (Figure S8).
In order to form 2D arrays with the DNA origami
blocks we employed a set of staples that pairwise
connected the diagonally opposing corners of a block
(cf. Figure 1 and Figure S9). When the monomer
structures were incubated with the multimerization
staples without the support of SLBs, TEM images
revealed the formation of arrays containing ∼10
monomers (Figure 3B). Even the addition of fresh
monomers to the solution did not dramatically in-
crease the size of the resulting arrays. In contrast, when
the structures were incubated on the SLBs, the ﬂuo-
rescence images showed the formation of extended
structures on the micrometer scale (Figure 3B). The
area of the largest structure observed corresponds to
an assembly of approximately 200 block monomers.
High-speed AFM imaging on supported bilayers pre-
pared on mica conﬁrmed our assumptions. For this we
Figure 3. Programmable polymerization of DNA origami blocks on supported lipid bilayers. (A) One-dimensional polymer-
ization. Left: TEM image of polymerized origami blocks after 24 h of incubation in TE buﬀer with 11 mM Mg2þ (scale bar:
50 nm). Middle: Fluorescence images of polymerized origami blocks after 24 and 72 h of incubation on DOPC lipid bilayers
(scale bar: 5 μm). Right: Histogram of the estimated number of origami blocks per ﬂuorescent particle after 24 and 72 h of
incubation. (B) Two-dimensional polymerization. Left: TEM image of polymerizedDNAorigami blocks after 24 h of incubation
in TE buﬀer with 11mMMg2þ (scale bar: 40 nm). Middle: Fluorescence image of polymerized DNAorigami blocks after 72 h of
incubation (scale bar: 5 μm). Inset: Magniﬁed image of one of the particles including a scheme of a 2D origami lattice for size
comparison (scale bar: 400 nm). Right: Histogram of the area of the lattices after 72 h of incubation. (C) AFM image
demonstrating lattice formation on the lipid bilayer (scale bar: 300 nm, scan rate: 10 Hz, 512 " 512 pixels). (D) AFM images
showing the decomposition of a lipid bilayer over a time interval of 75 s, which results in the adsorption of an origami lattice
on the mica surface (scale bar: 300 nm, scan rate: 10 Hz, 1024 " 1024 pixels).
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prepared lipid bilayers on a mica surface using a
solution containing DOPC SUVs in water (cf. Materials
and Methods). After binding of the DNA origami
blocks on the bilayers and overnight incubation, we
imaged the samples under various buﬀer conditions.
Imaging in a “low-salt” HEPES buﬀer containing
150 mM NaCl was not successful, as the origami
structures appeared to be too mobile and were
pushed around on the bilayer by the AFM cantilever.
In order to electrostatically ﬁx the structures on the
SLBs, we used an imaging buﬀer containing high
concentrations of MgCl2 (125 mM MgCl2, 400 mM
Tris, 200 mM acetic acid, and 10 mM EDTA, pH 8.5),
which enabled the observation of DNA block ar-
rays of up to 2 μm in diameter (Figure 3C). Arrays
formed in solution, in contrast, were less ordered
and far smaller in size (Figure S10). Even at such
excessive Mg2þ concentrations, DNA nanostruc-
tures were still mobile on the mica-supported lipid
bilayer during imaging. This resulted in a compara-
tively low imaging resolution, especially for arrays
that were not immobilized at the edges of the bilayer
patches. By contrast, DNA arrays touching the under-
lying mica substrate did not move. As an example,
in Figure 3D a time-lapse image series is shown in
which a DNA array has initially formed on top of a
lipid bilayer. We speculate that due to the high MgCl2
concentration and the repetitive imaging of the
same area, the lipid bilayer is partly destroyed
and thereby the substrate exposed, this way immo-
bilizing the DNA lattice on the mica surface.
At lower MgCl2 concentrations, however, the lipid
bilayer stayed intact over several imaging cycles
(Figure S11).
Figure 4. Programmable polymerization of DNA origami triskelions. (A) TEM image of a truncated Y-shaped DNA origami
(scale bar: 20 nm). (B) TEM image of a triskelion DNA origami assembled from three truncated Y structures (scale bar: 20 nm).
(C) TEM image showing the polymerization of DNA origami triskelions into hexagonal lattices in solution (scale bar: 200 nm).
(D) AFM image demonstrating extended polymerization of DNA origami trimers into 2D arrays on supported lipid bilayer
(scale bar: 2 μm, scan rate: 4 Hz, 1024 " 1024 pixels).
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To further illustrate the potential of our approach
to mimic cellular self-assembly processes on artiﬁcial
lipid bilayer membranes, we designed a second
DNA origami structure that is inspired by the pro-
tein clathrin.4 This protein has a three-legged shape
(triskelion) and helps to bud oﬀ vesicles from the
plasma membrane for internalization of molecules
that adhered to a cell. The three arms of the tri-
skelion form a 120! angle with respect to each other
and furthermore bend slightly out of plane. During
membrane budding, the clathrin molecules shape
round vesicles by assembling into polyhedral
networks consisting of pentagonal and hexagonal
rings, the so-called clathrin-coated pits. Our DNA
structure has the approximate shape of the letter
Y, in which one of the arms has been truncated
(Figure 4A). The remaining arm forms a 60! angle25,33
with the vertical line, and the tip of this arm can be
connected with a set of “trimerization” oligonucleo-
tides to the recess of the truncated arm. Three
truncated Y's thus form a homotrimer with three legs
arranged in 3-fold rotational symmetry (Figure 4B).
Upon addition of a set of multimerization oligonu-
cleotides that connect these legs to each other, the
homotrimers in turn can assemble into hexagonal
arrays (Figure 4C). As the DNA-based structures still
have some degree of angular ﬂexibility, also the
occasional formation of pentamers can be observed
(Figure S12). When we anchored preassembled tri-
mers via cholesterol linkers to SLBs on mica and then
added the multimerization oligonucleotides, we
were able to image arrays consisting of hexamers
and pentamers that were several micrometers in
diameter (Figure 4D).
Finally, we tested the formation of DNA origami
lattices on SUVs in suspension. Following a standard
SUV preparation protocol34 involving tip sonication
and extrusion, we obtained SUVs of up to 300 nm
in diameter (Figure S13). We ﬁrst incubated these
SUVs with the cholesterol-modiﬁed oligonucleotides
(HEPES buﬀer, 150 mM NaCl, pH 7.6) for 15 min,
followed by incubation with DNA origami blocks for
1 h. TEM imaging revealed successful binding of DNA
origami block monomers to the SUVs (Figure 5A).
Subsequent addition of array-forming connector sta-
ples led to the formation of 2D array patches on the
SUVs. TEM images suggest DNA origami-induced
shape deformation of the SUVs, but further studies
are required (Figure 5B).
CONCLUSIONS
In this study we explored cholesterol-mediated
binding and diﬀusion of DNA origami structures
on supported lipid bilayer membranes and utilized
it to create hierarchical assemblies and arrays of such
structures with sizes of several micrometers. We
found that the measured diﬀusion coeﬃcients of
the individual membrane-anchored DNA structures
scale both with the size of the object and with
the number of cholesterol anchors that couple the
objects to the lipid bilayers, which indicates that the
coupled cholesterol moieties are spaced far enough
apart to allow free draining of the lipid molecules
in between. Importantly, the orientation of the DNA
structures with respect to the bilayer is well-deﬁned,
as the anchoring is mediated exclusively through
DNA anchors that extend from the DNA origami
structures on a deﬁned side and couple to choles-
terol molecules embedded in the membrane. This
predeﬁned orientation of the objects and their
conﬁnement to diﬀuse in 2D allowed the growth of
DNA origami arrays that were an order of magnitude
larger than those assembled in solution and after-
ward deposited on a substrate. Arrays of oriented
nanostructures tethered to artiﬁcial lipid bilayers
could be employed to spatially order membrane-
associated proteins in their native environment,
which could help to study their structural properties
with cryo-electron microscopy or X-ray diﬀraction
methods. Moreover, we found that when the arrays
were assembled on membranes of small unila-
mellar vesicles, the binding interactions appeared
to be even strong enough to promote the defor-
mation of these SUVs. Our results encourage us to
Figure 5. DNA origami block polymerization on SUVs. (A) TEM image of DNA origami block monomers on an SUV (scale bar:
60 nm). (B) 2D lattice formation of the DNA origami blocks on SUVs (scale bars: 60 nm). Interactions between origami lattices
and SUVs apparently result in a shape deformation or even destruction of the vesicles.
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believe that it will be possible to build DNA objects
that mimic biological building blocks such as clathrin
or caveolin that play a crucial role in endocytotic
processes.
MATERIALS AND METHODS
Preparation of DNA Origami Blocks and Triskelions. All unmodified
DNA staple strands (HPSF purified) and dye-modified oligonu-
cleotides (HPLC purified) were purchased from Eurofins MWG
Operon (Ebersberg, Germany) (see the Supporting Information,
Tables 1 and 2 for sequences) Cholesterol-modified DNA (HPLC
purified) was purchased from Biomers (Ulm, Germany). DNA
origami structures were designed using caDNAno35 and pre-
pared by mixing 10 nM M13 based dsDNA scaffold (p8064 for
the block structure36 and p7560 for the origami triskelion) with
unmodified staple strands (100 nMeach) and 1μM fluorescently
modified staple strands in 1! TE-Mg2þ buffer (10 mM Tris-HCl,
1mMEDTA, 16mMMgCl2, pH 8.0). In the experiments, between
5 and 16 of the unmodified staple strands were extended at the
30-end to facilitate hybridization of a fluorescently modified
oligonucleotide (50-Alexa488-GGAAGTTGATATGGTTGATG-30)
to the DNA origami structures. Either four or eight of the
unmodified staple strands were extended at the 50-end to
enable hybridization to a cholesterol-modified oligonucleotide
(50-GGTAGTAATAGGAGAATG-CholTEG-30). The solution was
heated to 80 !C for 5 min, cooled to 65 !C over the course of
15 min, and cooled further to 25 !C in 16 h.
Purification and Characterization of DNA Origami Structures. Excess
staple strands were removed from DNA origami blocks by
agarose gel purification. For this 0.7% agarose was dissolved
in 0.5! TBE buffer (pH 8.2) by heating until boiling. MgCl2
(11 mM) was added after cooling, and the solution was poured
into a gel cask for solidification. A 200 μL amount of sample
solution containing the assembled DNA origami structures and
excess staple strands was mixed with 40 μL of 6! loading dye
and then loaded into the gel pockets. The gel was run for 2 h
at 70 V in an ice-cold water bath to prevent heat-induced
denaturation of DNA origami structures. After running, the
corresponding band for fluorescently labeled DNA origami
structures was cut out from the gel with a razor blade and
extracted from the gel by running through spin columns
(Freeze'n Squeeze spin columns, Biorad) at 8000g for 7 min.
The typical concentration of DNA origami structures was 2 nM.
To characterize assembled DNA origami structures, samples
were imaged using a JEM-1011 transmission electron micro-
scope (JEOL). DNA origami structures were incubated on argon
plasma-exposed (24 W for 1 min) Formvar/carbon-coated grids
and then negatively stained with 1% uranyl acetate for 15 s.
Preparation of Lipid Bilayers and DNA Origami Structure Binding. 1,2-
Dioleoyl-sn-glycero- 3-phosphocholine (Avanti Polar Lipids) and
1,10-dioctadecyl-3,3,30 ,30-tetramethylindodicarbocyanine perchlo-
rate (Life Technologies) were prepared with 25 and 1 mg/mL
concentration in chloroform for supported lipid bilayer forma-
tion. DOPC and DiD were mixed at a 99:1 (w/w) ratio in a clean
glass vial with a final concentration of 1 mg/mL DOPC. This
solution was dried with nitrogen flow for 30 min and further
dried in a vacuum oven overnight to make sure any trace
chloroform was removed. Dried lipid film was resuspended in
1mLof PBS buffer (pH 7.4) to obtain a 1mg/mL lipid suspension.
A stock of hydrated lipid suspension was stored at 4 !C for at
most 2 weeks.
To prepare supported lipid bilayers, the hydrated lipid
suspension stock was diluted to 0.1 mg/mL in 1! PBS buﬀer.
A 100 μL portion of this suspension was injected into the ﬂuidic
chamber of a six-channel microscopic slide (Sticky Slide VI0.4,
Ibidi, Germany) and ﬁlled up with 1! PBS buﬀer. After 1 h
incubation of lipid vesicles, the suspension was washed with
double-distilled Milli-Q water to induce lipid bilayer formation
by osmotic pressure and also to remove excess lipid vesicles.
Then, 50 μL of 10 nM cholesterol-TEG-modiﬁed oligonucleotide
was added to the chamber, and the mixture was incubated for
1 h to embed them into the lipid bilayers. A lipid buﬀer with
monovalent cations (10 mM HEPES, 150 mM NaCl, pH 7.6) was
used to dilute cholesterol-modiﬁed oligonucleotides and for
further washing steps.22 The stability of the DNA origami
structures under these conditions was conﬁrmed using TEM
imaging and gel electrophoresis (Figure S14). After incubation
for 1 h, unbound oligonucleotides were washed away using
lipid buﬀer. Finally, DNA origami structures were added at a
concentration of 10 pM.
Fluorescence Microscopy. Fluorescence images of DNA origami
blocks were obtained on a fluorescence microscope (Olympus
IX71) equipped with a CCD camera (Hamamatsu ORCA II) using
a Olympus PlanApo 100!, 1.4 NA oil immersion objective.
Lipid bilayer formation was checked at 647#670 nm (Ex/Em)
wavelengths, and DNA origami blocks were visualized at
499#519 nm (Ex/Em) wavelengths.
Fluorescence Recovery after Photobleaching. For FRAP analysis, a
DOPC-supported lipid bilayer was prepared as described above,
but Texas Red-DHPE was used instead of DiD at the samemolar
ratio (99:1) for the dye labeling. FRAP was performed with a
532 nm laser (20mW), and a circular bleach spot with a radius of
6.7 μm surrounding the bleached area was used for data
collection and analysis. For the analysis, 20 images were
acquired with an interval of 500 ms. The first image captured
prior to photobleaching was used to calculate the initial fluo-
rescence intensity followed by 19 consecutive images, in which
bleaching and recovery were recorded. FRAP data were further
processed using the ImageJ “FRAP Analyzer” plugin. The fluo-
rescence signal was normalized to its respective initial fluores-
cence intensity prior to photobleaching, and the FRAP curve
was constructed using the average fluorescence intensities of
the recovery images. Then, the FRAP curve was fitted to a one-
phase association fit model with the equation
f (t) ¼ aþ b! (1 # e#λt )
with the fit parameters a =#0.116, b= 0.92, and λ= 0.2798/s. To
calculate the diffusion coefficient (D) for lateral diffusion of
lipids within the lipid bilayer, the “characteristic” diffusion
time (τ1/2 = ln 2/λ) required to recover 50% of the original
fluorescence intensity was calculated from the equation above
(τ1/2 = 2.477 s) and inserted in the following equation:
D ¼ 0:224w2=τ1=2
wherew is the radius of the photobleached spot.37 The diffusion
coefficient (D) of the lipid bilayer was found to be 4.1 μm2/s.
Single-Particle Tracking and Mean Square Displacement Analysis.
DNA origami blocks were added at 10 pM final concentration
into a fluidic chamber containing a DOPC SLB. After 1 h of
incubation, unbound origami structures were washed away
using lipid buffer (10 mM HEPES, 150 mM NaCl, pH 7.6). Lateral
diffusion of DNA origami blocks was monitored using mercury
lamp excitation. To analyze diffusion, 100 frames from the same
spot were acquired with 0.132 s exposure time per frame. At
least 20 different fields of viewwere captured for analysis. Time-
averaged mean square displacement analysis was performed
using the ImageJ software plugin “Manuel Tracking”. Only
trajectories of the particles remaining within the frame and
which could be tracked for all 100 frames (13.2 s) were analyzed.
To analyze the eﬀect of the DNA origami block size on
diﬀusion, we produced DNA origami block dimers from mono-
mers by connecting them from the same side of two origami
block monomers. Twelve connector staples were designed in
such away that half of them could bind to single-strand loops at
the edge of one origami block, while the other half could bind to
the same edge of another origami block. Each pair of connector
staples could hybridize together over a length of 10 nt. Tracking
and MSD analysis of block dimers were performed as men-
tioned above. In total, 81 block monomers and 49 block dimers
were analyzed.
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1D and 2D Polymerization of Membrane-Bound DNA Origami Blocks.
To polymerize DNA origami blocks on DOPC-supported bilayers,
DNA origami blocks were added into the fluidic chamber at
10 pM final concentration. After 1 h of incubation, connector
staples were added at 100 pM final concentration. 1D polymer-
izationwas accomplished using 35 connector staples designed in
such a way that every staple could bind to the single-stranded
scaffold loop at the other endof the samehelix (Figure S7). For 2D
polymerization, 16 connector staples were designed to connect
opposite corners of the structure by sticky end hybridization
(Figure S9). Images were taken by fluorescence microscopy after
24 and 72 h of incubation. The characterization of the DNA block
polymers was done using ImageJ software.
AFM Imaging. AFM measurements were performed in tap-
ping mode with an Asylum Research Cypher ES and Olympus
BioLever minicantilever (0.1 N/m spring constant) driven at
its respective resonance frequency around 18 kHz. A DOPC-
supported bilayer was formed on the mica surface by mixing a
DOPC/DiD (99:1) solution and distilled water in 1:1 ratio directly
after cleavage and incubating for at least 30 min at 37 !C. The
sample was washed with distilled water to remove excess
vesicles. In order to adsorb DNA nanostructures (500 pM) on
the SLB and to facilitate the formation of lattices, the same
protocol was applied as for the fluorescence microscopy sam-
ples on glass, followed by incubation for at least 12 h. The buffer
(10 mM HEPES, 150 mMNaCl, pH 7.6) was then exchanged with
a solution containing high concentrations of MgCl2 (125 mM
MgCl2, 400 mM Tris, 200 mM acetic acid, and 10 mM EDTA,
pH 8.5) to fix the DNA nanostructures to the substrate.
TEM Imaging of SUVs. To visualize DNA origami block polyme-
rization on small unilamellar vesicles, a 1 mg/mL DOPC solution
in 10 mM HEPES buffer (150 mM NaCl) was sonicated for
15min with a tip sonicator. Then, a 0.25 mg/mL SUV suspension
was mixed with 100 nM cholesterol-modified DNA in the same
buffer. Thirty minutes after incubation, 100 pM DNA origami
blocks were added. Finally, connector staples were added at
200 pM final concentration and incubated overnight. Samples
were imaged using a JEM-1011 transmission electron micro-
scope (JEOL). DNA origami blocks were incubated on argon
plasma-exposed (24 W for 1 min) Formvar/carbon-coated grids
and then negatively stained with 1% uranyl acetate for 20 s.
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4  DNA-based Nanostructures as Immune-Modulatory 
Agents in vivo 
4.1 DNA-based Nanostructures for Immune-Stimulation and Vaccination 
! DNA based nanostructures can also be used for immune stimulation and vaccination 
through the hybridization with immunoactive oligonucleotides. In eukaryotic cells, DNA 
molecules outside of the nucleus or mitochondria are considered as pathogen-associated 
molecular patterns (PAMPs) which alerts the host cell against pathogen invasion or in the 
presence of damaged cells around [111, 112]. This induces the activation of innate immune 
system by the production of pre-inflammatory cytokines which recruit the leukocytes to 
remove the infectious microbes and clear the damaged cells. One of the main signaling 
pathways sensing foreign DNA is through unmethylated cytosine-phosphate-guanine (CpG) 
motifs. These motifs are highly specific to bacterial or viral DNA and rarely found in the 
mammalian genome are recognized by Toll-like receptor 9 (TLR9) localized in the endosome 
[113, 114]. Upon interaction with the internalized CpG motif, TLR9 is translocated to 
endolysosomal complex and activates downstream myeloid differentiation primary response 
88 (MYD88)-mediated signaling pathway [115]. The activation of this pathway leads the 
production of proinflammatory cytokines such as type I interferon (IFN) and interleukin 6 
(IL-6) in phagocytic and antigen presenting cells (APCs). For this reason, synthetic 
oligonucleotides containing CpG motifs are commonly used as vaccine adjuvants to improve 
APC funtion and co-administered with antigens to induce adaptive immune system for the 
therapy of cancer, allergy and infectious diseases [116]. 
 Since DNA nanostructures are more stable in compare to free oligonucleotides, several 
groups have developed DNA carriers decorated with CpG motifs. Takakura et al. developed 
Y-shaped DNA structure consisted of 3 CpG motifs where the halves of each ODN are 
partially complementary to the half of the other 2 ODNs [117]. These structures induced 
increased amount of tumor necrosis factor α (TNF- α) and IL-6 in macrophage-like 
RAW264.7 cells compared to the single stranded or double stranded ODNs due to the 
increased amount of uptake by the cells. More branched structures such as polypod-like and 
dendrimer-like structures or rolling circle amplification (RCA) products with high CpG 
density showed the further enhanced efficiency of immune stimulation in vitro [118-120]. 
(Figure 4.1A and B) Schüller et al. showed that 30-helix DNA origami tubes covered with 62 
individual CpG sequences induced the immune response in freshly isolated spleen cells 
especially when the CpG motifs partially phosphorothioate (PTO) modified [121]. (Figure 
4.1C) It is highlighted that DNA origami tubes carrying CpG motifs induced higher IL-6, IL-
12 and C-type lectin 69 (CD69) expression in compare to bare DNA origami structures and 
free oligonucleotides with CpG or GpC motifs. Liu et al. showed for the first time in vivo 
application of a DNA tetrahedron containing CpG motifs [122]. (Figure 4.1D) 
Functionalization of biotinylated CpG sequences with a model antigen, phycoerythrin-
conjugated streptavidin a synthetic vaccine construct was developed. Immunization of the 
mices with this constructs showed the enhanced antibody production over time.  
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Figure 4.1: Immune stimulation by CpG ODNs using various DNA nanostructure designs. A) 
Polypod-like DNA nanostructures with 3 or 6 CpG oligonucleotides per particle. Reprinted 
with permission from [118] Copyright 2012 American Chemical Society. B) CpG nanoflower 
self-assembled from RCA reaction. Reprinted with permission from [120] Copyright 2015 
American Chemical Society. C) DNA origami tube-like structure decorated with 62 CpG 
oligonucleotides. Reprinted with permission from [121] Copyright 2011 American Chemical 
Society. D) CpG-ODN containing DNA tetrahedron-vaccine complex for in vivo immune 
stimulation. Reprinted with permission from [122] Copyright 2012 American Chemical 
Society. 
 
4.2 CpG-Decorated DNA Nanotubes as Immune-Stimulatory Agents in vivo 
In this study, we investigated the effect of DNA nanotubes carrying CpG sequences in 
real time using in vivo microscopy where the results were presented in associated publication 
P3.1 8-helix DNA nanotubes were formed using single stranded tile assembly method as seen 
in the electron micrograph image. (Figure 4.2A and B) To investigate the uptake and 
inflammation in vivo microscopy setup was used as depicted in Figure 4.2C. DNA 
nanostructures were microinjected locally to the cremaster muscle of the anesthetized mice. 
(Figure 4.2D) The initiation of the inflammatory response is started upon the uptake of the 
DNA nanostructures by tissue macrophages or mast cells. The uptake of the structures by 
these cells was seen in Figure 4.2E. These cells then release pro-inflammatory cytokines that 
results with the activation of the endothelial cells.  
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
1!Portions of Chapter 4.2 is reprinted (adapted) with permission from Sellner, S., Kocabey, S., Nekolla, K., Krombach, F., 
Liedl, T., and Rehberg, M. DNA Nanotubes as Intracellular Delivery Vehicles in vivo. Biomaterials, 2015, 53, 453-463. 
Copyright 2015 Elsevier. Contributions to the Chapter 4.2 were as follows: DNA nanostructure design and characterization 
experiments were performed by S.K. and supervised by T.L. Microinjection of DNA nanostructures into anesthesized mice, 
flourescence microscopy experiments and leukocyte recruitment analysis were performed by S.S. and supervised by M.R. 
The images used in Figure 4.2 C-E and Figure 4.3 B were kindly adapted from S.S and M.R. 
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Figure 4.2: Injection of CpG decorated DNA nanotubes. A) Design of 8-helix nanotubes with 
CpG motifs. B) TEM image of CpG nanotubes. (scale bar: 50 nm) C) Microscopy setup. D) 
Cremaster muscle of the mice. E) Distribution of Atto-488 labeled CpG nanotubes around the 
muscle tissue. (scale bar: 50 µm)   
Leukocytes are regularly rolling inside the blood vessels via continuous binding and 
unbinding of the selectins to their glycosilated ligands expressed on the endothelial cells 
[123]. When the cytokines released by tissue macrophages they bind to the cytokine receptors 
of the endothelial cells located in the basement membrane and this mediates the activation of 
rolling leukocytes to arrest and strong adhesion on the endothelium. (Figure 4.3A) The 
adhesion of the leukocytes is regulated by the expression of integrins and vascular cell 
adhesion molecules (VCAMs) which is the result of G-protein coupled receptors (GPCRs)-
triggered signaling by cytokines [124, 125]. In the last step, strongly adhered leukocytes 
extend membrane protrusions into the endothelial cell bodies and cell junctions by expressing 
several adhesion molecules such as intercellular cell adhesion molecule 1 (ICAM1) and 
platelet/endothelial cell adhesion molecule 1 (PECAM1) which trigger paracellular or 
transcelluar migration to the tissue side [126, 127]. In our experiments, the leukocyte 
recruitment was investigated by counting the adhered and transmigrated cells in 100 µm2 area 
including the both sides of the blood!vessel. (Figure 4.3B) (ipsilateral: is the area next to the 
injection side, contralateral: the opposite side of the vessel)! We observed that DNA 
nanostructures were rapidly uptaken by tissue macrophages and localized in the endosome 
which induce the release of cytokines to activate rolling leukocytes. The number of adhered 
and transmigrated leukocytes were significantly higher for CpG nanotubes in compare the 
plain nanotubes and CpG oligonucleotides. As mentioned also in previous section, CpG-
mediated TLR9 activation induces MYD88-mediated signaling pathway which results in the 
acetylation and translocation of p65, a subunit of the NF-κB transcription factor complex, to 
the nucleus to start NF-κB pro-inflammatory gene expression. (Figure 4.3C) In our 
!
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experiments, immunohistochemistry results showed that only!CpG decorated DNA nanotubes 
showed the p65 translocation which is the indicator of NF-κB activation. 
It is important to note that the in vivo conditions are totally different than the in vitro 
conditions which tile-based DNA nanotubes are tested for the uptake experiments in section 
2.2 although the same tile assembly method was used to fold 8-helix tubes for CpG delivery 
experiments. The stability experiments for CpG nanotubes were performed by considering the 
DNAse concentration and distribution over the muscle tissue.  In these conditions, by 
incubating DNA nanotubes in the DNAse containing buffer and the diluted mice serum we 
observed that the structures are stable at least for 2 hrs.  Moreover, the structures were rapidly 
uptaken by tissue resident macrophages and CpG mediated inflammation and leukocyte 
recruitment was clearly showed. 
55!
!
Figure 4.3: CpG mediated leukocyte recruitment and NF-κB activation. A) Leukocyte rolling 
and adhesion cascade. Reprinted with permission from [123] B) The area showing the 
leukocytes adhered and transmigrated to the both sides of the blood vessel. C) CpG nanotube-
TLR9 mediated cell signaling. Reprinted with permission from [116] Copyright 2004 Nature 
Publishing group. 
To summarize, we demonstrated an efficient delivery system using CpG decorated 
DNA nanotubes in vivo. Using this approach, we showed that tissue macrophages could be 
targeted and leukocyte recruitment could be induced in a really short time. Most importantly, 
the elevation of inflammation is only possible by the conjugation of CpG sequences on the 
structure, plain nanotubes do not induce inflammation. 
 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
56!
!
4.3 Dexamethasone-Conjugated DNA Nanotubes as Anti-Inflammatory Agents in vivo 
! The balance of the immune system is severely important for the host system during the 
abnormal auto-immune responses. In this kind of cases, the manipulation of the immune 
system could be required with an external agent. The ease of fabrication of DNA-based 
nanostructures allow designing of such agents to use as drug carriers. The synthetic 
glucocorticoid drug known as dexamethasone is commonly used to treat inflammatory and 
autoimmune disorders such as rheumatoid arthritis, asthma and severe allergies [128, 129]. It 
has the ability to penetrate into cell nuclei via intracellular glucocorticoid receptors thereby 
suppressing immune response by binding to glucocorticoid responsive elements (GREs) [130, 
131].  
! In this study, we investigated the effect of dexamethasone conjugated DNA nanotubes 
in real time using in vivo microscopy. We designed 6-helix DNA nanotubes using single 
stranded tile assembly method where each tile has 21 base-long domains to hybridize with 4 
adjacent tiles. (Figure 4.4A)  Longer single stranded tiles were used in order to increase the 
stability and resistance to low Mg conditions as discussed in the section 2.2. As illustrated in 
the Figure 4.4A, dexamethasone was conjugated to the nanotubes using i-motif sequence. The 
electon micrograph image shows the folded structure in figure 4.4B. The i-motif structure is a 
four-stranded DNA structure that can be formed in sequences contain stretches of cytosine 
residues [132, 133]. In this structure, when the pH is low, cytosines are protonated and form 
noncanonical base pairs with an unprotonated cytosine which leads the formation of 
quadruple helix. This motif is commonly used for pH-dependent dynamic studies and drug 
delivery applications. Krishnan group recently showed that i-motif based DNA nanodevices 
could be used to map temporal pH changes during endosomal maturation in living cells [59, 
134]. Our purpose was the use of this pH dependent release mechanism to increase the rate of 
endosomal escape in the macrophages to induce the anti-inflammatory responses.  
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Figure 4.4: Dexamethasone conjugated DNA nanotubes. A) 6-helix DNA nanotube design 
carrying i-motif sequence and i-motif dependent release mechanism of dexamethasone 
conjugated ssDNA oligonucleotide. B) TEM image of a single DNA nanotube. (Scale bar: 30 
nm) C) Gel analysis showing i-motif dependent release of the hybridized oligonucleotides 
labeled with Alexa647N at pH 5.5 at 37 °C. 
First we showed that pH dependent release mechanism is working at pH 5.5 only 
when the nanotubes are carrying i-motif sequence. (Figure 4.4C) It is important to note that 
the structures were incubated and filtered at physiological temperature, 37 °C, in order to 
observe the release of dye-modified oligonucleotides. Then, we investigated the anti-
inflammatory effect of the nanotubes using the injection method shown in section 3.2. DNA 
nanotubes were similarly uptaken by tissue macrophages and localized in the endosome. The 
number of adhered and transmigrated leukocytes was decreased for the nanotubes conjugated 
with dexamethasone via i-motif sequence in compare to the plain nanotubes, nanotubes 
without i-motif sequence and dexamethasone conjugated ODNs that were not folded into 
structure. (Figure 4.5) The anti-inflammatory effect, particularly the number of transmigrated 
leukocytes, for dexamethasone-conjugated nanotubes was almost similar with the treatment of 
high dose dexamethasone (1 µg/ml), which demonstrates the potential of DNA-based drug 
carriers with targeting molecules.  
 
Figure 4.5: Quantitative analysis of intravascular adherence and transmigration of leukocytes 
after microinjection of DNA nanotubes. Leukocyte adherence and transmigration were 
quantified in postcapillary venules in the cremaster muscle using in vivo transillumination 
microscopy at 60 min upon microinjection of Dexa tubes, plain tubes, Dexa ODNs, Dexa 
tubes w/o imotif, dexamethasone or saline into postischemic cremaster tissue at onset of 
reperfusion.  
It has been shown that Dexamethasone mediates the immunosuppressive effect by inhibiting 
the recruitment of leukocytes [135]. In order to understand the mechanism behind the 
inhibition of leukocyte recruitment we checked the expression levels of several cellular 
adhesion molecules such as VCAM and PECAM [136]. Immunohistochemistry analysis 
showed that expression levels of these cell adhesion molecules were significantly decreased 
for dexamethasone conjugated nanotubes in compare to the other controls. (Figure 4.6) 
!
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Figure 4.6: Expression patterns of VCAM-1 after the treatment of DNA nanotubes into postischemic 
cremaster tissue. Confocal immunofluorescence of DNA nanotubes (green), VCAM-1 (blue), and 
PECAM-1 (red) showed significant lower VCAM-1 signal in vessels next to the injection site of 
Dexamethasone conjugated DNA nanotubes compared to saline after the treatment. Injection of DNA 
tubes, Dexamethasone DNA nanotubes w/o i-motif as well as of Dexa-ODNs into the cremaster tissue 
led to equivalent VCAM-1 expression levels 60 min after the treatment. Scale bar: 50 µm. 
In summary, we demonstrated the effective use of DNA nanotubes as drug carriers to 
inhibit the inflammation in vivo.2 The conjugation of dexamethasone to the nanotubes and i-
motif dependent release from the structures were successfully indicated. Although endosomal 
escape of dexamethasone could not be proven in vivo by using confocal microscopy, the 
quantitative data clearly indicates that dexamethasone conjugated DNA nanotubes effectively 
blocked the recruitment of leukocytes by inhibiting the expression of cell adhesion molecules 
on the endothelial cells.  !!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
2!Portions of Chapter 4.3 is reprinted (adapted) with permission from Sellner, S., Kocabey, S., Zhang, T., Nekolla, K., Hutten, 
S., Krombach, F., Liedl, T., and Rehberg, M. Dexamethasone-conjugated DNA nanotubes as anti-inflammatory agents in 
vivo. (manuscript in revision) Contributions to the Chapter 4.3 were as follows: DNA nanostructure design and i-motif 
dependent release experiments were performed by S.K. and supervised by T.L. Microinjection of DNA nanostructures into 
anesthesized mice, flourescence microscopy experiments and leukocyte recruitment analysis were performed by S.S. and 
supervised by M.R. The images used in Figure 4.5 and Figure 4.6 were kindly adapted from S.S and M.R.!
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a b s t r a c t
DNA-based nanoconstructs possess great potential for biomedical applications. However, the in vivo
behavior of such constructs at the microscopic tissue/cell level as well as their inﬂammatory potential is
largely unknown.
Unmethylated CpG sequences of DNA are recognized by Toll-like receptor 9 (TLR9), and thus initiate an
innate immune response. In this study, we investigated the use of DNA-based nanotubes as carrier
systems for CpG delivery and their effect on immune cells in vivo and in real time. DNA nanotubes were
microinjected into skeletal muscle of anesthetized mice. Using in vivo microscopy, we observed that the
DNA tubes were internalized within minutes by tissue-resident macrophages and localized in their
endosomes. Only microinjection of CpG-decorated DNA nanotubes but not of plain DNA nanotubes or
CpG oligonucleotides induced a signiﬁcant recruitment of leukocytes into the muscle tissue as well as
activation of the NF-kB pathway in surrounding cells.
These results suggest that DNA nanotubes are promising delivery vehicles to target tissue macro-
phages, whereupon the immunogenic potential depends on the decoration with CpG oligonucleotides.
© 2015 Elsevier Ltd. All rights reserved.
1. Introduction
All mammals (andmany other living organisms) have developed
complex mechanisms to ﬁght off pathogens or foreign substances
entering their bodies [1]. Importantly, the physical introduction of
the critical substance into the body marks the beginning of an
immune response. Despite the fact that our immune system
evolved several effective mechanisms against foreign substances,
external manipulation and modulation of the immune system is
required in the case of severe conditions such as viral and bacterial
infections, immune deﬁciency-related diseases (genetic or ac-
quired, e.g. AIDS), and cancer. Since conventional therapies
including the application of cytostatic and (anti)inﬂammatory
drugs mainly act non-speciﬁcally and systemically, they might
cause serious adverse reactions. In addition, antimicrobial drugs
used against infections cause the emergence of drug-resistant
pathogens over time. For this reason, functionalized nanoscale
carriers have been developed for the targeted delivery of drugs
with the aim to reduce the quantity and the adverse reactions of
therapeutics [2,3]. After the introduction of the concept of DNA-
based nanostructures over three decades ago, the ﬁeld of DNA
nanotechnology has now reached a level where it enables advanced
technology in a variety of research ﬁelds [4e6]. The use of DNA
structures in biological and biomedical studies is particularly
promising due to a number of advantages: DNA structures can be
modiﬁed with a plethora of (bio)chemical moieties with nanoscale
precision [7], there is full control over stoichiometry [8,9], they are
non-cytotoxic [10,11], they can survive in cell media, blood serum
and cultured cells for extended periods of time [12e14] and they
can be used as carriers for immune-stimulatory motifs including
unmethylated CpG sequences [10,15]. Particularly the recently
introduced DNA tile-assembly method [16,17] could foster
biomedical applications, as the tile-assembly method is extremely
versatile, easy to apply, results in high yields of folded structures,
and different than in DNA origami applications, no virus-derived
scaffold is needed for assembly of DNA nanotubes.
Unmethylated CpG sequences have immunogenic properties
and are used as adjuvant in vaccination [18] or to overcome tumor-
associated immunosuppression [19]. These sequences, that are
highly speciﬁc for bacterial DNA, are recognized by a specialized
receptor of the innate immune system localized in the endosome,
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the Toll-like receptor 9 (TLR9), causing production and secretion of
inﬂammatory mediators [20,21].
The initiation of an inﬂammatory response by macrophages -
which are phagocytic cells along with monocytes, dendritic cells,
and mast cells - is accompanied by the activation of other immune
cell populations as well as clearance of cellular debris to maintain
tissue homeostasis [22e24]. On the other hand, they contribute to a
tumorigenic environment by the release of proangiogenic media-
tors [25] and suppression of adaptive immunity [26] in cancer-
related inﬂammation. The acute inﬂammatory response is associ-
ated with the release of soluble proinﬂammatory mediators, e.g. by
tissue macrophages or mast cells, resulting in the activation of the
endothelium. This includes the expression of endothelial adhesion
molecules that facilitate capture and rolling of leukocytes along the
vessel wall. Rolling leukocytes are then activated by the interaction
with chemokines presented or secreted by endothelial cells leading
to arrest and ﬁrm adhesion of leukocytes. Subsequently, leukocytes
emigrate through the vascular wall into the interstitial tissue [27].
To directly observe this immediate response of immune cells,
attracted by chemical signaling in living tissue, can help to under-
stand and circumvent those aspects of the immune system if
needed. Since macrophages are major players, not only in inﬂam-
matory diseases, but also in antimicrobial defense, autoimmunity,
allergy and asthma, antitumor immune responses, tumorigenesis,
metabolic disorders, atherosclerosis, ﬁbrosis and wound healing,
there is great interest in being able to effectively target these cells
[28,29].
In this study we therefore investigated the use of DNA-based
nanotubes as carrier systems for CpG sequences in vivo. To
analyze the uptake of plain as well as CpG sequence-decorated DNA
nanotubes by tissue macrophages and to monitor their effect on
immune cells in real time, we applied in vivo ﬂuorescence micro-
scopy upon local microinjection of DNA nanoconstructs in intact
muscle tissue of healthy mice.
2. Materials and methods
2.1. DNA nanotubes
DNA nanotubes were designed using the single stranded tile (SST) method,
where each tile oligonucleotide is 42 bases long and consists of four domains with 10
or 11 bases. Each domain is complementary to one domain on the neighboring tiles
[17,30]. We designed 8-helix tubes consisting of 48 individual tile oligonucleotides
folding into 8 parallel double helices. Tile strands located at the ends of the tube
contain non-pairing poly-A sequences in order to prevent sticky end formation and
polymerization. For CpG labeling, the 30 ends of 24 tiles (every second tile in each
helices) were extended by 20 bases containing the immune stimulatory CpG motif,
GACGTT, twice (CpG 1826: TCCATGACGTTCCTGACGTT). For the control tubes that do
not carry the CpGmotif, tiles without CpG extensionwere used. All oligonucleotides
were purchased from Euroﬁns Operon MWG (Ebersberg, Germany) with HPSF
puriﬁcation.
2.2. Enzymatic dye labeling of tiles
To visualize the DNA nanotubes in vivo, the 30 ends of some of the tile strands
were enzymatically labeled with Atto488-dUTP or Cy3-dUTP [31]. For this, Atto488-
dUTP or Cy3-dUTP (80 mM, purchased from Jena Bioscience, Jena, Germany), CoCl2
(5 mM), terminal transferase enzyme (16 U/ml, Roche, Penzberg, Germany), and all
DNA tiles (400 pmol) were mixed in a 20 ml, 1! TdT reaction buffer. The solutionwas
incubated at 37 "C for 30min. Then, 2.5 ml of NaOAc (3 M) was added and the solution
was ﬁlled up to 80 ml with ice-cooled ethanol (99%). After 1 h incubation at #20 "C,
samples were centrifuged at 13,000 g for 30 min. Then, samples were washed with
70% ethanol for 10 min again and the supernatant was discarded. The remaining
pellet was redissolved in distilled water. For CpG-labeled tubes, 24 of the unmodi-
ﬁed tiles and for the control tubes, 40 of the core tiles were used for dye labeling. For
CpG ODNs, 24 of the tiles with CpG sequence were labeled with dye.
2.3. DNA nanotube assembly and puriﬁcation
For the annealing of DNA nanotubes, 800 nM of each tile (dye-modiﬁed and
unmodiﬁed) were mixed with folding buffer (10 mM TriseHCl, 1 mM EDTA, pH 8.0,
20 mM MgCl2). The DNA nanotubes were folded over the course of 16 h (5 min at
80 "C, cooling down to 65 "C at 1 "C/min, cooling down to 25 "C at 2.5 "C/h). The
assembled DNA nanotubes were then puriﬁed using 30 K Amicon Ultra 0.5 ml
centrifuge ﬁlters (30,000 MWCO, Millipore, Schwalbach, Germany) in order to
remove excess strands that were not folded into the structures. 100 ml of assembled
DNA tube solution was mixed with 400 ml of folding buffer, ﬁlled into the centrifuge
ﬁlter, and centrifuged 3 times at 13,000 g for 6 min. After every centrifuge step, the
ﬂow-through was removed and the ﬁlter was reﬁlled up to 500 ml with buffer. After
ﬁnal centrifugation, the remaining solution at the bottom of the ﬁlter (~50 ml) was
pipetted out and the concentration of tubes was determined by measuring the
optical density at 260 nm. Overall, 50e60 % of the initial amount of DNA nanotubes
was obtained after puriﬁcation.
2.4. Gel electrophoresis and transmission electron microscopy
To analyze DNA nanotubes, the samples were run in an agarose gel. 2% agarose
was dissolved in 0.5! TBE buffer by heating to boiling. After cooling, MgCl2 was
added to 11 mM ﬁnal concentration and the solution was poured into a gel cask for
solidiﬁcation. 10 ml of each ﬁlter-puriﬁed DNA tube sample were mixed with 2 ml of
6! loading dye before loading into the gel pockets. 6 ml of 1 kb ladder was also
loaded adjacent to the samples. The gel was run for 2 h at 70 V in an ice-cold water
bath to prevent heat induced denaturation of DNA nanotubes. After running, the gel
was stained with ethidium bromide (0.5 mg/ml) for 30 min.
DNA nanotubes were visualized by electron microscopy using a JEM-1011
transmission electron microscope (JEOL). The DNA nanotubes were incubated on
plasma-exposed (240 kV for 1 min) carbon-coated grids and then negatively stained
with 1% uranyl acetate for 15 s.
2.5. Stability of DNA nanotubes
Stability of DNA nanotubes and pUC 18 double stranded plasmid were tested in
DNAse I-containing buffer, mice serum and FCS separately. For DNAse I experiments,
50 ng/ml of each sample was incubated in buffer at 37 "C for different time periods.
To emulate in vivo conditions, the DNAse I concentration was adjusted to 1.97
U ! 10#4 U/g wet weight [32]. For some experiments, also the mice serum was
diluted 37 times to mimic conditions prevalent in the skeletal muscle [32]. The DNA
nanotubes were also incubated in pure FCS (not heat-inactivated) for up to 2 h. Zeta
potential and size measurements were performed with a Malvern Zetasizer at
100 nM nanotube concentration.
2.6. Animals
Male C57BL/6 mice at the age of 10e12 weeks were purchased from Charles
River (Sulzfeld, Germany), MacGreen mice (JAX, Stock Number: 018549) were ob-
tained from The Jackson Laboratory. Animals were housed under conventional
conditions with free access to food and water. All experiments were performed
according to German legislation for the protection of animals.
2.7. Experimental groups
In a ﬁrst set of experiments, mice (n ¼ 6 each group) received saline, DNA
nanotubes, CpG-decorated DNA nanotubes, or CpG oligonucleotides via microin-
jection 20 min after the preparation of the cremaster muscle. Additional experi-
ments were performed in mice (n ¼ 6) receiving cromolyn (0.2 mg/kg), an inhibitor
of mast cell degranulation, as a bolus via intra-arterial injection 30 min before
cremaster preparation and subsequent application of CpG-decorated DNA nano-
tubes. The animals were randomly assigned to the experimental groups.
2.8. Surgical procedure
The surgical preparation was performed as described by Baez with minor
modiﬁcations [33]. Brieﬂy, mice were anesthetized by i.p. injection of a ketamine/
xylazine mixture (100 mg/kg ketamine and 10 mg/kg xylazine). The left femoral
artery was cannulated in a retrograde manner for administration of 2 mm Fluo-
Spheres (Invitrogen, Carlsbad, CA, USA) for measurement of blood ﬂow velocities.
The right cremaster muscle was exposed through a ventral incision of the scrotum.
The muscle was opened ventrally in a relatively avascular zone, using careful elec-
trocautery to stop any bleeding, and spread over the pedestal of a custom-made
microscopy stage. Epididymis and testicle were detached from the cremaster
muscle and placed into the abdominal cavity. Throughout the procedure as well as
after surgical preparation during in vivo microscopy, the muscle was superfused
with warm buffered saline. The body temperature was maintained at 37 "C using a
heating pad placed under the mouse. After in vivomicroscopy, tissue samples of the
cremaster muscle were prepared for immunohistochemistry. Blood samples were
collected by cardiac puncture for the determination of systemic leukocyte counts
using a Coulter ACT Counter (Coulter Corp., Miami, FL, USA). Anaesthetized animals
were then euthanized by an intra-arterial pentobarbital overdose (Narcoren, Merial,
Hallbergmoos, Germany).
2.9. In vivo microscopy
The setup for in vivo microscopy was centered around a VisiScope.A1 imaging
system (Visitron Systems GmbH, Puchheim, Germany), equipped with an LED light
source for ﬂuorescence epi-illumination. For DNA nanotubes or oligonucleotide
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excitation the 470 nm or 550 nm LED modules (exposure time 700 ms), and for
transillumination the 655 nm LEDmodule (exposure time 10ms) were used in a fast
simultaneous mode. Light was directed onto the specimen via a triple dichroic ﬁlter
NC316973 (z 405/488/561 rpc; Chroma Technology Corp., Bellows Falls, VT, USA).
Microscopic images were obtained with a water dipping objective (20!, NA 1.0).
Light from the specimen was separated with a beam splitter (T 580 lpxxr Chroma
Technology Corp., Bellows Falls, VT, USA) and acquiredwith two Rolera EM2 cameras
and VisiView Imaging software (Visitron). Oblique transillumination was obtained
by positioning amirroring surface (reﬂector) directly below the specimen and tilting
its angle relative to the horizontal plane as described previously [34].
2.10. Microinjection of DNA nanotubes and LysoTracker dye
Local administration of 250 ± 100 pl of ﬂuorescently labeled DNA nanotubes
(500 nM), CpG-decorated DNA nanotubes (500 nM), CpG oligonucleotides (12 mM),
or saline into the cremaster muscle was performed via perivenular microinjection in
regions at a distance of 25e75 mm from a postcapillary venule. Venules with di-
ameters ranging between 25 and 35 mm were selected for the experiments.
Microinjection was performed under visual control of the intravital microscope,
with a long distance air objective (20!, NA 0.4 Olympus), using borosilicate glass
micropipettes (GB150TF-8P, Science Products GmbH, Hofheim, Germany) - pulled
with a micropipette puller (PC 10, Narishige, London, United Kingdom) - which were
connected to the injection system consisting of a micromanipulator (PatchStar
Micromanipulator, Scientiﬁca, Uckﬁeld, United Kingdom) and a microinjector
(FemtoJet, Eppendorf, Hamburg, Germany). The tip pressure during injection was
3000 hPa and the tip diameter <1 mm. The vessel and the surrounding tissue were
visualized during a time period of 1 min at baseline conditions before injection and
up to 90 min after injection. For LysoTracker Red DND-99 (Invitrogen, Carlsbad, CA,
USA) co-microinjection, the stock solution was diluted to a concentration of 750 nM
in saline and further diluted to an end concentration of 75 nM in the respective DNA
nanotube sample. Different ﬂuorescent labels (as described above) did not affect the
distribution and localization of DNA nanoconstructs.
2.11. Quantiﬁcation of leukocyte kinetics and microhemodynamic parameters
To quantify the sequential steps of leukocyte extravasation, in vivo microscopy
records were analyzed ofﬂine using ImageJ software (National Institutes of Health,
Bethesda, MD). Firmly adherent cells were determined as those resting in the
associated blood ﬂow for more than 30 s and related to the luminal surface per
100 mm vessel length. Transmigrated cells were counted in regions of interest,
covering 75 mm on both sides of a vessel over 100 mm vessel length, and are pre-
sented per 104 mm2. Green ﬂuorescent beads (FluoSpheres 2 mm, Invitrogen, Carls-
bad, CA, USA) were injected via the femoral artery catheter and their passage
through the vessels of interest was recorded (ﬁlter T580lpxxr, LED 470 nm, exposure
50 ms, cycle time 1 min). Centerline blood ﬂow velocity was determined by
measuring the progression of free ﬂowing ﬂuorescent beads in subsequent images
in the blood stream.
2.12. Immunostaining
To determine NF-kB activation after microinjection of DNA nanotube constructs
or CpG ODNs, immunostaining of the cremaster muscle was performed. After
dissection, the tissue was ﬁxed with 2% paraformaldehyde for 15 min at room
temperature, then blocked and permeabilized in PBS, supplemented with 2% bovine
serum albumin (Sigma Aldrich, Munich, Germany) and 0.5% Triton X-100 (Sigma
Aldrich, Munich, Germany) for 1 h at room temperature. After incubation with a
rabbit anti-mouse anti-NF-kB p65 (acetyl K310) antibody (Abcam, Cambrige, UK) at
room temperature for 2 h, the tissue was washed with PBS and incubated with an
Alexa-Fluor 546-linked goat anti-rabbit antibody and TO-PRO3®-Iodide (Invitrogen,
Carlsbad, CA, USA) for another 2 h at room temperature. Immunostained cremaster
muscles were mounted in PermaFlour (Thermo Fisher Scientiﬁc Inc, Braunschweig,
Germany) on glass slides. For localization of microinjected DNA constructs in Csfr1-
EGFP mice as well as colocalization with LysoTracker dye, the dissected cremaster
muscle was mounted in a custom-made imaging chamber and immediately viewed.
Images were obtained using a Leica SP5 confocal laser-scanning microscope e
equipped with a Leica HyD GaAsP hybrid detection system ewith an oil-immersion
lens (63!; NA 1.40; Leica Microsystems, Wetzlar, Germany), as previously described
[35]. Images were processed with ImageJ software and ﬁgures for publication were
assembled in Photoshop 9 (Adobe Systems, Mountain View, California, US).
2.13. Stimulation of RAW 264.7 cells
RAW 264.7 macrophage-like cells were grown in Gibco DMEM medium (Life
technologies, Darmstadt, Germany) supplemented with 10% fetal calf serum (Bio-
chrom, Merck Millipore, Berlin, Germany), 4 mM L-Glutamin and 1 g/L D-Glucose at
37 "C and 5% CO2. Cells were seeded on 24-well culture plates at a density of 4 ! 105
cells and cultivated for 24 h. For stimulation, RAW 264.7 cells were incubated with
DNA nanotube constructs or CPG ODNs for 18 h. Culture supernatants were collected
and stored at #80 "C for further analysis. Cells were washed and resuspended in
DMEM medium, and uptake of DNA constructs and oligonucleotides was visualized
using a confocal laser scanning microscope (Leica SP5, Leica Microsystems, Wetzlar,
Germany) equipped with a GaAsP hybrid detection system (Leica HyD).
2.14. Flow cytometry
Upon incubation with DNA nanoconstructs, RAW 264.7 cells were washed with
DMEM and transferred into FACS tubes. The ﬂuorescence intensity of incorporated
Cy3 coupled DNA constructs was determined by a Gallios ﬂowcytometer (Beckmann
Coulter, Krefeld, Germany), in order to quantify the uptake of DNA nanoconstructs.
Post-acquisition analysis was performed using FlowJo software (Tree Star, Ashland,
US).
2.14.1. ELISA
The concentration of TNF-a in culture supernatants was determined by enzyme-
linked immunosorbent assay (ELISA) according to the manufacturer's instructions
(R&D Systems, Wiesbaden, Germany).
2.15. Statistical analysis
GraphPad Prism 6 (GraphPad Software Inc., La Jolla, USA) was used for statistical
analysis. Groups were compared with one-way ANOVA followed by a multiple
comparison test (Tukey's test). In all cases, p values of p < 0.05 were considered to be
signiﬁcant.
3. Results
3.1. Design, assembly, and characterization of DNA nanotubes
To test the potential immunostimulatory effects of CpG-
decorated DNA nanostructures (CpG tubes) in vivo, we designed
DNA nanotubes consisting of 48 different oligonucleotides, each of
which is 42 base pairs long. During a temperature-controlled
annealing these oligonucleotides assemble into eight parallel
double helices that form a DNA tube with a designed length of
~40 nm and a diameter of ~8 nm (Fig. 1) [17,30]. To trigger TLR9-
mediated activation of an immune response, the well-
characterized 20-nt long CpG oligodeoxynucleotide (ODN) CpG
1826 was conjugated to the DNA tube. This B type CpG sequence
includes two highly stimulative GACGTT motifs, which are recog-
nized by murine TLR9 receptors [10,20].
In order to present the CpG 1826 sequence on the surface of the
DNA nanotubes, 24 of the 48 tile strands were extended on their 30
ends with the ODN 1826 sequence (Fig. 1). DNA nanotubes without
CpG extensions (plain tubes) and oligonucleotides carrying CpG
motifs (CpG ODNs), which are not folded into a structure, served as
control samples in all experiments. Gel electrophoresis analysis
revealed prominent bands for the folded structures (Lane 2 þ 3 in
Fig. 2A). Note the lower mobility of the CpG-decorated tubes (Lane
2) compared with the plain tubes (Lane 3). Characterization by
transmission electron microscopy (TEM) clearly showed the correct
assembly of the nanotubes and the monodispersity of the samples.
The measured length of 41 ± 1 nm and the measured diameter of
8 ± 1 nm are in perfect agreement with the designed dimensions
(Fig. 2B and C).
To test the stability of DNA nanotubes, they were treated with
DNAse I and incubated in different serum conditions for various
incubation times. A double-stranded plasmid (pUC 18) was used as
a control sample. If the DNAse concentration was adjusted to
concentrations that are prevalent in murine tissues such as liver,
testis or pancreas (0.5 U/ml) which is 40 times higher than the
DNAse amount in skeletal muscle [32], no degradation of DNA
tubes was observed for 2 h while the plasmid pUC18 degraded
completely within 30 min (Fig. S1A) Also at high DNAse I concen-
trations (10 U/ml) the DNA tubes survived for up to 15 min while
the double-stranded plasmid was instantaneously degraded
(Fig. S1B). When adjusting serum concentrations to conditions
prevalent in the muscle tissue only little degradation of DNA
nanotubes was observed over 24 h (Fig. S1C). However it has to be
noted that all samples are degrading over the course of hours in
pure serum (Fig. S1D).
S. Sellner et al. / Biomaterials 53 (2015) 453e463 455
3.2. Release of inﬂammatory cytokines after stimulation with DNA
nanotubes and oligonucleotides in vitro
To test whether the DNA nanotubes induce a cytokine response
in immune cells, macrophage-like RAW 264.7 cells were incubated
either with CpG-decorated DNA nanotubes, plain DNA nanotubes,
CpG oligonucleotides, CpG oligonucleotides mixed with plain tubes
or lipopolysaccharide (LPS), which served as positive control.
All constructs localized in vesicular structures of RAW 264.7
cells after 1 h of incubation (Fig. 3). The cellular uptake of ﬂuo-
rescently labeled CpG tubes, plain tubes, plain tubes þ CpG ODNs
and CpG ODNs constructs was further analyzed by ﬂow cytometry
and revealed no apparent differences in the uptake of these con-
structs (Fig. S2), as well as the viability of the RAW 264.7 cells (up to
18 h of incubation) (Fig. S3). The concentration of secreted tumor
necrosis factor alpha (TNF-a) in culture supernatants wasmeasured
by ELISA. CpG tubes induced at 1 h of incubation a 3-fold and at 3 h
a 5-fold induction of TNF-a release in RAW 264.7 macrophages as
compared to unstimulated cells (Fig. 3D, E). Interestingly, incuba-
tion with plain tubes, CpG ODNs and CpG ODNs þ plain tubes eli-
cited only a slight increase in TNF-a production at 3 h (Fig. 3E). From
this we conclude that the complexation of CpG oligonucleotides
with the DNA tubes is of critical importance for the TNF-a pro-
duction and that the CpG-DNA tube complexes withstand degra-
dation within the ﬁrst 3 h of incubation.
3.3. Localization of DNA nanotubes in skeletal muscle tissue after
microinjection
Next, we performed in vivo ﬂuorescence microscopy to explore
the behavior of DNA nanotubes in the mouse cremaster muscle.
Accordingly, ﬂuorescently labeled CpG tubes, plain tubes, and CpG
ODNsweremicroinjected 25 mme50 mmdistant to a venule into the
muscle tissue. Within ﬁve minutes after microinjection, we
observed rapid internalization of all DNA nanoconstructs by peri-
vascular and tissue resident cells in the vicinity of the injection site
(Fig. 4A and B) (Supporting Information, Movie S1).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.biomaterials.2015.02.099.
In order to characterize these cells, we repeated the microin-
jection of the DNA nanoconstructs in the cremaster muscle of Csf1r-
EGFP transgenic (MacGreen) mice [36]. In MacGreen mice, cells of
Fig. 2. Characterization of DNA nanotubes. (A) Gel electrophoresis analysis of assembled nanotubes after puriﬁcation. 1) 1 kb ladder, 2) CpG tube 3) plain tube and 4) CpG ODNs.
Electron micrographs of (B) CpG tubes and (C) plain tubes. Scale bars: 100 nm (left) and 40 nm (inset).
Fig. 1. Design of CpG-decorated DNA nanotubes. Left: Mixture of 48 different DNA tiles. Middle: Secondary structure of assembled tiles. Red arrows represent CpG domains, blue and
green tile domains contain random sequences, stars at the 30 ends represent Atto488 dye and vertical lines indicate the base pairing. Left: 3D side and front views of 8-helix tube.
Transparent cylinders indicate double helices and red extensions represent CpG domains. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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Fig. 3. Uptake of DNA nanoconstructs and TNF-a response by RAW 264.7 cells. RAW 264.7 cells were incubated with 5 nM of (A) plain tubes, (B) CpG tubes, and (C) CpG ODNs for 3 h at
37 !C. The different DNA nanotubes (red) were internalized by RAW 264.7 cells. (D, E) ELISA analysis of TNF-a levels in supernatants of 4 " 105 RAW 264.7 cells incubated for (D)1 h
and (E) 3 h with 5 nM CpG tubes, plain tubes, CpG ODNs, CpG ODNs þ DNA tubes, LPS (10 nM) which served as positive control or without additive (control) (n ¼ 3, mean ± SEM;
*p < 0.05, ***p < 0.001 vs. control). Scale bar: 20 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. Distribution of CpG-decorated DNA nanotubes in the cremaster tissue. In vivo ﬂuorescence microscopy images of CpG tube (red) distribution after microinjection into the
cremaster muscle revealed a rapid uptake of CpG tubes by tissue-resident cells (arrowheads) in the vicinity of the application site (arrow). At 30 min and 60 min, transmigrated
leukocytes are visible in the tissue adjacent to the postcapillary venule (A, B) to the injection site. The ﬂuorescence channel images (B) are merged with the corresponding
transmitted light images from the cremaster tissue (A). Images were taken at the indicated time points after microinjection of 250 pl of CpG tubes and selected from a movie
(Supplementary Movie 1.) Scale bar: 50 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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the myeloid lineage, in particular macrophages and to some extent
polymorphonuclear leukocytes, can be identiﬁed by the expression
of green ﬂuorescent protein under the control of the CSF-1R (c-fms)
promotor. Microinjected CpG or plain DNA nanotubes as well as
CpG ODNs were present in intracellular vesicles of EGFPþ tissue
resident macrophages (Fig. 5AeI). Moreover, concomitant micro-
injection of LysoTracker dye and DNA nanotubes revealed that
internalized nanotubes accumulated in the late endosomes/lyso-
somes of these phagocytic cells (Fig. 5GeL).
Overall, the distribution pattern did not differ between CpG
tubes, plain tubes, and CpG ODNs. DNA nanotubes also
accumulated in muscle ﬁbers, if these have been pierced by the
glass capillaries during the microinjection process (Fig. 7).
Furthermore, CpG tubes as well as plain DNA tubes were attached
to tissue structures, presumably collagen ﬁbers (Figs. 4 and 7).
3.4. Microinjection of CpG tubes induced leukocyte adhesion and
transmigration
To assess the immunogenic potential of the DNA nanotubes,
the extent of local inﬂammation upon perivenular microinjection
in the cremaster muscle was analyzed by means of in vivo
Fig. 5. DNA nanotubes are localized in the endolysosomes of tissue macrophages. Confocal imaging of CpG-decorated (A-C), plain tubes (D-F) and CpG ODNs (G-I) microinjected in the
cremaster muscle of Csfr1-EGFP (MacGreen) mice. Images show that DNA nanotubes (A, D, red) as well as CpG ODNs (G) were internalized by EGFP positive macrophages (B, E, H,
green). The ﬂuorescence channel images (A, B, D, E, G, H) are merged with the corresponding transmitted light images depicting the muscle tissue (C, F, I). Scale bar: 50 mm. Confocal
imaging of co-microinjected DNA nanotubes (red) and LysoTracker (green) showing the presence of plain tubes (J) as well as CpG tubes (M) in the late endolysosome (K, N). Merged
image (L, O). Scale bar: 30 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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transillumination microscopy. The preparation of the mouse cre-
master muscle is a well-deﬁned and widely used model system to
study inﬂammation-related events and the associated recruitment
of leukocytes [27,34,37].
No statistically signiﬁcant differences in microhemodynamic
parameters and systemic leukocyte counts were detected among
experimental groups uponmicroinjection of CpG tubes, plain tubes,
CpG ODNs, or vehicle control (Supporting Information, Table S1),
thus assuring intergroup comparability.
As shown in Fig. 6A, microinjection of CpG ODNs or plain tubes
did not affect leukocyte recruitment, whereas a signiﬁcant increase
in numbers of ﬁrmly adherent leukocytes (3.5 ± 0.31/104 mm2) at
the vessel walls of postcapillary venules was found 30 min upon
application of CpG tubes as compared to the injection of plain tubes
(0.75 ± 0.35/104 mm2). 60 min post microinjection of CpG nano-
tubes, the number of adherent leukocytes was increased by a factor
of ﬁve in postcapillary venules (2.89 ± 0.23/104 mm2) compared to
the experimental group receiving saline (0.67± 0.31/104 mm2) and a
factor of two or four compared to the group receiving plain tubes or
CpG ODNs, respectively (Fig. 6B). In accordance with the typical
length of time for the different steps of leukocyte recruitment upon
application of inﬂammatory mediators [38] the effect of CpG
nanotubes on leukocyte adherence ceased 90 min after injection
(data not shown).
To test whether local microinjection of the different constructs
resulted in a directed transmigration of leukocytes into the adja-
cent tissue, we compared the numbers of transmigrated cells on the
vessel side ipsilateral to the application site with those on the
contralateral side.
Consistent with the results obtained for leukocyte ﬁrm adher-
ence, the number of transmigrated leukocytes detected within the
perivascular tissue on the ipsilateral side was signiﬁcantly elevated
after microinjection of CpG tubes (Fig. 6D, 60 min, 7.3 ± 0.32/
104 mm2) as compared to saline (Fig. 6D, 60 min, 1.3 ± 0.51/104 mm2)
at all investigated time points (Fig. 6C and D), but not after
microinjection of CpG ODNs or plain DNA tubes.
Taken together, these data indicate that only CpG-decorated
DNA tubes, but neither plain DNA tubes nor CpG ODNs, elicit
leukocyte recruitment in the cremaster muscle preparation.
3.5. Mast cell inhibition abolishes CpG tube-evoked leukocyte
adhesion and transmigration
Mast cells are another important key player in the initiation of
inﬂammation as well as in the recognition of pathogens and the
modulation of appropriate immune responses [39]. These cells are
able to facilitate the exit of leukocytes frompostcapillary venules by
rapid degranulation and the release of proinﬂammatory mediators
[40]. Mast cells are not affected by the microsurgical preparation
and do not contribute to the low baseline levels of preparation-
induced leukocyte recruitment as we and others have reported
previously [35,41]. To test whether mast cells are involved in the
local recruitment of leukocytes after microinjection of CpG tubes,
mice were pretreated with cromolyn, an inhibitor of mast cell
degranulation, prior to microinjection.
CpG tube-elicited leukocyte adherence (Fig. 6B, 60 min,
1.3 ± 0.33/104 mm2) as well as transmigration to the injection side
(Fig. 6D, 60 min, 1.7 ± 0.71/104 mm2) were signiﬁcantly diminished
in cromolyn pre-treated animals as compared to non-treated mice
(Fig. 6B, adherence 60 min 2.8 ± 0.24/104 mm2, Fig. 6D, trans-
migration 60 min, 7.3 ± 0.48/104 mm2) and matched almost the
values obtained in the control group (Fig. 6B, adherence 60 min,
0.7 ± 0.32/104 mm2, Fig. 6D, transmigration 60 min, 1.3 ± 0.62/
104 mm2).
3.6. CpG tube microinjection results in NF-kB pathway activation
Activation of the TLR9 signaling cascade induces a translocation
of the transcription factor NF-kB from the cytoplasm into the nu-
cleus and thus regulates a broad range of genes expressed during
inﬂammatory and immune responses [42,43], such as the expres-
sion of the inﬂammatory mediators TNF-a and IL-1 in macrophages
[44].
To examine whether the injection of CpG nanotubes promotes
NF-kB activation, we stained the muscle tissue for phosphorylated
p65, a subunit of the NF-kB complex, which indicates nuclear NF-kB
[45].
Remarkably, 90 min upon microinjection, almost all cell nuclei
adjacent to the CpG tube application site in the tissue (Fig. 7B and E)
were phospho-p65 positive, which was not the case in plain tube
(Fig. 7A and D) and CpG ODN (Fig. 7C and F) injected tissues. A high
proportion of phospho-p65 positive cells that accumulated at the
injection site exhibited roundish nuclei, reminiscent of multi-lobed
granulocyte nuclei (Fig. 7B and E), whereas p65 positive cells with
elongated nuclei are tissue resident cells, contributing to the in-
ﬂammatory process.
4. Discussion
Schueller et al. previously showed in vitro that splenocytes
moderately expressed IL-6 and CD69 after exposure to CpG ODNs,
whereas exposure to CpG-decorated DNA nanotubes led to a
considerably enhanced expression [10]. In our experiments, RAW
264.7 cells responded to CpG DNA nanotubes in a similar manner,
in which the release of TNF-a is low after incubation with CpG
ODNs and markedly increased upon incubation with CpG-
decorated DNA tubes, although the amount of CpGs was equal for
all samples. Thereby the ﬁrm attachment of CpG-sequences to the
DNA nanotubes is a prerequisite, since coincubation of RAW 264.7
macrophages with plain DNA tubes mixed with CpG ODNs failed to
induce TNF-a production. These ﬁndings and our stability analysis
allow the conclusion that the DNA tubes are stable over the course
of our experiments.
In line with our in vitro ﬁndings, CpG ODNs did not exhibit
immunostimulatory effects in the skeletal muscle during the
observation time. It has been previously shown by Kiemer et al. that
ISS 1018 (B type CpG ODNs) only weakly induced TNF-a production
in human monocyte-derived macrophages compared to genomic
DNA isolated from an attenuated Mycobacterium bovis BCG strain
[46]. Wu et al. also described that a high aggregation of CpG ODNs is
essential to crosslink and activate TLR9 [47]. Hence, the activation
of TLR9 seems to depend on structural parameters of its agonist.
Our experiments also clearly show that the conjugation of CpG
ODNs to DNA tubes e which is equivalent to forming a high local
density of CpG sequences e strongly enhances the release of
immunostimulatory reagents in vitro, possibly by effectively
crosslinking TLR9 receptors. This is in accordance with recent
studies, where it has been shown that particulate- or aggregated
CpG evoke strong immune responses via TLR9 activation [48,49].
Perivascular as well as tissue-resident macrophages are profes-
sional phagocytes and fulﬁll fundamental homeostatic and immune
functions, such as clearance of cellular debris and pathogens [22]. It is
well documented that the phagocytosis of different nanoparticles by
alveolar macrophages is crucial for the production and release of
cytokines [50,51], as well as the production of inﬂammatory medi-
ators in monocytes [52] and macrophages [53]. Moreover, we have
previously reported that the surface chemistry of quantum dot
nanoparticles determines their uptake by perivascular macrophages
as well as their proinﬂammatory properties upon systemic injection
[35,54]. We found in these studies that solely negatively charged
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quantum dots (with carboxyl-surface modiﬁcations) were rapidly
taken up by perivascular macrophages upon systemic injection and
subsequently elicited leukocyte recruitment in a mast cell-
dependent manner. In remarkable accordance with these results,
we found in the present study that the negatively charged DNA
nanotubes (zeta potential; CpG tube: !13.2 ± 0.4 mV and plain
tube: !11.4 ± 0.2 mV) were rapidly localized in the endolysosomal
system of tissue-resident macrophages upon microinjection. Most
recently, King et al. described that negatively charged, immune-
modifying microparticles are readily taken up by inﬂammatory
monocytes, mediated via the macrophage receptor with collagenous
structure (MARCO) [55]. Since the observed cellular localization and
uptake pattern of CpG-decorated as well as plain DNA nanotubes
were indistinguishable (Fig. 4A and B), it seems that the absorption
route from the extracellular space into the endosome is independent
of the CpG motif present on the DNA tube surface. The rapid intra-
cellular localization of the DNA nanotubes argues for an active up-
take, which could possibly be mediated by scavenger receptors. In
this regard, Minchin et al. recently demonstrated, that macrophage
scavenger receptor A1 (SR-A1) andMARCOmediated the clearance of
Fig. 6. Quantitative analysis of intravascular adherence and transmigration of leukocytes after microinjection of DNA nanotubes. Leukocyte adherence was quantiﬁed in post-
capillary venules in the cremaster muscle using in vivo transillumination microscopy at 30 min (A) and 60 min (B) upon microinjection of CpG tubes, DNA tubes, CpG ODNs, or
saline. The numbers of adherent leukocytes were signiﬁcantly increased at 30 min and 60 min after CpG tube injection. Pretreatment with cromolyn prior to CpG tube injection
diminished leukocyte adherence. Leukocyte transmigration was quantiﬁed on the vessel side ipsilateral to the microinjection site (white bars) and on the contralateral side (black
bars) at 30 min (C) and 60 min (D) after microinjection. CpG tube injection elicited leukocyte transmigration into the tissue. Cromolyn pretreatment attenuated the leukocyte
transmigration induced by microinjection of CpG tubes (n ¼ 6, mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001 vs. all groups). (E, F) depicts representative in vivomicroscopy images
of postcapillary venules in the cremaster muscle 30 min after microinjection of either saline (E) or CpG tubes (F) with adherent as well as transmigrated leukocytes. Scale bar, 25 mm.
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albumin-covered nanomaterials by macrophages [56]. Furthermore,
Latz et al. have previously shown that the receptor for advanced
glycation end products (RAGE) directly binds DNA and promotes its
uptake via the endocytic pathway [57]. It has also been proposed,
that TLR9 activation by DNA-containing immune complexes is
mediated partly by RAGE [58]. In general, macrophages can inter-
nalize nanoparticles via several pathways, including constitutive
macropinocytosis, phagocytosis, as well as clathrin-mediated path-
ways [59,60]. Although, we clearly observed internalized DNA tubes
within the endosomal/lysosomal compartment, the precise details of
uptake and the subsequent compartmentalization ofDNA tubes need
to be addressed in future studies, since this is pivotal for intracellular
targeting as well as payload release. For some applications of DNA
nanotubes as in vivo carriers, endosomal escape of the therapeutics
has to be ensured. In this regard it seems promising to tune DNA
secondary structure by pH change (i.e. by using i-motifs), in order to
enable the release of DNA bound molecules [61].
The inﬂammatory response and the extent of leukocyte trans-
migration upon microinjection of CpG nanotubes was considerable
and highly dependent on the activation of mast cells as judged by
the reduction of CpG nanotubes-elicited leukocyte transmigration
to control levels in the presence of the mast cell stabilisator cro-
molyn [62,63]. Surface-localized cytokine receptors enable mast
cells to respond to macrophage-released cytokines [39,64]. There-
fore, it is possible that mast cells, which are predominantly located
in close vicinity to the abluminal side of the vessel walls [65], were
stimulated by macrophage-released cytokines [66,67] during the
CpG nanotube-elicited inﬂammatory response. Although we were
not able to detect CpG nanotubes by means of confocal microscopy
in mast cells in the cremaster muscle (data not shown), we cannot
exclude direct mast cell activation (e.g. via activated complement
factors). In any case, activated mast cells amplify the proin-
ﬂammatory cascade via the release of inﬂammatory mediators,
such as histamine, platelet-activating factor, or TNF-a from their
intracellular granula by rapid exocytosis [68] which in turn rapidly
(within 10 min) increases leukocyte adherence [35,69,70]. The
considerable increase of adherent leukocytes already 30 min after
microinjection of CpG nanotubes could likewise be explained by
mast cell activation.
5. Conclusion
Taken together, we demonstrated an effective delivery system
in vivo using CpG-decorated DNA nanotubes. With this DNA
nanotube in vivo approach, we have observed that tissue-resident
macrophages can be targeted and that these cells are reached in
intact muscle tissue almost immediately upon application. Most
important, plain DNA nanotubes on the other hand do not induce
an immune response. However, the attachment of conjugating li-
gands allows gearing the tissue homeostasis in a certain direction,
since modiﬁcation of nanotubes with CpG sequences induced a
strongly elevated immune response, particularly the recruitment of
leukocytes from postcapillary venules to the tissue and nuclear
translocation of p65, a subunit of the NF-kB transcription factor
complex, which is commonly used as an indicator of NF-kB acti-
vation. Inhibition of mast cells with cromolyn also revealed that
CpG-dependent immune stimulation requires mast cell degranu-
lation. Additionally, the stability of DNA nanotubes against DNAse I
under conditions present in muscle tissue is promising for further
in vivo applications of DNA-based nanostructures. So far, DNA
nanostructures have been used to successfully deliver different
Fig. 7. NF-kB p65 translocation occurs in the vicinity of microinjected CpG-decorated DNA nanotubes. Confocal immunoﬂuorescence of DNA nanotubes (red), NF-kB p65 (green), and
TO-PRO (blue) counterstaining showed marked NF-kB p65 nuclear staining of cells adjacent to the injection site of CpG tubes (B, E). Injection of plain tube (A, D) as well as of CpG
ODNs into the cremasteric tissue (C, F) caused only weak nuclear p65 staining. Scale bar: 50 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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cargos to cells in vitro, such as apoptosis-inducing antibodies [11] or
anticancer drugs such as anthracyclines or doxorubicin [71].
Our results encourage further research to use DNA nanotubes to
effectively target macrophages in vivo, thus facilitating versatile
applications.
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Table S1. The list of oligonucleotide sequences used in the 6-helix tile-tube assembly. 
(A) Oligonucleotides for folate conjugation. X: C8-Alkyne-dU. 
ODN-1 XAAAACGCTAAGCCACCTTTAGATCCAAA 
ODN-2 XGGATCTAAAGGACTTCTATCAAAGACGGGACGACTCCGGGAG 
ODN-3 XAAACTCCCGGAGTCCGCTGCTGATCAAA 
ODN-4 XGATCAGCAGCGCCCGTCTCGACTGCAGAAATAGGACCCCCAG 
ODN-5 XAAACTGGGGGTCCTCGAGGCGAAACAAA 
ODN-6 XGTTTCGCCTCGTAGCCTTCGCCCGCACGACCTGGCTTAGCGT 
(B) Oligonucleotides for fluorescent dye labeling. Z: Atto488-dUTP or overhang sequence 
for Atto647 modified oligonucleotide (GGTAGTAATAGGAGAATG). 
GGTCGTGCGGACTGTCGAACACCAACGATGCCTGATAGAAGTZ 
GCGTGGCAATTGCCATAAATTCATACATAACGGCGCCAGACGZ 
TTTCAAGACCGGCACTTGTATGGCGTAGGGCGGGTTTAGCGGZ 
CGTTATGTATGCCGCTAAACCTTGCAATGACTGAACTCGAACZ 
GTCCCGTCTTTGGATCCGAAAGCCATAATATATCGAGACGGGZ 
TCGAAGTCGTGTTCGAGTTCAAATGTCTATGCGATGCAGCAGZ 
GTCATTGCAATAGCTCCCATCATTTAATGTCGTTTACAGTAAZ 
GCATAGACATTTTACTGTAAAACCTTACGTAACTTACAGCCAZ 
ATTTCTGCAGGGAATTCAGCCTATTCACATAGGCGAAGGCTAZ 
ATGCCAGGAATGGCTGTAAGTTGCATCATGGGGGTCCTCAATZ 
TACGTAAGGTCAATACTCATCCCTGAGTGATCCATGACCCTTZ 
CCCATGATGCAAAGGGTCATGGGTCTTGAAAAATTTATGGCAZ 
(C) Oligonucleotides for siRNA labeling. 
GGCATCGTTGGCGTCTGGCGCACGACTTCGATTTCGGATCCAAGGATGTAGGTGGTAGAG
CGCCCTACGCCAAAAAAGATGGGAGCTAAGGATGTAGGTGGTAGAG 
TATATTATGGCCTGCTGCATCTTCCTGGCATGGCTGAATTCCAGGATGTAGGTGGTAGAG
CGACATTAAATAAAAAAGATGAGTATTGAGGATGTAGGTGGTAGAG 
CTATGTGAATAATTGAGGACCATTGCCACGCTGTTCGACAGTAGGATGTAGGTGGTAGAG
GATCACTCAGGAAAAAAATACAAGTGCCAGGATGTAGGTGGTAGAG 
Table S2. Molecular weights of 6 oligonucleotides before and after folate conjugation. 
Samples MW (g/mol) MW (g/mol) after reaction expected experimental expected experimental 
ODN-1 8913 8920,382 9554,64 9547,765 
ODN-2 14355 14602,380 14996,64 14992,571 
ODN-3 8937 8931,952 9578,64 9574,670 
ODN-4 14197 14195,535 14838,64 14842,370 
ODN-5 9075 9071,732 9716,64 9710,265 
ODN-6 14119 14142,973 14760,64 14759,459 
Folate-PEG3-Azide 641,64 
Nanomaterials 2015, 5 S2 
 
 
Figure S1. RP-HPLC chromotogram of a single DNA oligonucleotide before (upper 
chromatogram) and after (bottom chromatogram) folate conjugation. 
 
Figure S2. Cont. 
Nanomaterials 2015, 5 S3 
 
 
 
Figure S2. Cont. 
Nanomaterials 2015, 5 S4 
 
 
 
Figure S2. Mass spectrometry analysis of 6 oligonucleotides before and after folate conjugation. 
 
Figure S3. Endosomal uptake of unmodified (a,b) and folate-modified (c,d) DNA 
nanotubes after 24 h and 72 h of incubation. 
Nanomaterials 2015, 5 S5 
 
 
Figure S4. Mitochondrial colocalization of the mitochondrial dye Mito-tracker green 
(shown in green) and DNA nanotubes coupled to Atto 647 (shown in Red) after culture 
medium (a) without FCS and (b) with FCS. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
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Figure S1. Schematic design of DNA origami block. Scaffold routing and staple design in two-
dimensional representation. Graphics and sequences were created using caDNAno software 
package.1 Black staples show the staples chosen for cholesterol labeling and dark green staples show 
the staples chosen for dye labeling. 
 
 
 
  
Schematic design of DNA origami triskelion. Scaffold routing and staple design in two-dimensional 
representation. Graphics and sequences were created using caDNAno software package.1 Black 
staples indicate the staples chosen for cholesterol labeling, dark green staples for dye labeling, grey 
staples were used for trimer formation and blue staples were used for lattice formation.  
 
 
Figure S2. Gel Analysis of DNA Origami Blocks Folded with Cholesterol. 2 % Agarose gel, 1x TAE 
buffer 11 mM Mg2+.  1) 1 kb ladder 2) p8064 scaffold 3) Block with 1 cholesterol 4) Block with 2 
cholesterol 5) Block with 3 cholesterol 6) Block with 4 cholesterol 7) Block without cholesterol. 
 
 
 
 
Figure S3. Schematic design of DNA origami block dimer (right edge). Scheme showing DNA origami 
block dimer formation. 6 pairs of complementary staples at the right edge of the origami were used. 
Arrows indicate the hybridization of 10 nt-long complementary regions. The helix numbers and their 
positions within the square lattice orientations are depicted at the bottom right corner. 
 
 
 
 
 
 
 
Figure S4. Schematic design of alternative DNA origami block dimer (left edge). Scheme showing 
DNA origami block dimer formation. 6 pairs of complementary staples at the left edge of the origami 
were used. Arrows indicate the hybridization of 10 nt-long complementary regions. The helix 
numbers and their positions within the square lattice are depicted at the bottom right corner. 
 
 
 
 
 
 
 
 
 
Figure S5. Gel Analysis of DNA Origami Block Monomers and Dimers. 2 % Agarose gel, 1x TAE buffer 
11 mM Mg2+.  1) 1 kb ladder 2) Block monomer 3) Block dimer assembled from the left side 4) Block 
monomer 5) Block dimer assembled from the right side. 
 
 
 
Figure S6. FRAP Analysis of DOPC/Texas Red Membrane. Left: Representative fluorescence images 
of DOPC bilayer before and after photobleaching. 20 frame were captured over the course of 14 s. 
For clarity, only 6 frames are depicted here. Right: Time (in s) vs. Intensity plot acquired from the 
images shown in the left panel. A one-phase association approach was used for curve fitting.2  
 
 
 
 
 
  
Figure S7. Schematic design of DNA origami block for 1D polymerization. The connector staples for 
1D polymerization are depicted in orange. 
 
 
 
Figure S8. Fluorescence images of DNA origami arrays. Images show the 1D polymerization of DNA 
origami blocks. The same region on the SLB was captured with 1 h intervals. (scale bars: 5 µm)  
 
Figure S9. Schematic design of DNA origami block for 2D polymerization. The connector staples for 
2D polymerization are depicted in pink and turquise for the each two opposite corners.  
 
 
 
 
  
Figure S10. AFM images of DNA origami block arrays formed without SLB support. The DNA 
structures were assembled in solution and then deposited on the mica using high Mg2+ concentration 
(125mM MgCl2, 400mM Tris, 200mM acetic acid, and 10mM EDTA, pH 8.5). The scan rate of the 
images is 5 Hz and the scan size of the images is 512x512 pixels. 
 
Figure S11. AFM images of the lipid bilayer at low salt concentration (10 mM HEPES, 150 mM NaCl, 
0 mM Mg2+, pH 7.6). The scan rate of the images is 6.5 Hz and the scan size of the images is 512x512 
pixels. 
 
Figure S12. TEM image of triskelion arrays. Both hexagons and pentagons form during the assembly. 
Clusters and multiple layers of lattices were also observed. The triskelion lattices were assembled in 
solution (without SLB support) and deposited on the carbon-coated EM grids. (scale bars: 100 nm)  
 
      
 
Figure S13. SUVs without DNA origami nanostructures. Left: TEM image of SUVs without DNA 
origami nanostructures. Right: DLS measurements of SUVs without DNA origami nanostructures.  
 
Figure S14. Stability of DNA Origami Block Nanostructures in Mg2+-free buffer (10 mM HEPES, 150 
mM NaCl, pH 7.6). Left: TEM images of DNA origami blocks after 24 hrs of incubation. Middle: TEM 
images of DNA origami blocks after 72 hrs of incubation. Right: Agarose gel analysis of DNA origami 
blocks after 72 hrs of incubation in Mg2+-free buffer. (2 % Agarose gel with 11 mM Mg2+)  
Amicon 100K Filter (Millipore) was used for buffer exchange. To 100 µl of solution containing DNA 
origami after folding (with 100 nM staple strands and 10 nM scaffold strand) 400 µl of Mg2+-free 
buffer was added. The solution was centrifuged at 13000 g for 6 min. The centrifugal steps were 
repeated 3 times with fresh Mg2+-free buffer added in every step. The final solution (~30 µl) was 
used for TEM imaging and gel electrophoresis after 72 hrs of incubation at room temperature. 
 
 
 
 
 
Table S1. Staple sequences for DNA Origami Block Assembly and Polymerization 
  Unmodified Staples 
    
Oligo1 GCCCCCGAAAAAGGGATTGACGCTAGAGCCAGTAGAAGTATTAATTTT 
Oligo2 GTCAAAGCCCTTCTGCAGGAAAACACCTTGGAGCCGTCTTGCGGA 
Oligo3 AGCCCGAGATAGGGTATCATGGTGCGTTGCGTTGAGTGT 
Oligo4 AAATCCCTTGTTATCCTGCCTAATGGTGCTGCCGGTGCCGCATCCCTT 
Oligo5 TCACCGCATTAATTCATAGCTGCAGTTGA 
Oligo6 AGGCCGATTAAAGGGAGAAAGGAGCCTACATTCATTCTGGCAGCAGAA 
Oligo7 CTCGTTAGAATCAGAGGTAGCGGTCATTGCAAACCTGAAAACATCGCC 
Oligo8 GACGAGCACGCCGCGCCTGGTAATATATTTTTGAATGTCG 
Oligo9 GAGACGGGCAACAGCTGATTCGCGCCCGCTT 
Oligo10 AGTCTGTCTGAGGATTCAGCAAATTCAAAATTTACCTTTTTTACATTT 
Oligo11 GCAATACTATAGATTACTGAACCTCTGAATAATTCGCCTGGATGAAAC 
Oligo12 TCCAGTCACGATCCAGCGCAAAAATGGGTA 
Oligo13 TTAATGAAGCAGCCAGGGCCAGAATCCGCCGGAGGTGTCCCGGACTTG 
Oligo14 CGGCCTTGTTAATGCGGTTCCAGTTTGGAACA 
Oligo15 CCAGTAATTTTAGAGCAGGAAGGGAAGAAAGCTTTTAGACAGTAAAAG 
Oligo16 GATAGAAGGCGAAAAAGGGCGCTGGCAAGTCGGGAGCTCGTTGTA 
Oligo17 ATACGTGGCTATTAAAGCGTAACCACCACACCCGTATAACACATCACT 
Oligo18 AATTCGTATGAGTGTTCCGCTACAGGGGCCCT 
Oligo19 TGTGAAATTATAAATCGAGAGAGTTGCAGCAATTTTCTTTCAGCTGCA 
Oligo20 GATAAAACAGTAACAGATTTGCACTGAGTGAAGCTGATGCTAATTTCA 
Oligo21 ATTAAAAATAACGGATGGAAGGGCTATTAACTTAGGTTTGAAATA 
Oligo22 GGATCCCCCGTCGGTGGCCCTGCGGAAGATGC 
Oligo23 TCTTCGCGACGGCTGGGCGCGGTTGTCCGTTTACAGGCGGTCATTTGC 
Oligo24 CACTGCGCACTGTTGTGCCATCTGGTCAG 
Oligo25 AATACATTCATCACGCTGGAAATACGGGCGCTACCGTCTATCAAGGGA 
Oligo26 AACAACTATCTTTGATCCGCCAGCCACGCTGCGAACGTGGACTCCAAC 
Oligo27 GGAAGGTTTAGAAGAACTCAAACTGTACTATGGTTGCTTT 
Oligo28 TGCATCAGGGGAAACCTAACTCACCTGGCCCTAAAAGAAT 
Oligo29 AAAAGTTTATGTAAATTAACCTTGGCTTAATTAAAGTACCAGAAACCA 
Oligo30 ACAAAGAAACCTCCGGTTAATTTTTACCAGTACCAGACGAAATAATAT 
Oligo31 ATCATATTCAAAATCACGATAGCTCTGTTTAGAATGCAGATTATCAAC 
Oligo32 AAGGTTTGTAAAGTTAAACGAGCAGAAACA 
Oligo33 ACACTGGTAAAGCCGCTTTCGTCTGAGAGATAAATCGGCGAAGTTGGG 
Oligo34 GCAATTCAGTTGGCAAAGCGCTATTAGTCTTT 
Oligo35 GAATATACAGAGGTGACCACGCTGCAAT 
Oligo36 AGAAACAATACCGAATAAAGCATACGCTCAAAATTAACAAACAGG 
Oligo37 GAATACCAAACTGATAAAACCCTCCAATATTATAGTAATAGTGCTTTC 
Oligo38 GGCAGCACGGGTACCGATCAACAGCTCACTAT 
Oligo39 ACCAGCTTTCCGTGAGCACTCTGTGAGTGAGCTGTCGTGCTCACCAGT 
Oligo40 AACAATTTGAGAATATGAGAATCGCGCACTCAGCTACAATAGTTACAA 
Oligo41 AAACATCAATTCTGTTAAAGCCATTTTCATTAAATCAACAATCCA 
Oligo42 CAGCAACCGGTGGAGCCGGAAAAAGGTTTCAG 
Oligo43 TAGAACGTCCGGAAACGACTTTCTGATCGGTGTCTGGTGCTTTGAGGG 
Oligo44 TGATTGCGCTCTCACGCCACGGGACGTTG 
 
Oligo45 ATAACTATGAGTAACACTACCATAGAAAAATCCGAACCACCCAACAGA 
Oligo46 CCTTTTTAACCACCAGTTATACTTCAAATATCGCCCTAAAGCGTAAGA 
Oligo47 ATTTATCCTGATTATCAGAGGTGGAATTGA 
Oligo48 GATGAAGGCTTTGCTCAGCCGGGTCGCCTGTGCCTCCTCATTTCCTG 
Oligo49 TCTTCTGATGCACCCATCGAGAACATTGAGCGAGCTATCTAACGTAGA 
Oligo50 CCGACCGTTGAAGCCTCGTAGGAAAACTGAACGTAAGCAGTTAAGACT 
Oligo51 AATAAACATTTTAGCGAAATCAGAAAAAACAGGAAACCGATAATAACG 
Oligo52 GCGGATCCGCCATTCGCCAATTGATGGGCG 
Oligo53 CGCCAGCAGCACCGCTCGGGCCTCTCCGTGGGGCTTTCATACGTTAAT 
Oligo54 GAAAAAGCTAGATTAAGCCCGAATAGAGGAAC 
Oligo55 AGTAATAACATTTGAAAATATATGGTAAAACAGAACGTTATTAGACTT 
Oligo56 GTAAAGTAAGAAAACAATCGTCGTTAGAACTTATCATTAATAGAT 
Oligo57 AACAACATCTGAGCAAATCCTTGATGTTTGGAAAGGAGCGGGAGCACT 
Oligo58 CTTTCAGAGCAAGAATGACGCTGAGCTTGATG 
Oligo59 TAACCTCACAGCGTGGCAAACGCGGCGGTATGGTCATAAAGTGCCCCC 
Oligo60 ATCAATAAATAGCAATCTAATATCAGTTTATTTTACCATTAGCGACAG 
Oligo61 CCCATCCTAAGAAAAACCCTGATATGGTTATTAGAGCACTGTAG 
Oligo62 TAAAACGAGCCATCAAGTCACGTTTATTAAAA 
Oligo63 TAACGCCATGTAGCCAAACAAACGCCGGTTGATCTGGAGCATTAATGC 
Oligo64 GCTGCGCGGGATAGAAATAATTTTTTGTT 
Oligo65 TGCTATTTCCTAAATTACAGTAGGCTTCTGTAAAAATTAAACATCGGG 
Oligo66 GGAGGTTTGTGATAAACAAATTCTCCCTTAGAAAGAAGATATTGCTTT 
Oligo67 AGGCAAAGAAACTTAAAAGGGATACGTTCCGGTGCTGGTCCCACGCA 
Oligo68 AATAAACATAGCACCATTGTCACAACCCTCAGTCAGACGAGGGTCAGT 
Oligo69 AATAAGAAATTTGGGATACCAGCGCTCCCTCAATAAATCCTACAGGAG 
Oligo70 ATGAAAATAAGGTGAAACCGATTGATCACCGGCAGTCTCTTTCCAGTA 
Oligo71 CATCGTAGAACGGTAATCGTGACAATATGA 
Oligo72 GACGACGACCTGAGAGTAATCAGATGTAGGTAAATTTTTAAATTAAGC 
Oligo73 AATAACATTATAGAAGGCCCCTGTACGCGAAG 
Oligo74 ACAATGAATCGGCTGTCCAAGTACCCATATTTATTTTAGTAAATCCAA 
Oligo75 CCCTTTTTAATTTACCGTTTTTAACGCTCATAATGGTTGGGTTAT 
Oligo76 ATAGGAACCGGCCAGTGCTTATCCGAGTACTA 
Oligo77 GGCCTTCCGGGTTTTCGGAAGGGCCCGTGGTGATTTCTGCCCTTTAGT 
Oligo78 AAATACATGAGGCAGGAGCCACCATATTATTCGAACCGCCTGTACCGT 
Oligo79 CCTTATTACAAACAAGAGCCGCCTGAGACTAGTACCGCAAACTAC 
Oligo80 GAATACCCGGAAAGCGAACCAGAGCGGGGTTTGGAATAGGGCCCTCAT 
Oligo81 AAATCAGCCTTTTGCGAGTCAAATCCGTGGGG 
Oligo82 ATTTTGTTAGGATAAAAAGATTCAATTCTACTCAAATGGTCCATATAA 
Oligo83 CTAGCATCGGAGACGGAGAAGCAAATCGG 
Oligo84 ATCACCAGGCCATATTAGAGGGTAAAGCAAGCGAGCATGTGACAAAAG 
Oligo85 CTTGAGCCACGATTTTGGAGAATTTCATTACCACAAGAAACGACAATA 
Oligo86 ATTCATTAAGCAGCCTTTACAGTACTAAGAAC 
Oligo87 GAATCGATACCGTGCAACCGTAATAACTGTTGCCAGTCACGAACGGA 
Oligo88 AATCAAGTCACCCTCATGAAACATGGAGTGAGAAAGGAGCGTTAAAGG 
Oligo89 CGCGTTTTGGAGGTTTCCTCAAGAATTTTGCTCTTGCTTTCGATATAT 
Oligo90 CCTTATTATATAGCCCTGCTCAGTCCAGACGTGATACCGAGACAATGA 
Oligo91 TATTCAATATATTTTCATTTCGCAACTAAA 
Oligo92 CGGAGAGGACATTTCGAATA 
Oligo93 AGGAGGTTACATAAAGACGGAATAAGAGAGATAATTTGCCTTTATCCT 
Oligo94 GATATTCACGCAGTAAAAATTCAACAAAGTCATTTATCCGATTAGT 
Oligo95 CTGTAATATCATTTTTAAGGTAAAGGTGAGAG 
Oligo96 TCAACGCAAAAATTCGTATGTACCGCGGATTGTCTGCCAGCGGAAACC 
Oligo97 GCCTTGAGAGGCTCCAAATAGAAAGCAACGGCGTATCATCGAGGCGCA 
Oligo98 TGTACTGTTTATCAGAAACAACTCTTTTTCCCAAGCGCACTGACC 
Oligo99 AGCGTCATAACAGCTTTAGTAAATTAAAATACAAAACACTGGTGTACA 
Oligo100 TTGTACCACCAGACCGATGTTTTACCTAAATG 
Oligo101 AATAAAGCATTAGAGATTAATTGCAATGACCATGCGGAATTTTTGCAA 
Oligo102 CGCGAGCGCTCAACGAAGCAAATTCAAAT 
Oligo103 AGAACCGCTTGCCTTTGAACCGCCATCAATAGTGTTAGCATACCGAAG 
Oligo104 GATATAAGGCGTTTGCCATCTCATCGGAAATT 
Oligo105 TGTTTAGCCCGTTCTAAGAAAGGCGTCAATCACATTAAATCGCGTCT 
Oligo106 AACACTGAGGAGATTTTACAGAGGTGAATAAGGTGAATTACCTTATGC 
Oligo107 AACGCCTGCGATTATAATGAGGAACCAAATCACTCATTATACCAGTCA 
Oligo108 AGTTAGCGAATACACTGTAATGCCAGTAATCTAATCTACG 
Oligo109 GTACGGTTGAATCCCCCTCAAAGACGACGATAAAAAC 
Oligo110 TCGTCTTTACCAGGCGATGTACCGGAATTACC 
Oligo111 CAAAAAAATAACAGTGTCGGAACCCCCTCAGATAATCAGTAGCAAGGC 
Oligo112 GTATCGGGTAATAAGTAAGAGGCACCCTCAAGCGTCAGCAGCAAA 
Oligo113 AAAGCGAAAAAACATTGATAAGTGCACTTTCA 
Oligo114 AGGTCAGGCTCAGAGCTGGCATCAAAAGGGTGGCTGATAAAAACAAGA 
Oligo115 CCGCTTTTTAATCATTGCTTGCCCTGACGAGAGCCGGAACGCCTGATA 
Oligo116 TCGGTCGAGAACTGGACGTAACAAAGCTGCGGAACCGAGAAACAA 
Oligo117 CAACAACCGGAAGAAATGACAAGAACCGGATAAGATGAACCATCTTTG 
Oligo118 ATCGCGTTACGGAACACCCTCGTTTAGACCT 
Oligo119 AGATTAAGCATCAGTTTACGAGGCATAGTAAGCGAGAGGCCGTCATAA 
Oligo120 GGTAGGAACAACGGAACCCAACCCTCAG 
Oligo121 CTTTAAATATCATAAACATTATTACAGGTA 
Oligo122 AGTACAACGTTTCGTCGTTTCAGCGAAAGTATTTTTAACGTTGGCCTT 
Oligo123 ACCCCCAGTAGCATTCTGTATGGGGAAGGATTTTTGATGATCATTAAA 
Oligo124 GGCAAAAGTAACGATCTAAAGATGAGAGGGTT 
Oligo125 ATATTCATGTCTGGAAATGCTGTATGAAAAGGATAAAGCTCTTTATT 
Oligo126 GACGGTCAATCATAAGTCATTCAGCTTTGAGGTGCAGGGACTTTAATT 
Oligo127 AACTTTGAAAGAGGACTTCATTACGTTTCCATCGCATAACCGAGGTGA 
Oligo128 GACCAGGCGCATAGGCTGGCTCCAACGAAAGA 
Oligo129 CAAAATAGAGCAACACCAGTTCAGCGAAAGACCTCCAAC 
Oligo130 TCATCAAGACTACGAAAGCGCGCCTAGTTTTC 
Oligo131 GATTTTACTGAGGCTACTAAAGATTCAACAACCAGTACCACCCTC 
Oligo132 GGACGTTGATCGCCCATAAACGGGGAATTTTCCACAGACATGTATCAC 
Oligo133 TTAATAAAACGAACTATTAATTCGGGCACCAAAATTTTTG 
Oligo134 GAAAGATTAGGAAGCCAAAACGAGTGAATATAGTTTCATTCAATAACC 
Oligo135 TGGGCGCCAGGGTGGTGCGGTCCAGCCTGGGGGCTCACAAGTGCCTGT 
Oligo136 CGTCGGCCACCGAGGAACGGTACGCCAG 
Oligo137 TACAAACAATCAGTGATGAAATGGGGCGAGAATTGACGGG 
Oligo138 GGTTACCTTCGGCCAAAGTGTAAACGCTGGTTGGTTCCGAAATCGGCA 
Oligo139 TCGCAAGACTTTGCCCGAAA 
Oligo140 CCGTAAAAGTGTTCAGGCACTCAATGCGGCGGCAGCACGCTTCCACAC 
Oligo141 GAATCTTATCAAATATAACAACGCCATAAATCTTACCTTTCGTCAGAT 
Oligo142 GCTTTCCGGTTGGGCGGAATTTGTCGTCGCTGGAACGTGCAGCATCAG 
Oligo143 CGGAAACGCAGAGCCTAACCCACAGTATTAAACTTTCCTTTTCGAGCC 
Oligo144 GGTCATTGCAGTATCGTCGGATTCTTCGCTATAGGCGATTAAACGTAC 
Oligo145 AGCCACCACAGCACCGGCCGCCACAAGACACCGTGGCAACAGCAAGAA 
Oligo146 CATTAGATGTAGCTATGAGTAATGAAAGCCCCAATTGTAACAACATTA 
Oligo147 CAGTTGATTCCAATACTAAATCAAAAAGGAATGAGATTTAGGAATACC 
Oligo148 AATTGTGTGCCCAATATAAAGGAATGCCTATTCCCGTATAGCATTGAC 
Oligo149 GGATAGCGTCCCAATTGCGGATGGTAGCATTAATTAGCAAGAACCCTC 
Oligo150 GTTACTTAAACACCAGCATCGGAAGTCACCCTAAAATCTC 
Oligo151 AAGAAGTTTTGCCAGATAACGCCAAAATCAGGGCGGATTGAATTGCTC 
Oligo152 GGTTTAATTTCAACTTGCGGGATCCGAG 
Oligo153 AATGCGCGAGTTACAAATCCTGATAAACATAGTAGGTCTGTAAATAAG 
Oligo154 AGAGTCCACACAGACAATCCAGAAAATCAATATATCTTTAGAATTATC 
Oligo155 ACAAAGTTAGTCCTGAGCGCCCAAGCGTTATATAAGGCGTAGAGACTA 
Oligo156 TCAATTACGTTCAGCTTATCATATTAGCAAGCAACCTCCCCGTCAAAA 
Oligo157 TGCCTGAGATCTAAAATCTGGTCATCAATATAAATCGCGCTATTCATT 
Oligo158 GCCAGAATAAAAGAACAAAAGGGCATTAGACGTTGTTTAAGACTTGCG 
Oligo159 GCGAGGCGCCGGAATCATAATACGTCAATAGTGA 
Oligo160 AATAGATAACCAGAAGGGAAGCGCGACATTCATTATCACCCATAGCCC 
Oligo161 ATTTCTTAACATGGCTAGGATTAGCCACCACCTTTTCGGTGTCACCGA 
Oligo162 CGTACTCACATCGGCAGGAACCGCCCAAAGACTGGCATGAATAGCCGA 
    
  Staples for Cholesterol labeling 
  (Anchor sequences for cholesterol labeling were shown with orange color) 
Oligo1 CATTCTCCTATTACTACCTTTAAACATCAATTCTGTTAAAGCCATTT 
Oligo2 TCATTAAATCAACAATCCA 
Oligo3 CATTCTCCTATTACTACCTTCAGCAACCGGTGGAGCCGGAAAAAGGTTTCAG 
Oligo4 CATTCTCCTATTACTACCTTTTGTACTGTTTATCAGAAACAACTCTT 
Oligo5 TTTCCCAAGCGCACTGACC 
Oligo6 CATTCTCCTATTACTACCTTGTACCACCAGACCGATGTTTTACCTAAATG 
Oligo7 CATTCTCCTATTACTACCTTTACAAAGAAACCTCCGGTTAATTTTTACC 
Oligo8 AGTACCAGACGAAATAATAT 
Oligo9 CATTCTCCTATTACTACCTTAAGGTTTGTAAAGTTAAACGAGCAGAAACA 
Oligo10 CATTCTCCTATTACTACCTTTCGCGTTTTGGAGGTTTCCTCAAGAATTT 
Oligo11 TGCTCTTGCTTTCGATATAT 
Oligo12 CATTCTCCTATTACTACCTTTATTCAATATATTTTCATTTCGCAACTAAA 
    
  Staples for dye labeling 
  (Anchor sequences for dye labeling were shown with green color) 
Oligo1 GAGACGGGCAACAGCTGATTCGCGCCCGCTTCATCAACCATATCAACTTCC 
Oligo2 ATTTATCCTGATTATCAGAGGTGGAATTGACATCAACCATATCAACTTCC 
Oligo3 GCGGATCCGCCATTCGCCAATTGATGGGCGCATCAACCATATCAACTTCC 
Oligo4 GATATAAGGCGTTTGCCATCTCATCGGAAATTCATCAACCATATCAACTTCC 
Oligo5 GGCAAAAGTAACGATCTAAAGATGAGAGGGTTCATCAACCATATCAACTTCC 
Oligo6 ACCAGCTTTCCGTGAGCACTCTGT 
Oligo7 GAGTGAGCTGTCGTGCTCACCAGTCATCAACCATATCAACTTCC 
Oligo8 TGTGAAATTATAAATCGAGAGAGT 
Oligo9 TGCAGCAATTTTCTTTCAGCTGCACATCAACCATATCAACTTCC 
Oligo10 ATACGTGGCTATTAAAGCGTAACC 
Oligo11 ACCACACCCGTATAACACATCACTCATCAACCATATCAACTTCC 
Oligo12 GATAGAAGGCGAAAAAGGGCGCT 
Oligo13 GGCAAGTCGGGAGCTCGTTGTACATCAACCATATCAACTTCC 
Oligo14 TCCAGTCACGATCCAGCGCAAAAATGGGTACATCAACCATATCAACTTCC 
Oligo15 GCGAGGCGCCGGAATCATAATACGTCAATAGTGACATCAACCATATCAACTTCC 
Oligo16 ATTCATTAAGCAGCCTTTACAGTACTAAGAACCATCAACCATATCAACTTCC 
Oligo17 CATCGTAGAACGGTAATCGTGACAATATGACATCAACCATATCAACTTCC 
Oligo18 TATTCAATATATTTTCATTTCGCAACTAAACATCAACCATATCAACTTCC 
Oligo19 GACCAGGCGCATAGGCTGGCTCCAACGAAAGACATCAACCATATCAACTTCC 
Oligo20 TCGGTCGAGAACTGGACGTAAC 
Oligo21 AAAGCTGCGGAACCGAGAAACAACATCAACCATATCAACTTCC 
    
  Connector Staples for dimerization (right side) 
  (Complementary sequences for dimerization were shown with the same colors) 
Oligo1 TTGATGGTTGCCCCAGCAGGCGAATACGCATGAT 
Oligo2 GAAGCAAATCTTTACCCTGACTATGCTAAATTTA 
Oligo3 GTTTCTGCGCCGTTTTCACGGTCACCGTAAGTAC 
Oligo4 GGCAAAGAACATCCAATAAATCATCCCGTATTGG 
Oligo5 TCATAACGGCAGCCTCCGGCCAGAAACTGACCTC 
Oligo6 AATATTTAAAAAACAGGAAGATTGCAACTATGGA 
Oligo7 GAAGCAAATCTTTACCCTGACTATATCATGCGTA 
Oligo8 TTGATGGTTGCCCCAGCAGGCGAATAAATTTAGC 
Oligo9 GGCAAAGAACATCCAATAAATCATGTACTTACGG 
Oligo10 GTTTCTGCGCCGTTTTCACGGTCACCAATACGGG 
Oligo11 AATATTTAAAAAACAGGAAGATTGGAGGTCAGTT 
Oligo12 TCATAACGGCAGCCTCCGGCCAGATCCATAGTTG 
    
  Connector Staples for dimerization (left side) 
  (Complementary sequences for dimerization were shown with the same colors) 
Oligo1 ACGTATTATTTACATTGAAATGTAACT 
Oligo2 ACAGAACGAGTAGTAAACCGAATACGA 
Oligo3 CCTGGAAATTGCGTAGAATTCTAAGGA 
Oligo4 CCCCTTGCGAATAATATTTCGGAGGTC 
Oligo5 AGTACAACATGTAATTTTATAGGCCCT 
Oligo6 CGCACAGAACCACCACGATAAAACACC 
Oligo7 ACAGAACGAGTAGTAAAAGTTACATTT 
Oligo8 ACGTATTATTTACATTGTCGTATTCGG 
Oligo9 CCCCTTGCGAATAATATTCCTTAGAAT 
Oligo10 CCTGGAAATTGCGTAGAGACCTCCGAA 
Oligo11 CGCACAGAACCACCACGAGGGCCTATA 
Oligo12 AGTACAACATGTAATTTGGTGTTTTAT 
    
  Connector Staples for 1D polymerization 
    
Oligo1 GAAAGCCGAATCCTGTTTGATGGTTGCCCCAGCAGG 
Oligo2 GCGCTTTCCAAATCGTTAACGCGT 
Oligo3 CATCCTCATAACGGCAGCCTCCGGCCAGAAAA 
Oligo4 CAGTACAACATGTAATTTTACCAGTCCCGGTTGTGTACATCGAGA 
Oligo5 GGGATGTGCTGCATACGCCAGCTGGCGAAAAG 
Oligo6 ACAACCCGGCCTCAGGAAGATGAG 
Oligo7 AAGCAAATATTTAAAAAACAGGAAGATTGGAA 
Oligo8 CAATGCCTTTTTGAGAGATCTACC 
Oligo9 GGCAAGGCAAAGAACATCCAATAAATCATATG 
Oligo10 TCATTTTTCTGCGAACGAGTAAGG 
Oligo11 AGTCAGAAGCAAATCTTTACCCTGAC 
Oligo12 AAGCATAACGCGCGGGGAGAGGTG 
Oligo13 AAAATGCAGATACAGGGGGT 
Oligo14 GGGGGTTTCTGCGCCGTTTTCACGGTCAACCG 
Oligo15 CGAAGCGAACGTATTATTTACATTGCGG 
Oligo16 CGGGGTCATTGTTTTCAGGTTTAATTTAATGGGCA 
Oligo17 AACGGAGAATTGAGTTAAGTA 
Oligo18 AGCGCCATGTTAGGCAGAGGCATTATCATTCCAGG 
Oligo19 AATGTGAGCGAGCCCAATAATAAGATATAAAATAT 
Oligo20 ACGCACAGAACCACCACCATG 
Oligo21 ATATATTTTAAAGAGCCGCCGCCAAACAGTTAACA 
Oligo22 CCCCCTTGCGAATAATAAAGG 
Oligo23 CTTTTGATAAGTTTTTTCACGTTGCAGCAGCGTAT 
Oligo24 TATAAAGACAGAACGAGTAGT 
Oligo25 AATAGTAACCTGCTCCAT 
Oligo26 AACATACGAGCGCAGATTCACCAGGTATTAACTACC 
Oligo27 CCTGGAAATTGCGTAGACAG 
Oligo28 AAACTTTTCCAACGCTAACCGCACTCCAGCCA 
Oligo29 CGTCTTTCTCACCAATGAAACAAAGGCTATCA 
Oligo30 AATCCTGAGAAGCGGTTTGCGTAT 
Oligo31 ATCGATAGCCCTCATTTTCGATTTAGTTTGAC 
Oligo32 TTTTTATAATTCGACAACTGCATCAGATGCCG 
Oligo33 GATAGCAACGAAATCCGCGAAATGTTTAGACT 
Oligo34 ACATTCAACTATTGGGCTTGAGAT 
Oligo35 ATTAAATCCAAAGAACGCGACATAAAAAAATC 
    
  Connector Staples for 2D polymerization 
    
Oligo1 GAAAGCCGACAGGCAAGGCAAAGAACATCCAATAAATCATGCGAACGT 
Oligo2 AATCCTGAGAAGATTTAGTTTGAC 
Oligo3 ATTATTTACATTGAGGTCATTTTTCTGCGAACGAGTAGTGTTTTTATA 
Oligo4 GTATTAACTATAGTCAGAAGCAAATCTTTACCCTGACTATACCGCCTG 
Oligo5 ATTCGACAACTAAATGTTTAGACT 
Oligo6 GAAATTGCGTAGAATGCAGATACAGGGGGTAATAGTACGTATTAAATC 
Oligo7 CTTTTGATAAGGCAGATTCACCAG 
Oligo8 ACATTCAACTATTTTCAGGTTTAA 
Oligo9 TGCCCCAGCAGGCGAAATGCCCCCTTGCGAATAATAACGGAAGCATAA 
Oligo10 CGCGCGGGGAGAGAGGGATAGCAACGAAATCCGCGGCATCAGATGCCG 
Oligo11 AACATACGAGCTTTTTTCACGTTGCAGCAGCGTACCGGGGGTTTCTGC 
Oligo12 GCCGTTTTCACGGTCAAAAGACAGAACGAGTAGTAAACAGGCGCTTTC 
Oligo13 CAAATCGTTAACGACCTGCTCCAT 
Oligo14 CGGGGTCATTGTTGGGCTTGAGAT 
Oligo15 AACAGTTAAATCCTGTTTGATGGT 
Oligo16 CCCTCATTTTCGCGGTTTGCGTAT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2. Staple sequences for DNA Origami Triskelion Assembly and Polymerization 
 
Unmodified Staples 
    
Oligo 1 CCACTACGTGAACCAACCCTAAAAGGAACGCTGCGGGTTGCTACAGGAG 
Oligo 2 ATCAGGGTTTAGAGCTTGAGATACCGACGCAAGTG 
Oligo 3 TCCAACGTCAAAGGTCCGAAAGGCGAAAGCCAGGGGGG 
Oligo 4 AGACGCTTCTGTGCTGAATTAATGCCGGAGAATCAGGTGTCA 
Oligo 5 CCCCAAGAGTCCACTATTAAAGAATATAAATCCACGCTACCA 
Oligo 6 CCCAGCATCGGCAACGCCCTGCGCACGATATTTTTGAAGGGT 
Oligo 7 GTATCGGCCTGCCATTGAACATCGTAATCCTGATTGTTCATA 
Oligo 8 GCTTAGTTAAGCTACGGCCCTTTAATGGCTATTAGATTAACACCGCCAA 
Oligo 9 GTGTAATGAAACTCACATTAATTGTGTTATCAGCTCGAGGTC 
Oligo 10 GTACTATCGTAACCTGAGTAGCTCATGGTGCGCGATAACCAGAACACAG 
Oligo 11 AGAGGGGTGCCTAATGAGCACAACAACGGAGGCGCA 
Oligo 12 ACGCGCGTGGTTTTGTGTAAT 
Oligo 13 CGTTAGAATCAGAGCGGATCAGTGCAAATTATCTAAAGCCAGCAG 
Oligo 14 GCCGATTATCCTGAACTTCTTGAGC 
Oligo 15 CAGTGTAAAGCCTGGCGGTTTGCATGCGCCGCTACTTTTAGA 
Oligo 16 TTTATAGAGCTAATTGACGAGCACGTAAAGT 
Oligo 17 CGGAAGCATAAAGGGTGCTTGGGTGCAACAGTGCCGCAAAGC 
Oligo 18 TGTTTCCTGTGTGAAATCGTTGCGCGTGCCAGCTGCATAGACGGGCGAA 
Oligo 19 TAATATGAACGGTACGCCAGAAAAGGGAAGGGCGC 
Oligo 20 ACTAGCGGTCAGGGAAGAAAGCGAAAAGCACTCATTGGCGGAC 
Oligo 21 ACTTGCCACCACACGCGAACGTGGCGAGAAGGGAGTCGT 
Oligo 22 GCTATTGGGCATCCTGTTTCGGGGAAAGCCGCCGCCGC 
Oligo 23 CTCGGTACCGCGCTCACAATTCCATGAGCTATCGGCCA 
Oligo 24 CTCTAGGGGCTTTCCCACAGGAGACAGTCAACTGATAAATT 
Oligo 25 GGCTTACGCTAATCCCTCGTGGAC 
Oligo 26 CTGTAGAACCAGCGGAATTATCATTGGATTAACTGATAAACA 
Oligo 27 GTTGTGAATTCATGGAGTGACGTAAGCAACTCGTCAAACGACGATCTAC 
Oligo 28 TTCCTGGCCAACAGAGAAAATGGAAAAAACGAAGA 
Oligo 29 GGATGTTCTTCTGTAAGAATACGTGGGGCTTCTGA 
Oligo 30 ACAATATTTTTGTCTCAGGAGAAGCCGAGGCCAGT 
Oligo 31 AAAGGCTGGGTAGCCTTAAGTG 
Oligo 32 GCCAAGCGCCATCTTCTATGATGGTGGTGCGAAAAACCGTCT 
Oligo 33 CGATACGCCATTGGTGTTTTGAGGGGACCCGTCGGATTTGGG 
Oligo 34 AAGATAAGCCCTAACAACAGGTTATTTAAAATCGGATCACCC 
Oligo 35 GAGCAGCAAAAATATCTGGGCCGGAAACCAGACGCTGATGATTAG 
Oligo 36 GGGCGATCGGTGCGTAGCGCAACTGTTGTTACCTCCAGG 
Oligo 37 CAGGTGAGGCGGTCAGTTCTTTAAAAATACCTACATTGCGACATC 
Oligo 38 TCGGGCCTCTTCGCTATCGTTGTAGGTG 
Oligo 39 ACGGCTGGCGAAAGGGGCCAGGGTCTTGAATATAACCCATAG 
Oligo 40 ATAATTCGTAATTTCTCCAACAGCTTGCAGCAAGCGGTCAAA 
Oligo 41 ACCTCAAATATCAAACCCTCAATCTGAAAAAACCGTTGCAA 
Oligo 42 GCCATTCGCCATTCAGGCTACCGTGCAT 
Oligo 43 CTGCCAGAGATGGGATCCCCGCTGGTTGTCTTTTCGGTTTGC 
Oligo 44 AAATCAACAGTTGATAGG 
Oligo 45 ACCGCTTCTGGTTCGATTAGACGTCGCTTACATAAAAT 
Oligo 46 GTATCGGCCTCAGGCCAT 
Oligo 47 TAACAACTGGCCTTAGTACGGTACATTTAGAA 
Oligo 48 CAGCAAACATTAAATGTGAGCGAG 
Oligo 49 ACCGATATCTTGATACGGATAGCAAGCCCACACCCTCA 
Oligo 50 ACATACAACAACCATCGCCCACGCATA 
Oligo 51 ACGCAATAATAACGGAATACCCAAACAAAGTTTTCCAG 
Oligo 52 AGCCCTTAGATACCTTTTTTAATGGTTAAATAAGAATATACAAATTAC 
Oligo 53 TTTTCCTAACCTTGCTTCTATCAAAATCTCCTTTTGATATTGA 
Oligo 54 CAAATTCCATAGATTTATCAGGTCATACTGCGGAATCGTTGCAAAAGGC 
Oligo 55 GAGAACACCAGATATTCATTCATCTGCAGATACATAAGAGC 
Oligo 56 AGCAATGAGGAAGTTTCCAAGGCACCCCTTCATACCGAACACTA 
Oligo 57 TAAACAGATTCGGTCGCTGAGGCTTGCAGGAGAGGCTTATAA 
Oligo 58 AGAGAGCCACACCGGAAATGGCTGTTTTAACGGGGCAG 
Oligo 59 GCAAAAATAGAAAATTCATATCAACCGATTAGCGTTTCAAGTTATG 
Oligo 60 TAGCCGAAAGAACTGGCATGATTAAGACCGGAATACCCTCAGGGA 
Oligo 61 GGATTTATTGAGTAAAACAAAGAGGCGATATCATACAACGCC 
Oligo 62 TAAAAGGAACGAAGATCGCACTCCAGCCAGCTATT 
Oligo 63 CAAATATCCAGCTTTCATCGCATGTTTTAACCTGTAATTAAA 
Oligo 64 ACGAGCATCGATCGTCACCCT 
Oligo 65 GGTGAAGGACTAAAGAGGCAAAACCAGGCGAGAGGACGAGGCAAGAACG 
Oligo 66 TTAATTGTGCGCCGACAATGACAAGCCACCTGAGTTTGAGGGGT 
Oligo 67 ACCGGCAACATAACGTAGAAAAT 
Oligo 68 AGTAATTTATTTTGAAATATTTTTCGGTGACTGTAAGTGCCCGTAGAAA 
Oligo 69 CCCTTTTATAAGAGATTTTTTGTTTACACAAATTT 
Oligo 70 GCCGAGCTGACAAAATTATAGCGACGACAAAAGGTAAA 
Oligo 71 CTAACTTTGACCCCCAGCGGATTTGTGAACGAGGCGCAGA 
Oligo 72 AAGACTTTTTCACGGCTACGAGTTAAAGGCCGCTTTTGCGGGGAAC 
Oligo 73 TCTTGTAGCATTCCAGGCTCAATAGGAACCCCAG 
Oligo 74 AAAAGGAACAACTAAAGGATTGCTAAAGTAAATGAATTTTCACCAGAC 
Oligo 75 AAAAGGAACCAGTAGATCTAAGAACCTAACAAGA 
Oligo 76 GAGAGGTGAATTATCACCGCAAAATCAGATAGCAGCACCGTA 
Oligo 77 GGTTCACAATCGACACCATCCTTATTACGCAGTATGTTAGCAATAAA 
Oligo 78 AAACCCTAGATTTTGTACCTT 
Oligo 79 CAAAAGGCAGGAAGATTGTCGCTATATTCAGAGCACAGA 
Oligo 80 GATAAAAATTTTTAAAGAGAAAATCATACAT 
Oligo 81 CCTTTTGCGGGAGAAGCAAATCATAATAGTAAACG 
Oligo 82 TGCACATTATGACCCTGGAATTAGAAAGGTGCATT 
Oligo 83 ATGTGTAGGTAAAAGCTAAATC 
Oligo 84 GAAATCTATGGGATTATTGCGAATAATAATACACTAAAATTGTGTC 
Oligo 85 AACAGTTTCAGCGTTTTGTCGTCTTTCCAGCGTAACCAAA 
Oligo 86 CAAGGTAACTGAACACAAGAATTGAGCGGAAATTACCATTAG 
Oligo 87 CTGACATTAGACGGGAGATTACGTCAAAAATGCGCACTCGCTGTCT 
Oligo 88 TCAACTGAATATACATTTCAATTACCACAATA 
Oligo 89 CGGTCAACAAAGTACAACGGAATTATACACTACGATTAA 
Oligo 90 ATCAGTTGGGAATTAGAGCCAGTCACCGACGCGACATTGGTTT 
Oligo 91 AACGTCACCAATGAAGCGTCACATAGCCCACC 
Oligo 92 AAAAGGGAGAATAAAGAAATTGCGTTCTGAATTAAA 
Oligo 93 TTCAGTAACACAGGTTTAACGTCATCTGCGGAACAAAG 
Oligo 94 AAATAATACTCATATATTTTAAATGCCTGAGTAAT 
Oligo 95 TAAGGGACAAGAGTAATCTAGTAATGCCCAAGCGCGAAGATT 
Oligo 96 AGCCCTCATGAAAACAATAGATAAGTCCTGATTATTCTAGGAT 
Oligo 97 AAAAGAATATGTGAGTGAAAATATAGTCGTTTAGA 
Oligo 98 TTTCATCCAAAAGGTTGAGCCATGAGTGAGAATAGAAAAGGCTCC 
Oligo 99 AGTATAACAGAGAGGTCATTTTTGTCAGGATAGATTAAGAGGAAGTCA 
Oligo 100 AATAAATATGATAATGCTGTAGCTACAGCTTCAAAGCG 
Oligo 101 AGAACCGGAACGAGTAGTAACGAAAGACGGTAAAATAATAAG 
Oligo 102 AAAATCCACCCTCAGAGCCAGTAAAGGTAGCGCCAAAGAGCCT 
Oligo 103 ACCAACCGCCCCGCCAGCATTGACAGGAGTAGCCGCCAAGGCAGA 
Oligo 104 ACCGCGTTCCACCTTGAGTACAAGCCGTTTTTGAAGGCT 
Oligo 105 GCCAGTTAGATATAATTTTCATCGTAGGCAAGTACAAAATAGGGAA 
Oligo 106 TTCACTAACATAGACTTTACAAACAACGTTAAATTAATACCAAGTTCTT 
Oligo 107 AAATGCCGTCAATAGATCTTCCGGC 
Oligo 108 TTCAACCAATTTTTTGTTAAATCAAAAACTATATGAGC 
Oligo 109 TTCAAATAATTTTGTTAAAATTCGTGTACCCTTCTACTACAGGCAAGAA 
Oligo 110 GGCCGTAACACATTATAAGGAATTCTGAGACTCCTGATAAGT 
Oligo 111 AGCCTGAGTTGCTATTTTGCAAGCCTTAACGCGAGGCG 
Oligo 112 AGCGATAGCTTAGATTAAGGTTGGTCCAATCGCAAGACACCT 
Oligo 113 TCAATATACCTTTGCGAGAA 
Oligo 114 TTAATTCCGGAAGGACTTCAAATATCGGAAA 
Oligo 115 TCATTGTGAAGCTTCAGTGATGATTTCT 
Oligo 116 GAACCGAGGAGGGATATAAGTATACAGTACATGTACCCAACGCCCCAAA 
Oligo 117 GCCACCCAAGGTGTATCACCGTA 
Oligo 118 AACCAGAGCTGAATCAACTAACCTGTAGTTAAATTGTAAACGAAAA 
Oligo 119 TCATACGTTAATAAAATAGAAAGATTACCCTGGCTGAAAC 
Oligo 120 CTTATGAACGGAACTCGAGAGGGTTTTTAGTACCTTAC 
Oligo 121 CTCCCACCCTTTTTCAGCGATAGTTATCGGTTTATCAGCTTGAAAA 
Oligo 122 ATAAGAATGGAAAGCTCATACCCAGAGCCCCTTATTGAGG 
Oligo 123 GGCAGGTTCTGAATTTGGTATTCTAAGAAATCAAGATGTTGA 
Oligo 124 CTTGCGGGAGGTTTTGACCCAGCTGAGCGTCTACCAGAACCGAAG 
Oligo 125 AACTTTTTCAAAAATAGGTCTGAGAGACGTGAATTTGT 
Oligo 126 TTTTGCAAATCACAAAATAGAAACGCAAGAAACAGAGAGATAACCCACC 
Oligo 127 AAATTTAATGAAAACAATTAATTTAATGGAAGGGTTAGACAG 
Oligo 128 CTGAAAGAACTTAACCTCCGGCTTAGACGCTAATT 
Oligo 129 TTCAGAATCATAATTACTAGAAAATAGTATAT 
Oligo 130 TTTAGTTATCAATAGATGATGACATTATCATTTGTGCTAATACATTTGA 
Oligo 131 CTATTTCTGCGGTAGCATGCATGTCTCGATGAACGGTAAGAGCAAG 
Oligo 132 CCCATCAAAATAGAGAGTACCTTTAATTGCAGCAAAGCGGATTGCTGA 
Oligo 133 AAAAGTTTGACGCATCAACGGTTGAAGTCTGGAGCAAACGAAC 
Oligo 134 AAACCCGAAACAAACTCCAACAGGCGGATGGAAGT 
Oligo 135 TGATATTCATTGAATCCAACCAAAAAGCAATACCAAAACTGAGTA 
Oligo 136 ACGCGCAAATGGGGCGCCCAAAAAGTGAGAAAGGCCTTGCAA 
Oligo 137 CAGTTCACGTTTTAATTCGGTTGGGAAGATTTAGGTTTGACA 
Oligo 138 GAGAAAAATCTTATACCAGTCAGGCAAATTGGGCTTGAGATGGTTTGGC 
Oligo 139 AGGCGAACTCGATTTTAAGAACTAATTTCGACGAGAGGT 
Oligo 140 GCCGAAAAGCTGTGTACAGAGAATTTTTTCACGTTGCTTTCGA 
Oligo 141 GCGCAAGAGAAGGATTGAAACATAGTTAGACGTTACAACTTTC 
Oligo 142 TTTGCTGCCCGGAATAATCCTCATTGATACAGCGTAATC 
Oligo 143 GATAAAGCCTTCACAAACAAATTCGCCACCAGAACCACCACCTTG 
Oligo 144 GCGGCAGTCCAGACGATTGGCCAGAGCCGACCCTCAAAC 
Oligo 145 TATCCACCCTCCCTTCGGCATGATTAAGCCCAATATAAGAAA 
Oligo 146 CTGGATAAGGGGGTATCCAATCTTTATT 
Oligo 147 TAGCGTGTACTGGTATTTCGAGTAGCGACAGAATGCCATCT 
Oligo 148 ACCATTGAGAATCGCCATATTTAATGCGTTAAACACCGTCTT 
Oligo 149 GTAGCAGAGGCATTTTCGAGCCAGTTGCCAGGCGTCCATTTA 
Oligo 150 GTTTAATAAGAGAATATAAAGTACGAGGCTTTCATAAACCAT 
Oligo 151 CGATGTCCAGACGACGACAATAAATAACCCTCAACTAAAGTT 
Oligo 152 TCACAACATGTTCAGCTAATGCTAGTAACGCCAATAC 
Oligo 153 AACTGACCAATTAGCCGATCATCGCCTGATAAACACTCATAACGA 
Oligo 154 CCCATCCTAATTTACGAGCATGTATAAATCAGTGGTAA 
Oligo 155 TTATGCCTTTAACCATCCCAGTAGCACCATTATTCATTAAGGAA 
Oligo 156 AACATGTAATTTAGAAAAGCCTGTTTAGATTA 
Oligo 157 GTAATTCCGATAAACCCTCAAATGCTTACCACATTCGTTTACTAAATCA 
Oligo 158 CGCCTGTTTATCAGTATTAAGAGGACAGATGATGCGCGACCTGCTC 
Oligo 159 AAAATAATATCCCCCTGCCTAATAATTT 
Oligo 160 CCAATCAATAATCGATCGAGAACAAGACGCGCGTTATCCGGA 
Oligo 161 GGGCGCTGGCTAACGTGCTTTCTA 
    
  Staples for Cholesterol Labeling 
  (Anchor sequences for cholesterol labeling were shown with orange color) 
Oligo 1 CATTCTCCTATTACTACCCCTGAAAAGTTTGACGCTCAACCCCCGACGATGGC 
Oligo 2 CATTCTCCTATTACTACCTCCTTAAATCTATACGAATATGAC 
Oligo 3 CATTCTCCTATTACTACCTTACATCTCGCGCACATCAAGGAA 
Oligo 4 CATTCTCCTATTACTACCGGTTGTAAAGCCTTTCATTTGGTC 
Oligo 5 CATTCTCCTATTACTACCCATGTTACCTTTGAACATAGGCAAAT 
    
  Staples for Dye Labeling 
  (Anchor sequences for cholesterol labeling were shown with orange color) 
Oligo 1 ACTTAGCAATGAAGTGTTTTCCTCTACCACCTACAT 
Oligo 2 GAGTAAAGATAAAGTACGAGCTTCCTCTACCACCTACAT 
Oligo 3 AGTGAAGTATACTAATAAGTTGGCTTCCTCTACCACCTACAT 
Oligo 4 CAGTTAATATTCGCGTCGACGACATTCCTCTACCACCTACAT 
Oligo 5 CTAGTAACACACCCTCACAGAACCTTCCTCTACCACCTACAT 
Oligo 6 ACAGATTAATTGAGAAGAGTTCCTCTACCACCTACAT 
Oligo 7 AGATGTCTGGCTTAGAGCTTCCTCTACCACCTACAT 
Oligo 8 CAATTGCCCTAACTTTAATTCCTCTACCACCTACAT 
    
  Connector Staples for Trimer Formation 
    
Oligo 1 GTTCCAGTTTGGAAGAGATAGGGTTGAGTGCG 
Oligo 2 TGGCCCTGAGAGAGTGATTGCCCTTCACCGGC 
Oligo 3 GTCGGGAAACCTGTCTCACTGCCCGCTTTCGA 
Oligo 4 CACATAAATCATCATGGTCATATC 
Oligo 5 TCCCGCCAAACGGCTGACGCATTA 
Oligo 6 GTCAACCTTATGACAAAA 
Oligo 7 TTCAACCGTTCTAGATCACCATCAATATGAGA 
Oligo 8 TAAGTTGGGTAACGGATGTGCTGCAAGGCGAA 
Oligo 9 CGGATTGACCGTAACTCCGTGGGAACAAACAA 
Oligo 10 TAGCTATCTTAGGAAACCGAGGGG 
Oligo 11 GCGCTAATATCAATGAAATAGCAT 
Oligo 12 GCGACAAAGTCAGAGGGTAATTTA 
Oligo 13 TAACATAAAAACAGCAGCCTTTACAGAGAGTG 
Oligo 14 TCCCAATCCAAATAAAACAGCCATATTATTTT 
Oligo 15 TTACCAACGCTAACACAATTTTATCCTGAAGC 
Oligo 16 CCAATAGCAAAGCGAACCTCCCCA 
Oligo 17 GGTATTAAACAATCATTACCGCCC 
Oligo 18 TTCCTTATCATTCCAAGAATT 
    
  Connector Staples for Polymerization 
    
Oligo 1 AAATCAAGTTTTTTGGGGTTC 
Oligo 2 AGGTGCCGTAAGGAGCGGGCGCGT 
Oligo 3 GTCTGTCCATCACGAGGCCACCGAGTAAAAAT 
Oligo 4 CAATATTACCGCCATGCTGGTAATATCCAGTT 
Oligo 5 ACCAGTAATAAAAGAGATTCACCAGTCACAAT 
Oligo 6 ATTCTGATTATCAGATGATGGCAT 
Oligo 7 TTCATCAATACCATTAAAAATATT 
Oligo 8 GAACGAACCACATCACCTTGCTTT 
Oligo 9 ATCTAAAATATCTTAAGGAATTGAGGAAGGGA 
Oligo 10 AAATCCTTTGCCCGAATTCGACAACTCGTACC 
Oligo 11 TATTTGCACGTAAAAACCTACCATATCAAAAA 
Oligo 12 AAAACAATAACGGATTCGCCTGCG 
Oligo 13 TGCTTTGAATTACATTTAACAAAA 
Oligo 14 TCATTTGAATATCCTTGAAAACGA 
Oligo 15 AATGCTGATGCAAAGTTATATAACTATATGCT 
Oligo 16 GTGATAAATAAGGCGTTTGAAATACCGACCTA 
Oligo 17 AACAGTAGGGCTTAAGTATAAAGCCAACGCCG 
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Fig. S1. Stability of DNA nanotubes. (A) Gel analysis of CpG tube, plain tube, and pUC 18 (left to 
right) incubated in the reaction buffer containing 5 x 10-1 U / ml DNAse I at 37°C for 2 h. (B) Gel 
analysis of CpG tube, plain tube, and pUC 18 (left to right) incubated in reaction buffer containing 
high concentration of DNAse I (10 U/ml) at 37°C for 15 min. (C) Gel analysis of CpG tube, plain tube 
and pUC 18 (left to right) incubated in 37x diluted mice serum. (D) Gel analysis of CpG tube, plain 
tube and pUC 18 (left to right) incubated in pure FCS (not heat-inactivated) for 2 hrs. E) DLS analysis 
of CpG tube and plain tube. 
 
 
 
Fig. S2. Uptake of DNA nanoconstructs by RAW 264.7 macrophages after 1 h of incubation.  
Representative histograms show fluorescence shift indicating the uptake of Cy3 coupled DNA 
nanoconstructs by RAW 264.7 macrophages. Cells were incubated with 5 nM of different DNA 
nanoconstructs (CpG DNA tubes, DNA tubes, CpG ODNs, DNA tubes + CpG ODNs), LPS (10 
ng/ml) or without additive for 1 h at 37°C.   
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Fig. S3. Cell viability after incubation with DNA nanoconstructs. FACS analysis of RAW 264.7 
macrophage viability after incubation with 5 nM of different DNA nanoconstructs (CpG DNA tubes, 
DNA tubes, CpG ODNs, DNA tubes + CpG ODNs), LPS (10 ng/ml) or without additive for 1 h (A) 
and 18 h (B) at 37°C. The numbers indicate the percentage of viable cells within the sample.  
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Table S1. Systemic leukocyte counts and microhemodynamic parameters 
 
 
 Experimental 
group 
Inner 
vessel diameter 
[µm] 
Blood  
flow velocity 
[mm/s] 
Wall shear rate 
[s-1] 
Systemic 
leukocyte counts 
[x 106 ml-1] 
 
      
 
 
 
Saline 26.7 r 1,2 2.4 r 0.2 3489.0 r 129.7 2.6 r 0.5 
 Plain tubes 
 
26.7 r 2.8 2.3 r 0.7 3683.6 r 1554.6 1.5 r 0.3 
 CpG tubes 
 
30.6 r 3.8 2.1 r 0.3 2969.6 r 550.5 1.8 r 0.2 
 
 
CpG ODN 
 
26.0 r 2.3 1.9 r 0.4 2848.3 r 483.7 2.8 r 0.8 
 Cromolyn +  
CpG tubes 
 
24.8 r 1.5 2.0 r 0.3 3408.7 r 659.7 2.7 r 0.4 
 
Systemic leukocyte counts as well as microhemodynamic parameters, including inner vessel diameter, 
blood flow velocity, and wall shear rate, were obtained as detailed in Materials and Methods (mean+/-
SEM for n=3 per group). 
 
 
 
 
 
 
Supporting Information for Chapter 4.3 
DNA Nanotube Design 
DNA nanotubes were designed using single stranded tiles, where each single stranded tile 
oligonucleotide has 21-base long (2 full turn) domains complementary to the adjacent domains on the 
neighbouring tiles. 15 individual single stranded tiles were used to fold 6-helix nanotubes. The 
domains at the ends of the nanotube contain non-pairing poly-A sequences to prevent polymerization. 
For i-motif formation, 3 of the tiles were extended with the i-motif sequence. 
(CCCTAACCCTAACCCTAACCC). For Dexamethasone labeling, 3 of the tile oligonucleotides 
extended with either i-motif sequence or random sequence were hybridized with Dexamethasone-
conjugated single stranded oligonucleotides. All unmodified oligonucleotides (HPSF purified) and 
amine modified oligonucleotides (HPLC purified) were purchased from Eurofins Operon MWG 
(Ebersberg, Germany) (see the Supporting Information, Table S1 for the sequences).  
Dexamethasone Conjugation 
Amine modified single stranded oligonucleotides were conjugated with Dexamethasone using the 
method developed by Acedo et al.[6] In brief, Dexamethasone (0.4 g, 1 mmol, Sigma) was reacted 
with succinid anhydride (0.15 g, 1.5 mmol) and DMAP (0.13 g, 1 mmol) in pyridine at room 
temperature for 20 hrs. The reaction mixture was concentrated by drying in vacuum evaporator and 
then dissolved in 150 ml of DCM/MeOH(4:1) and washed twice with 75 ml of 1 M sulfuric acid and 
water. The organic white solid formed after the reaction, dexamethasone succinic acid (0.25 g, 0.5 
mmol), was reacted with N-hydroxysuccinimide (70 mg, 0.6 mmol) and DCC (125 mg, 0.6 mmol) in 5 
ml of THF at room temperature for 20 hrs. After several filtration and washing steps, the final residue 
was dissolved in 5 ml DMF (10 mM) and stored at 4 °C for months. For DNA coupling, 10 µl of 
5´amine-labeled oligonucleotide (100 µM) and 10 µl of Dexamethasone-NHS (10 mM) were mixed in 
Tris buffer (50 mM, pH 7.4) and incubated at room temperature overnight. Next day, the solution was 
centrifuged at 13000 g for 5 min and supernatant was collected. The solution was evaporated to 
remove DMF in vacuum centrifuge and redissolved in water. The centrifuge and evaporation steps 
were repeated several times. At the end, Dexamethasone-conjugated oligonucleotides were purified 
using 3K Amicon Ultra 0.5 ml centrifuge filters to further use in dye labeling and assembly.   
Enzymatic Dye Labeling of Tiles 
To visualize the DNA nanotubes in vivo, 6 of the tiles at the middle part of the structure and 
dexamethasone-conjugated oligonucleotide were enzymatically labeled with Atto488-dUTP and 
Atto647N-dUTP respectively. Atto488-dUTP or Atto647N-dUTP (80 µM, purchased from Jena 
Bioscience, Jena, Germany), CoCl2 (5 mM), terminal transferase enzyme (16 U/µl, Roche, Penzberg, 
Germany), and all DNA tiles (1 nmol) were mixed in a 20 µl, 1x TdT reaction buffer. The solution 
was incubated at 37°C for 1 h. Then, 2.5 µl of NaOAc (3 M) was added and the solution was filled up 
to 80 µl with ice-cooled ethanol (99 %). After 1 h incubation at -20°C, samples were centrifuged at 
13000 g for 30 min. Then, samples were washed with 70 % ethanol for 10 min again and the 
supernatant was discarded. The remaining pellet was redissolved in distilled water. 
DNA nanotube assembly and purification 
DNA nanotubes were assembled by mixing 1 µM of each tile with folding buffer (10 mM Tris-HCl, 1 
mM EDTA, pH 8.0, 20 mM MgCl2). The folding was completed over the course of 16 h (5 min at 
80°C, cooling down to 65°C at 1 °C/min, cooling down to 25°C at 2.5 °C/h). The assembled DNA 
nanotubes were then purified using 100K Amicon Ultra 0.5 ml centrifuge filters (Millipore, 
Schwalbach, Germany) in order to remove excess strands. 100 µl of assembled DNA nanotube 
solution was completed up to 500 µl with folding buffer in the centrifuge filter, and centrifuged 3 
times at 13000 g for 6 min. After every centrifuge step, the flow-through was removed and the filter 
was refilled up to 500 µl with buffer. After final centrifugation, the remaining solution at the bottom of 
the filter (~ 50 µl) was pipetted out and the concentration of tubes was determined by measuring the 
optical density at 260 nm.  
Gel electrophoresis analysis of i-motif formation and transmission electron microscopy  
DNA nanotubes were analyzed by running the samples in a 2 % agarose gel (0.5 x TBE, 11 mM 
MgCl2). 10 µl of each filter-purified DNA tube sample were mixed with 2 µl of 6x loading dye before 
loading into the gel pockets. 6 µl of 1 kb ladder was also loaded adjacent to the samples. The gel was 
run for 2 h at 70 V in an ice-cold water bath to prevent heat induced denaturation of DNA nanotubes. 
To test the i-motif dependent release of single stranded oligonucleotides, DNA nanotubes were 
assembled with varying MgCl2 concentrations, 2 mM, 5 mM or 20 mM respectively. After assembly, 
100 µl of folded DNA nanotubes were filled up to 500 µl in 50 mM MES buffer (pH 5.5) and 
incubated at 37 °C for 30 min. Then, the samples were centrifuged 3 times at 13000 g at 37 °C for 6 
min using 100K Amicon filters. DNA nanotubes were also visualized by electron microscopy using a 
JEM-1011 transmission electron microscope (JEOL). Prior to imaging, DNA nanotubes were 
incubated on plasma-exposed (240 kV for 1 min) carbon-coated grids and then negatively stained with 
1% uranyl acetate for 15s. 
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Table S1. The list of oligonucleotide sequences used in the 6-helix tile-tube assembly. 
Unmodified Oligonucleotides 
U1R1 AAAAACTTACTGAGGATATTGCCTGAAGCTGTACCGTTTTAGGGGAAA 
U2R1 CCCCTAAAACGGTACAGCTTCGGTACGTGCGGTACTAAGACTGGGGCGAATAGACAGGCTCCCCTCTCACTCGCTAGGAGGCAA 
U3R1 AAATTGCCTCCTAGCGAGTGAGAGGTTTCCCGCATATTAACGCCTAAA 
U4R1 AGGCGTTAATATGCGGGAAACGACGCTGACTCAACCACGGTACGTTAGATGCCTCGCTGTACTAATAGTTGTCGACAGATCGTC 
U5R1 AAAGACGATCTGTCGACAACTATTGGTCGGATCTGAGTCGACCAAAAA 
U6R1 TTGGTCGACTCAGATCCGACCGCTCCATGATACTCAAAGAGCTCGCCCCGAGTCTGGAGTTCAAGGCAATATCCTCAGTAAGTT 
 
Oligonucleotides for Atto488 dye labeling 
U1R2 TGAACTCCAGACTCGGGGCGACAACTCTTCATACATAGAGCAAGGGCGTCGAACGGTCGTGAAAGTCTTAGTACCGCACGTACC 
U2R2 TTCACGACCGTTCGACGCCCTTCGCGAGTTCAGTCATGAGAAATCGCTTGCCCAAGTTGTGAAGTGTCTATCACCCCTAGGCCC 
U3R2 GGGAGCCTGTCTATTCGCCCCGGGCCTAGGGGTGATAGACACGATTGTATCCGCATTTGATGCTACCGTGGTTGAGTCAGCGTC 
U4R2 GCATCAAATGCGGATACAATCGCTCTTAGTCAACTCTACTCACACTGTGCTGCGGCTACCCATCACGTTCGTCGGGTTCACCCG 
U5R2 AGTACAGCGAGGCATCTAACGCGGGTGAACCCGACGAACGTGGGACACACTCGAGCTCCGATCGCTCTTTGAGTATCATGGAGC 
U6R2 GATCGGAGCTCGAGTGTGTCCATTGGACTCATTCAACCATGGGAGGAGATCTTCAACCTTCCCTGCTCTATGTATGAAGAGTTG 
 
Oligonucleotides for Dexamethasone labeling 
U1R3-i-motif GGGAAGGTTGAAGATCTCCTCAAAAAATTCTCATGACTGAACTCGCGACCCTAACCCTAACCCTAACCC 
U3R3-i-motif TTCACAACTTGGGCAAGCGATAAAAAATGAGTAGAGTTGACTAAGAGCCCCTAACCCTAACCCTAACCC 
U5R3-i-motif ATGGGTAGCCGCAGCACAGTGAAAAAACCATGGTTGAATGAGTCCAATCCCTAACCCTAACCCTAACCC 
U1R3-control GGGAAGGTTGAAGATCTCCTCAAAAAATTCTCATGACTGAACTCGCGAAAAAAAAAAAAAAAAAAAA 
U3R3-control TTCACAACTTGGGCAAGCGATAAAAAATGAGTAGAGTTGACTAAGAGCAAAAAAAAAAAAAAAAAAA 
U5R3-control ATGGGTAGCCGCAGCACAGTGAAAAAACCATGGTTGAATGAGTCCAATAAAAAAAAAAAAAAAAAAA 
 
Oligonucleotides for Dexamethasone conjugation 
Dexa i-motif NH2-GGGTTAGGGTTAGGGTTAGGG 
Dexa control NH2-TTTTTTTTTTTTTTTTTTT 
 
 
 
 
 
 
 
 
 
Figure S1. HPLC chromotogram of a single DNA oligonucleotide before and after 
dexamethasone conjugation. The peak shifted to 7.1 min after dexamethasone conjugation. 
 
 
Figure S2. Mass spectrometry analysis of a single oligonucleotide before and after 
dexamethasone conjugation. 
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